Radiation Therapy

Search with Google Search with Bing

Information
Drug Name
Radiation Therapy
Description
Entry(CIViC)
2
CIViC
Disease Mutation EL ET ED CS VO TR Pubmed Links
head and neck squamous cell carcinoma PIK3CA MUTATION PIK3CA MUTATION D Predictive Supports Sensitivity/Response Somatic 3 26589432 Detail
head and neck squamous cell carcinoma CD274 EXPRESSION CD274 EXPRESSION B Predictive Supports Resistance N/A 4 28476872 Detail
Annotation
Description Associated Genes Associated Variants Sensitivity Supported Source Links
A panel of 26 HNSCC cell lines was tested for effi... PIK3CA PIK3CA MUTATION PIK3CA MUTATION Sensitivity true CIViC Evidence detail
Radiation-resistant cell lines exhibited upregulat... CD274 CD274 EXPRESSION CD274 EXPRESSION Resitance or Non-Reponse true CIViC Evidence detail
NCT ID Status Phase Summary Start date Completion date
NCT01920932 Active, not recruiting Phase 2 Adcetris (Brentuximab Vedotin), Combination Chemotherapy, and Radiation Therapy in Treating Younger Patients With Stage IIB, IIIB and IV Hodgkin Lymphoma August 12, 2013 May 2028
NCT01857934 Active, not recruiting Phase 2 Therapy for Children With Advanced Stage Neuroblastoma July 5, 2013 December 2024
NCT02883049 Active, not recruiting Phase 3 Combination Chemotherapy in Treating Young Patients With Newly Diagnosed High-Risk B Acute Lymphoblastic Leukemia and Ph-Like TKI Sensitive Mutations February 29, 2012 September 22, 2024
NCT04052555 Active, not recruiting Phase 1 Testing the Addition of an Anti-cancer Drug, Berzosertib, to the Usual Treatment (Radiation Therapy) for Chemotherapy-Resistant Triple-Negative and Estrogen and/or Progesterone Receptor Positive, HER2 Negative Breast Cancer September 24, 2020 November 20, 2024
NCT03904043 Active, not recruiting N/A Non-Operative Management and Early Response Assessment in Rectal Cancer July 1, 2020 April 30, 2026
NCT01852890 Active, not recruiting Phase 1 Gemcitabine, Ascorbate, Radiation Therapy for Pancreatic Cancer, Phase I January 2014 January 2026
NCT02724579 Active, not recruiting Phase 2 Reduced Craniospinal Radiation Therapy and Chemotherapy in Treating Younger Patients With Newly Diagnosed WNT-Driven Medulloblastoma November 17, 2017 June 30, 2027
NCT03829722 Active, not recruiting Phase 2 Radiotherapy, Carboplatin/Paclitaxel and Nivolumab for High Risk HPV-related Head and Neck Cancer September 5, 2019 September 2024
NCT01849146 Active, not recruiting Phase 1 Adavosertib, Radiation Therapy, and Temozolomide in Treating Patients With Newly Diagnosed or Recurrent Glioblastoma August 19, 2013 March 4, 2025
NCT01847326 Active, not recruiting Phase 1 Paclitaxel Albumin-Stabilized Nanoparticle Formulation and Carboplatin Followed By Chemoradiation in Treating Patients With Recurrent Head and Neck Cancer March 26, 2013 November 4, 2027
NCT03809000 Active, not recruiting Phase 2 A Study of Salvage Radiotherapy With or Without Enzalutamide in Recurrent Prostate Cancer Following Surgery April 15, 2019 September 15, 2029
NCT03313804 Active, not recruiting Phase 2 Priming Immunotherapy in Advanced Disease With Radiation October 26, 2017 February 2025
NCT01796197 Active, not recruiting Phase 2 Paclitaxel + Trastuzumab + Pertuzumab as Pre-Op for Inflammatory BrCa August 2013 July 2024
NCT02698254 Active, not recruiting N/A Radiation Therapy in Treating Patients With Recurrent Brain Tumors Who Have Undergone Previous Radiation Therapy July 20, 2016 July 1, 2025
NCT02679040 Active, not recruiting Phase 2 Histological Response Rate After Mastectomy and Immediate Breast Reconstruction at the End of Neoadjuvant Chemotherapy and Radiotherapy January 27, 2016 February 2025
NCT04047706 Active, not recruiting Phase 1 Nivolumab, BMS-986205, and Radiation Therapy With or Without Temozolomide in Treating Patients With Newly Diagnosed Glioblastoma August 13, 2019 June 1, 2025
NCT02655601 Active, not recruiting Phase 2 Trial of Newly Diagnosed High Grade Glioma Treated With Concurrent Radiation Therapy, Temozolomide and BMX-001 September 25, 2018 December 2024
NCT02641093 Active, not recruiting Phase 2 Phase II Trial of Adjuvant Cisplatin and Radiation With Pembrolizumab in Resected Head and Neck Squamous Cell Carcinoma January 2016 November 2, 2025
NCT04019262 Active, not recruiting Phase 1/Phase 2 Short Course Chemo-Radiation Therapy for Patients With Newly Diagnosed Glioblastoma December 14, 2021 July 2029
NCT04216290 Active, not recruiting Phase 2 A Study of Chemotherapy and Radiation Therapy Compared to Chemotherapy and Radiation Therapy Plus MEDI4736 (Durvalumab) Immunotherapy for Bladder Cancer Which Has Spread to the Lymph Nodes (The INSPIRE Study) March 17, 2021 June 30, 2026
NCT04420975 Active, not recruiting Phase 1 Nivolumab and BO-112 Before Surgery for the Treatment of Resectable Soft Tissue Sarcoma October 29, 2020 January 31, 2026
NCT01752491 Active, not recruiting Phase 1 A Phase I Trial of High-Dose Ascorbate in Glioblastoma Multiforme April 1, 2013 December 31, 2024
NCT04013542 Active, not recruiting Phase 1 Ipilimumab and Nivolumab in Combination With Radiation Therapy in Treating Patients With Stage 2-3 Non-small Lung Cancer September 13, 2019 December 31, 2024
NCT02626312 Active, not recruiting Phase 1 Radiation Therapy in Treating Patients With Hepatocellular Carcinoma, Cholangiocarcinoma, or Liver Metastasis Who Have Impaired Liver Function February 15, 2016 April 28, 2026
NCT01750073 Active, not recruiting Phase 2 Paclitaxel & Cyclophosphamide With or Without Trastuzumab Before Surgery in Treating Previously Untreated Breast Cancer December 7, 2012 June 2026
NCT02615275 Active, not recruiting N/A Bioelectrical Impedance Analysis in Estimating Body Composition in Patients With Stage I-IV Head and Neck Cancer Undergoing Radiation Therapy November 24, 2015 November 30, 2026
NCT01746238 Active, not recruiting Phase 1 Bevacizumab/Doxorubicin/Radiation for Sarcoma March 2013 January 2025
NCT00005584 Active, not recruiting Phase 3 Combination Chemotherapy With or Without Radiation Therapy in Treating Patients With Hodgkin's Lymphoma October 1998
NCT01546987 Active, not recruiting Phase 3 Hormone Therapy, Radiation Therapy, and Steroid 17alpha-monooxygenase TAK-700 in Treating Patients With High-Risk Prostate Cancer May 2012 June 2029
NCT03775265 Active, not recruiting Phase 3 Chemoradiotherapy With or Without Atezolizumab in Treating Patients With Localized Muscle Invasive Bladder Cancer June 3, 2019 June 1, 2027
NCT03738228 Active, not recruiting Phase 1 Atezolizumab Before and/or With Chemoradiotherapy in Immune System Activation in Patients With Node Positive Stage IB2, II, IIIB, or IVA Cervical Cancer January 7, 2019 September 21, 2024
NCT02567435 Active, not recruiting Phase 3 Combination Chemotherapy With or Without Temsirolimus in Treating Patients With Intermediate Risk Rhabdomyosarcoma June 1, 2016 October 1, 2024
NCT03528642 Active, not recruiting Phase 1 Telaglenastat With Radiation Therapy and Temozolomide in Treating Patients With IDH-Mutated Diffuse Astrocytoma or Anaplastic Astrocytoma May 1, 2019 December 5, 2024
NCT03517137 Active, not recruiting Phase 2 Very Early PET-response Adapted Targeted Therapy for Advanced Hodgkin Lymphoma: a Single -Arm Phase II Study August 1, 2019 November 16, 2026
NCT03503630 Active, not recruiting Phase 2 Short-course Radiation Followed by mFOLFOX-6 Plus COMPOUND 2055269 for Locally-advanced Rectal Adenocarcinoma July 20, 2018 July 2, 2024
NCT01517451 Active, not recruiting Phase 1/Phase 2 Radiation and Androgen Ablation for Prostate Cancer May 22, 2013 December 2026
NCT01407198 Active, not recruiting Phase 1 Nilotinib With Radiation for High Risk Chordoma August 2011 December 2025
NCT03307616 Active, not recruiting Phase 2 Nivolumab With and Without Ipilimumab and Radiation Therapy in Treating Patients With Recurrent or Resectable Undifferentiated Pleomorphic Sarcoma or Dedifferentiated Liposarcoma Before Surgery October 4, 2017 October 31, 2025
NCT01368588 Active, not recruiting Phase 3 Androgen-Deprivation Therapy and Radiation Therapy in Treating Patients With Prostate Cancer July 2011 July 2031
NCT02567422 Active, not recruiting Phase 1 Testing the Addition of M6620 (VX-970, Berzosertib) to Usual Chemotherapy and Radiation for Head and Neck Cancer April 17, 2017 April 23, 2025
NCT02525757 Active, not recruiting Phase 2 MPDL3280A With Chemoradiation for Lung Cancer January 26, 2016 January 31, 2026
NCT04396860 Active, not recruiting Phase 2/Phase 3 Testing the Use of the Immunotherapy Drugs Ipilimumab and Nivolumab Plus Radiation Therapy Compared to the Usual Treatment (Temozolomide and Radiation Therapy) for Newly Diagnosed MGMT Unmethylated Glioblastoma September 1, 2020 March 11, 2025
NCT03491683 Active, not recruiting Phase 1/Phase 2 INO-5401 and INO-9012 Delivered by Electroporation (EP) in Combination With Cemiplimab (REGN2810) in Newly-Diagnosed Glioblastoma (GBM) May 31, 2018 December 31, 2024
NCT01272050 Active, not recruiting Phase 3 Radiation Therapy in Treating Patients With Relapsed Prostate Cancer After Surgery January 6, 2011 December 2024
NCT02499367 Active, not recruiting Phase 2 Nivolumab After Induction Treatment in Triple-negative Breast Cancer (TNBC) Patients August 2015 August 2025
NCT00002462 Active, not recruiting Phase 3 RT or No RT Following Chemotherapy in Treating Patients With Stage III/IV Hodgkin's Disease September 1989
NCT03725059 Active, not recruiting Phase 3 Study of Pembrolizumab (MK-3475) Versus Placebo in Combination With Neoadjuvant Chemotherapy & Adjuvant Endocrine Therapy in the Treatment of Early-Stage Estrogen Receptor-Positive, Human Epidermal Growth Factor Receptor 2-Negative (ER+/HER2-) Breast Cancer (MK-3475-756/KEYNOTE-756) December 27, 2018 January 24, 2031
NCT02481635 Active, not recruiting Phase 1/Phase 2 A Study of Gemcitabine/Nab-paclitaxel and Radiation Therapy Followed by Surgery in Patients With Advanced Pancreatic Cancer July 2016 June 2024
NCT03999710 Active, not recruiting Phase 2 Determining Whether Durvalumab in Combination With Radiation Therapy Can Prevent the Progression of Non-Small Cell Lung Cancer July 19, 2019 July 2025
NCT01165632 Active, not recruiting Early Phase 1 Fluorine F 18 Fluorodopa-Labeled PET Scan in Planning Surgery and Radiation Therapy in Treating Patients With Newly Diagnosed High- or Low-Grade Malignant Glioma July 26, 2010 December 30, 2024
NCT03452930 Active, not recruiting Phase 1 Tinostamustine With or Without Radiation Therapy in Treating Patients With Newly Diagnosed MGMT-Unmethylated Glioblastoma August 13, 2018 December 30, 2024
NCT03935256 Active, not recruiting Phase 2 Adjuvant Sequential & Concurrent CarboTaxol + Radiotherapy for High Risk Endometrial Cancer March 5, 2019 December 31, 2024
NCT02466971 Active, not recruiting Phase 3 Testing the Addition of a New Anti-Cancer Drug, Triapine, to the Usual Chemotherapy Treatment (Cisplatin) During Radiation Therapy for Advanced-stage Cervical and Vaginal Cancers May 10, 2016 September 21, 2024
NCT02444741 Active, not recruiting Phase 1/Phase 2 Pembrolizumab and Stereotactic Body Radiation Therapy or Non-Stereotactic Wide-Field Radiation Therapy in Treating Patients With Non-small Cell Lung Cancer September 17, 2015 September 30, 2025
NCT03681535 Active, not recruiting N/A Dose-Reduced Consolidation Radiation Therapy in Patients With Diffuse Large B-cell Lymphoma February 13, 2019 August 2028
NCT02420613 Active, not recruiting Phase 1 Vorinostat and Temsirolimus With or Without Radiation Therapy in Treating Younger Patients With Newly Diagnosed or Progressive Diffuse Intrinsic Pontine Glioma October 5, 2015 October 31, 2024
NCT03916419 Active, not recruiting Phase 2 Magnetic Resonance-Guided Hypofractionated Adaptive Radiation Therapy With Concurrent Chemotherapy and Consolidation Durvalumab for Inoperable Stage IIB, IIIA, and Select IIIB and IIIC Non-small Cell Lung Cancer June 20, 2019 September 30, 2025
NCT03680586 Active, not recruiting Early Phase 1 Ultra Low-Dose Radiation Therapy in Treating Patients With Stage I-IV Stomach MALT Lymphoma February 4, 2019 April 30, 2025
NCT04376502 Active, not recruiting N/A Immune Checkpoint Inhibitor and MR-guided SBRT for Limited Progressive Metastatic Carcinoma. April 8, 2020 December 2024
NCT04183218 Active, not recruiting Characterizing Chemo-Radiotherapy Treatment-Related Cardiac Changes September 23, 2019 September 23, 2025
NCT02402920 Active, not recruiting Phase 1 Pembrolizumab and Concurrent Chemoradiotherapy or Radiation Therapy in Treating Patients With Small Cell Lung Cancer July 22, 2015 July 31, 2025
NCT02352883 Active, not recruiting N/A MRI and Gene Expression in Diagnosing Patients With Ductal Breast Cancer In Situ March 25, 2015 November 2027
NCT00975520 Active, not recruiting N/A Neurotropic Melanoma of the Head and Neck September 2009 March 2023
NCT03581292 Active, not recruiting Phase 2 Veliparib, Radiation Therapy, and Temozolomide in Treating Patients With Newly Diagnosed Malignant Glioma Without H3 K27M or BRAFV600 Mutations November 6, 2018 September 22, 2024
NCT02344355 Active, not recruiting Phase 2 A Phase 2 Trial of High-Dose Ascorbate in Glioblastoma Multiforme March 13, 2017 December 2027
NCT00945009 Active, not recruiting Phase 3 Combination Chemotherapy and Surgery in Treating Young Patients With Wilms Tumor July 13, 2009
NCT05555342 Active, not recruiting Early Phase 1 A Novel Method for Treating Lung Met w/Combo of Electric Fields & Rad Therapy: A Single-Arm January 3, 2023 December 2028
NCT02258659 Active, not recruiting Phase 2 Nab-paclitaxel and Carboplatin Followed by Response-Based Local Therapy in Treating Patients With Stage III or IV HPV-Related Oropharyngeal Cancer September 22, 2014 December 2025
NCT00942357 Active, not recruiting Phase 3 Carboplatin and Paclitaxel With or Without Cisplatin and Radiation Therapy in Treating Patients With Stage I, Stage II, Stage III, or Stage IVA Endometrial Cancer June 29, 2009 July 28, 2024
NCT03422003 Active, not recruiting N/A Study of Radiation Fractionation on Patient Outcomes After Breast REConstruction (FABREC) for Invasive Breast Carcinoma April 1, 2018 April 1, 2030
NCT03306901 Active, not recruiting N/A Chemoradiotherapy Versus Esophagectomy After Endoscopic Resection for Superficial Esophageal Squamous Cell Carcinoma October 20, 2017 December 31, 2033
NCT03279237 Active, not recruiting Phase 1 A Pilot Study of FOLFIRINOX in Combination With Neoadjuvant Radiation for Gastric and GE Junction Cancers October 24, 2017 September 2023
NCT03548285 Active, not recruiting N/A Stereotactic Ablative Radiotherapy for Early-stage Glottic Larynx Cancer May 15, 2018 December 2024
NCT03267498 Active, not recruiting Phase 2 Nivolumab + Chemoradiation in Stage II-IVB Nasopharyngeal Carcinoma (NPC) February 14, 2018 April 30, 2024
NCT00846742 Active, not recruiting Phase 2 Combination Chemotherapy With or Without Radiation Therapy in Treating Young Patients With Favorable-Risk Hodgkin Lymphoma June 5, 2009 October 2028
NCT03228537 Active, not recruiting Phase 1 Atezolizumab, Pemetrexed Disodium, Cisplatin, and Surgery With or Without Radiation Therapy in Treating Patients With Stage I-III Pleural Malignant Mesothelioma July 16, 2018 September 21, 2024
NCT04523818 Active, not recruiting Phase 1 Short-Course Chemoradiotherapy Followed by Chemotherapy for the Treatment of Resectable Gastric Adenocarcinoma August 11, 2020 December 31, 2028
NCT03217747 Active, not recruiting Phase 1/Phase 2 Avelumab, Utomilumab, Anti-OX40 Antibody PF-04518600, and Radiation Therapy in Treating Patients With Advanced Malignancies August 2, 2017 September 30, 2024
NCT00769223 Active, not recruiting Predicting the Risk of Failure in Patients Undergoing Radiation Therapy for Localized Prostate Cancer February 25, 1993 January 31, 2025
NCT03416153 Active, not recruiting Phase 2 Individualized Adaptive De-escalated Radiotherapy for HPV-related Oropharynx Cancer May 21, 2018 May 2024
NCT03414970 Active, not recruiting Phase 3 Hypofractionated Radiation Therapy After Mastectomy in Preventing Recurrence in Patients With Stage IIa-IIIa Breast Cancer March 12, 2018 August 2035
NCT03217266 Active, not recruiting Phase 1 Navtemadlin and Radiation Therapy in Treating Patients With Soft Tissue Sarcoma June 20, 2018 February 28, 2025
NCT04298983 Active, not recruiting Phase 2 Abemaciclib in Combination With Androgen Deprivation Therapy for Locally Advanced Prostate Cancer February 25, 2021 April 2026
NCT00707473 Active, not recruiting Phase 2 Docetaxel, Cisplatin and Fluorouracil in Treating Patients With Previously Untreated Stage II-IV Nasal Cavity and Paranasal Sinus Cancer June 16, 2008 September 30, 2025
NCT04174196 Active, not recruiting Phase 2 A Study of Lenalidomide and CC-486 With Radiation Therapy in Patients With Plasmacytoma November 19, 2019 November 19, 2024
NCT03174197 Active, not recruiting Phase 1/Phase 2 Atezolizumab in Combination With Temozolomide and Radiation Therapy in Treating Patients With Newly Diagnosed Glioblastoma June 30, 2017 June 30, 2025
NCT04484909 Active, not recruiting Phase 1 NBTXR3 Activated by Radiation Therapy for the Treatment of Locally Advanced or Borderline-Resectable Pancreatic Cancer July 1, 2020 December 31, 2026
NCT04522336 Active, not recruiting Phase 1 Pembrolizumab and Chemoradiotherapy for the Treatment of Unresectable Gastroesophageal Cancer September 16, 2020 July 18, 2024
NCT02959463 Active, not recruiting Phase 1 Pembrolizumab After Radiation Therapy in Treating Patients With Pleural Malignant Mesothelioma May 1, 2017 April 30, 2024
NCT00626990 Active, not recruiting Phase 3 Phase III Trial of Anaplastic Glioma Without 1p/19q Loss of Heterozygosity (LOH) December 2007 December 2029
NCT02186847 Active, not recruiting Phase 2 Chemotherapy and Radiation Therapy With or Without Metformin Hydrochloride in Treating Patients With Stage III Non-small Cell Lung Cancer August 2014 April 16, 2025
NCT02180867 Active, not recruiting Phase 2/Phase 3 Radiation Therapy With or Without Combination Chemotherapy or Pazopanib Before Surgery in Treating Patients With Newly Diagnosed Non-rhabdomyosarcoma Soft Tissue Sarcomas That Can Be Removed by Surgery July 11, 2014 December 22, 2024
NCT02177292 Active, not recruiting N/A High-Dose Lymph Node Intensity Modulated Radiation Therapy and Hypofractionated Prostate (SIB) June 23, 2010 December 2026
NCT02954874 Active, not recruiting Phase 3 Testing MK-3475 (Pembrolizumab) as Adjuvant Therapy for Triple Receptor-Negative Breast Cancer January 18, 2017 May 31, 2026
NCT00554788 Active, not recruiting Phase 3 Combination Chemotherapy, Autologous Stem Cell Transplant, and/or Radiation Therapy in Treating Young Patients With Extraocular Retinoblastoma February 4, 2008 December 31, 2024
NCT00066690 Active, not recruiting Phase 3 Suppression of Ovarian Function With Either Tamoxifen or Exemestane Compared With Tamoxifen Alone in Treating Premenopausal Women With Hormone-Responsive Breast Cancer December 17, 2003 December 2025
NCT03410901 Active, not recruiting Phase 1 TLR9 Agonist SD-101, Anti-OX40 Antibody BMS 986178, and Radiation Therapy in Treating Patients With Low-Grade B-Cell Non-Hodgkin Lymphomas April 9, 2018 October 10, 2024
NCT02114229 Active, not recruiting Phase 2 Phase 2 Study of Alisertib Therapy for Rhabdoid Tumors May 14, 2014 September 2027
NCT04220229 Active, not recruiting Phase 1/Phase 2 Cabozantinib With Radiation Therapy for the Treatment of Sarcomas of the Extremities June 1, 2020 January 23, 2027
NCT04481204 Active, not recruiting Phase 2 New and Emerging Therapies for the Treatment of Resectable, Borderline Resectable, or Locally Advanced Pancreatic Cancer, PIONEER-Panc Study April 18, 2023 April 6, 2025
NCT02112916 Active, not recruiting Phase 3 Combination Chemotherapy With or Without Bortezomib in Treating Younger Patients With Newly Diagnosed T-Cell Acute Lymphoblastic Leukemia or Stage II-IV T-Cell Lymphoblastic Lymphoma October 4, 2014 September 22, 2024
NCT04581382 Active, not recruiting Early Phase 1 Radiation Therapy, Plasma Exchange, and Immunotherapy (Pembrolizumab or Nivolumab) for the Treatment of Melanoma December 14, 2020 October 31, 2024
NCT00544414 Active, not recruiting Phase 2 Chemotherapy Followed by Surgery, Chemotherapy, and Radiation Therapy in Treating Patients With Locally Advanced Head And Neck Cancer June 7, 2000 December 30, 2024
NCT00508443 Active, not recruiting Phase 1/Phase 2 Evaluation of a Novel CT-On-Rails or Trilogy Stereotactic Spine Radiotherapy System (SSRS) October 25, 2002 October 31, 2026
NCT00476190 Active, not recruiting Phase 2 ALL Adult Consortium Trial: Adult ALL Trial April 2007 December 2024
NCT03907488 Active, not recruiting Phase 3 Immunotherapy (Nivolumab or Brentuximab Vedotin) Plus Combination Chemotherapy in Treating Patients With Newly Diagnosed Stage III-IV Classic Hodgkin Lymphoma August 29, 2019 April 1, 2025
NCT02101853 Active, not recruiting Phase 3 Blinatumomab in Treating Younger Patients With Relapsed B-cell Acute Lymphoblastic Leukemia December 17, 2014 September 22, 2024
NCT02037048 Active, not recruiting Phase 2 FOLFOX-6 Induction Chemotherapy Followed by Esophagectomy and Post-operative Chemoradiotherapy in Patients With Esophageal Adenocarcinoma February 10, 2014 October 1, 2025
NCT00411138 Active, not recruiting Phase 3 Randomized Trial of Radiation Therapy With or Without Chemotherapy for Endometrial Cancer November 23, 2006 December 31, 2024
NCT02023463 Active, not recruiting Phase 1 Enzalutamide, Radiation Therapy and Hormone Therapy in Treating Patients With Intermediate or High-Risk Prostate Cancer April 2, 2014 January 1, 2040
NCT02923778 Active, not recruiting Phase 2 Talimogene Laherparepvec and Radiation Therapy in Treating Patients With Newly Diagnosed Soft Tissue Sarcoma That Can Be Removed by Surgery December 31, 2019 December 1, 2024
NCT00408005 Active, not recruiting Phase 3 Combination Chemotherapy in Treating Young Patients With Newly Diagnosed T-Cell Acute Lymphoblastic Leukemia or T-cell Lymphoblastic Lymphoma January 22, 2007 March 7, 2025
NCT03410043 Active, not recruiting Phase 2 Osimertinib, Surgery, and Radiation Therapy in Treating Patients With Stage IIIB or IV Non-small Cell Lung Cancer With EGFR Mutations, NORTHSTAR Study January 17, 2018 June 1, 2025
NCT01972919 Active, not recruiting Phase 2 Magnetic Resonance (MR) Guided, Dose-Escalated Radiation Therapy (RT) + Chemotherapy in Pancreatic Cancer December 10, 2015 December 2024
NCT04460937 Active, not recruiting Phase 1 Testing the Addition of an Anti-cancer Drug, Adavosertib, to Radiation Therapy for Patients With Incurable Esophageal and Gastroesophageal Junction Cancers April 9, 2021 October 31, 2024
NCT00392327 Active, not recruiting Phase 3 Chemotherapy and Radiation Therapy in Treating Young Patients With Newly Diagnosed, Previously Untreated, High-Risk Medulloblastoma/PNET March 26, 2007 January 30, 2025
NCT05108428 Active, not recruiting Early Phase 1 Adaptive Radiation for Locally Advanced Rectal Adenocarcinoma December 23, 2021 October 2026
NCT00379041 Active, not recruiting Phase 3 Radiation Therapy With or Without Combination Chemotherapy in Treating Patients With Previously Untreated Stage I or Stage II Hodgkin's Lymphoma September 1, 1993
NCT00335816 Active, not recruiting Phase 2 Radiation Therapy and Fluorouracil With or Without Combination Chemotherapy Followed by Surgery in Treating Patients With Stage II or Stage III Rectal Cancer August 2008 December 2024
NCT00077285 Active, not recruiting Phase 2 Irinotecan and Carboplatin as Upfront Window Therapy in Treating Patients With Newly Diagnosed Intermediate-Risk or High-Risk Rhabdomyosarcoma October 2003 October 2024
NCT03359954 Active, not recruiting Phase 2 Radiation Therapy Before Surgery in Treating Patients With Hormone Receptor Positive, HER2 Negative Breast Cancer November 16, 2017 October 31, 2025
NCT03532295 Active, not recruiting Phase 2 Retifanlimab and Epacadostat in Combination With Radiation and Bevacizumab in Patients With Recurrent Gliomas April 20, 2020 April 25, 2026
NCT00334815 Active, not recruiting Phase 2 Combination Chemotherapy, Radiation Therapy, and Bevacizumab in Treating Patients With Newly Diagnosed Stage III Non-small Cell Lung Cancer That Cannot Be Removed by Surgery June 15, 2006 February 22, 2025
NCT05190315 Active, not recruiting Phase 1 Chlorpromazine and Standard of Care in Glioblastoma January 28, 2022 July 2024
NCT04580771 Active, not recruiting Phase 2 A Vaccine (PDS0101) and Chemoradiation for the Treatment of Stage IB3-IVA Cervical Cancer, the IMMUNOCERV Trial October 14, 2020 March 8, 2025
NCT04575922 Active, not recruiting Phase 2 Nivolumab+Ipilimumab+RT in MSS mCRC October 5, 2020 June 2024
NCT00310180 Active, not recruiting Phase 3 Hormone Therapy With or Without Combination Chemotherapy in Treating Women Who Have Undergone Surgery for Node-Negative Breast Cancer (The TAILORx Trial) April 7, 2006 September 30, 2030
NCT00182728 Active, not recruiting N/A Radiation Therapy During Surgery in Treating Older Women With Invasive Breast Cancer March 18, 2003 July 2, 2027
NCT00107198 Active, not recruiting Phase 2 Treating Young Patients With Newly Diagnosed, Low Stage, Lymphocyte Predominant Hodgkin Disease January 2, 2006 December 31, 2030
NCT04905316 Active, not recruiting Phase 2 A Study of Canakinumab With Chemotherapy, Radiation Therapy, and Durvalumab in People With Lung Cancer May 21, 2021 May 2025
NCT06110195 Active, not recruiting Phase 1 Study of Xevinapant With Radiation and Chemotherapy for Patients With Head and Neck Cancer January 24, 2024 October 2027
NCT02888743 Active, not recruiting Phase 2 Durvalumab and Tremelimumab With or Without High or Low-Dose Radiation Therapy in Treating Patients With Metastatic Colorectal or Non-small Cell Lung Cancer August 14, 2017 January 2, 2025
NCT00085735 Active, not recruiting Phase 3 Comparison of Radiation Therapy Regimens in Combination With Chemotherapy in Treating Young Patients With Newly Diagnosed Standard-Risk Medulloblastoma April 2004
NCT05320406 Active, not recruiting Phase 4 RElugolix VErsus LeUprolide Cardiac Trial June 6, 2022 January 30, 2026
NCT00003375 Completed Phase 2/Phase 3 Observation or Radiation Therapy With or Without Combination Chemotherapy in Treating Patients With Low-Grade Glioma October 1998 May 14, 2018
NCT00003377 Completed Phase 1 Radiation Therapy, Paclitaxel, and Cisplatin in Treating Patients With Cancer of the Cervix November 1999 July 2009
NCT00003379 Completed Phase 1/Phase 2 Radiation Therapy Plus Paclitaxel and Cisplatin in Treating Patients With Cervical Cancer November 1999
NCT00003387 Completed Phase 3 Carboplatin, Paclitaxel, and Radiation Therapy in Treating Patients With Stage III Non-small Cell Lung Cancer That Cannot Be Removed During Surgery July 1998 April 2009
NCT00003388 Completed Phase 2 Combination Chemotherapy in Treating Patients With AIDS-Related Lymphoma July 26, 1999
NCT00003396 Completed Phase 2 Peripheral Stem Cell Transplantation in Treating Patients With Hematologic Cancer September 1998 December 2002
NCT00003398 Completed Phase 4 Bone Marrow Transplantation in Treating Patients With Hematologic Cancer September 1998 May 2000
NCT00003409 Completed Phase 1 Motexafin Gadolinium Plus Radiation Therapy in Treating Patients With Newly Diagnosed Glioblastoma Multiforme July 1998
NCT00003411 Completed Phase 1 Radiation Therapy in Treating Patients With Bile Duct, Gallbladder, or Pancreatic Cancer November 1998 June 2002
NCT00003414 Completed Phase 3 Graft-Versus-Host Disease in Treating Patients With Recurrent or Refractory Lymphoma or Hodgkin's Disease October 1997 May 2004
NCT00003417 Completed Phase 1/Phase 2 Computer Planned Radiation Therapy Plus Chemotherapy in Treating Patients With Glioblastoma Multiforme September 1998
NCT00003421 Completed Phase 3 Combination Chemotherapy in Treating Patients With Advanced Hodgkin's Disease June 1998 November 2005
NCT00003422 Completed Phase 3 Radiation Therapy Before Surgery Compared With Chemotherapy Plus Radiation After Surgery in Treating Patients With Rectal Cancer That Can Be Surgically Removed January 1998 June 2010
NCT00003426 Completed Phase 1 Gemcitabine Plus Radiation Therapy in Treating Patients With Pancreatic Cancer April 1998 March 2002
NCT00003444 Completed Phase 3 Interferon Alfa-2b With or Without Radiation Therapy in Treating Patients With Melanoma That Has Metastasized to Lymph Nodes in the Neck, Under the Arm, or in the Groin March 29, 1999
NCT00003464 Completed Phase 2 Temozolomide in Treating Adults With Newly Diagnosed Primary Malignant Glioblastoma Multiforme September 1997 August 2003
NCT00003478 Completed Phase 1/Phase 2 Radiolabeled Monoclonal Antibody Therapy in Treating Patients With Primary Brain Tumors October 1997 July 2007
NCT00003541 Completed Phase 1/Phase 2 Combination Chemotherapy, Radiation Therapy, and Peripheral Stem Cell Transplantation in Treating Patients With Stage III or Stage IV Mantle Cell Lymphoma June 1998 July 2006
NCT00003546 Completed Phase 2 Gemcitabine Plus Radiation Therapy in Treating Patients With Pancreatic Cancer September 1998 January 2006
NCT00003572 Completed Phase 2 Total-Body Irradiation, Tacrolimus, and Mycophenolate Mofetil Plus Bone Marrow Transplantation in Treating Patients With Hematologic Cancers August 1998 April 2002
NCT00003573 Completed Phase 2 Etoposide Plus Radiation Therapy Followed by Combination Chemotherapy in Treating Children With Newly Diagnosed Advanced Medulloblastoma November 1998 March 2008
NCT00003576 Completed Phase 3 Surgery and Radiation Therapy Compared With Chemotherapy and Radiation Therapy in Treating Patients With Stage III or Stage IV Head and Neck Cancer That Can Be Removed During Surgery January 1997 August 2005
NCT00003577 Completed Phase 3 Combination Chemotherapy With or Without Epirubicin in Treating Women With Stage I or Stage II Breast Cancer March 1996 September 2008
NCT00003580 Completed Phase 2 Amifostine to Treat Side Effects of Treatment in Patients Receiving Radiation Therapy and Cisplatin for Advanced Head and Neck Cancer June 1998 May 2004
NCT00003582 Completed Phase 1/Phase 2 Radiation Therapy, Combination Chemotherapy, and Amifostine in Treating Patients With Head and Neck Cancer May 1988 December 1996
NCT00003591 Completed Phase 2 Radiation Therapy Plus Paclitaxel in Treating Patients With Nonmetastatic, Unresectable Pancreatic Cancer November 1998 October 2005
NCT00003596 Completed Phase 3 Chemotherapy Plus Radiation Therapy in Treating Patients With Stage II or Stage III Anal Cancer October 1998 December 2016
NCT00003606 Completed Phase 3 Combination Chemotherapy in Treating Patients With Extensive Stage Small Cell Lung Cancer March 1996 June 2001
NCT00003607 Completed Phase 3 Radiation Therapy in Treating Patients With Stage I, Stage II, or Stage III Prostate Cancer December 1997 January 2015
NCT00003610 Completed Phase 3 Capsaicin Lozenges in Treating Patients With Mucositis Caused by Radiation Therapy October 1998 July 2006
NCT00003621 Completed Phase 2 Combination Chemotherapy Plus Radiation Therapy in Treating Patients With Anaplastic Astrocytoma February 1999 July 2005
NCT00003625 Completed Phase 1 Combination Chemotherapy Plus Radiation Therapy in Treating Patients With Newly Diagnosed Brain Stem Glioma December 1998 April 2006
NCT00003627 Completed Phase 3 Radiation Therapy With or Without Combination Chemotherapy in Treating Patients With Advanced Cancer of the Oropharynx or Hypopharynx October 1998 January 2011
NCT00003631 Completed Phase 2 Chemotherapy Plus Radiation Therapy in Treating Patients With Refractory or Relapsed Hodgkin's Lymphoma August 1998
NCT00003650 Completed Phase 3 Combination Chemotherapy in Treating Children With Non-Hodgkin's Lymphoma February 1997 November 2013
NCT00003652 Completed Phase 3 Combination Chemotherapy Plus Radiation Therapy in Treating Patients With Stage II or Stage III Anal Cancer January 4, 1999 March 31, 2007
NCT00003661 Completed Phase 2 Chemotherapy, Radiation Therapy, and Umbilical Cord Blood Transplantation in Treating Patients With Hematologic Cancer June 1998 March 2006
NCT00003662 Completed Phase 2 Umbilical Cord Blood Transplantation in Treating Patients With Hematologic Cancer or Other Hematologic or Metabolic Diseases August 1998 January 2001
NCT00003667 Completed Phase 2 Combination Chemotherapy and Biological Therapy in Treating Patients With High-Risk Ewing's Sarcoma September 1998 August 2000
NCT00003685 Completed Phase 3 Radiation Therapy to Relieve Symptoms in Patients With Non-small Cell Lung Cancer August 1, 1997 February 10, 2009
NCT00003704 Completed Phase 1 Chemotherapy Plus Radiation Therapy in Treating Patients With Unresectable, Residual, or Recurrent Colorectal Cancer April 1999 July 2003
NCT00003749 Completed Phase 3 Surgery With or Without Lymphadenectomy and Radiation Therapy in Treating Patients With Endometrial Cancer April 1998 December 2008
NCT00003751 Completed Phase 2 Penicillamine, Low Copper Diet, and Radiation Therapy in Treating Patients With Glioblastoma March 1999 July 2005
NCT00003783 Completed Phase 2 Combination Chemotherapy in Treating Children With Very High Risk Acute Lymphocytic Leukemia March 1999 March 2007
NCT00003798 Completed Phase 1 Radiation Therapy Plus Gadolinium Texaphyrin in Treating Patients With Cancer of the Pancreas That Cannot Be Removed by Surgery April 2000
NCT00003799 Completed Phase 1 Chemotherapy, Radiation Therapy, and Surgery in Treating Patients With Locally Advanced Rectal Cancer May 1999
NCT00003812 Completed Phase 2 Chemotherapy Plus Radiation Therapy in Treating Patients With Limited-Stage Small Cell Lung Cancer March 1999 March 2006
NCT00003846 Completed Phase 2 Radiation Therapy, Chemotherapy, and Peripheral Stem Cell Transplantation in Treating Patients With Primitive Neuroectodermal Tumors July 1999 March 2007
NCT00003857 Completed Phase 3 Radiation Therapy With or Without Optional Tamoxifen in Treating Women With Ductal Carcinoma in Situ December 1999 May 20, 2022
NCT00003859 Completed Phase 3 Surgery Plus Radiation Therapy With or Without Chemotherapy in Treating Children With Primitive Neuroectodermal Tumors of the CNS April 1992 April 2003
NCT00003862 Completed Phase 2 Chemotherapy and Radiation Therapy in Treating Patients With Stomach Cancer November 1999
NCT00003868 Completed Phase 2 Radiolabeled Monoclonal Antibody, Cyclophosphamide, and Total Body Irradiation Followed By Donor Stem Cell Transplantation in Treating Patients With Advanced Acute Myeloid Leukemia February 1999 March 2005
NCT00003870 Completed Phase 2 Monoclonal Antibody Therapy, Cyclophosphamide, and Total-Body Irradiation Followed by Peripheral Stem Cell Transplantation in Treating Patients With Advanced Recurrent Acute Lymphocytic Leukemia February 1999 November 2001
NCT00003888 Completed Phase 3 Combination Chemotherapy Plus Radiation Therapy in Treating Patients With Advanced Head and Neck Cancer April 1999 March 2015
NCT00003893 Completed Phase 3 Adjuvant Chemotherapy Plus Radiation Therapy in Treating Women With Early-Stage Breast Cancer July 1998 April 2006
NCT00003909 Completed Phase 1 Motexafin Gadolinium Plus Radiation Therapy in Treating Children With Newly Diagnosed Brain Stem Glioma August 1999
NCT00003913 Completed Phase 2 Umbilical Cord Blood Transplantation in Treating Patients With Hematologic Cancer or Nonmalignant Hematologic Disease December 1998 August 2005
NCT00003916 Completed Phase 3 Standard Radiation Therapy With or Without Stereotactic Radiation Therapy in Treating Patients With Glioma April 1999
NCT00003930 Completed Phase 1/Phase 2 Radiation Therapy and Combination Chemotherapy in Treating Patients With Stage II or Stage III Bladder Cancer September 1999 November 2013
NCT00003935 Completed Phase 1 Combination Chemotherapy Plus Radiation Therapy in Treating Children With Newly Diagnosed Brain Stem Glioma September 1999 March 2007
NCT00003953 Completed Phase 2 Chemotherapy Followed by Surgery in Treating Women With Stage II or Stage III Breast Cancer February 1999 January 2013
NCT00003955 Completed Phase 2 Combination Chemotherapy Plus Radiation Therapy in Treating Patients With Metastatic Rhabdomyosarcoma or Sarcoma September 1999 October 2009
NCT00003958 Completed Phase 3 Combination Chemotherapy in Treating Patients With Previously Untreated Rhabdomyosarcoma September 2002
NCT00003972 Completed Phase 3 Combination Chemotherapy and Peripheral Stem Cell Transplantation in Treating Patients With Stage II or Stage IIIA Breast Cancer July 1998 March 2003
NCT00003996 Completed Phase 2 Combination Chemotherapy Plus Radiation Therapy in Treating Patients With Newly Diagnosed Glioblastoma Multiforme May 1999 May 2008
NCT00004005 Completed Phase 2 Irinotecan Followed By Fluorouracil and Leucovorin in Treating Patients With Stage III or Stage IV Colorectal Carcinoma (Cancer), Other Refractory Carcinoma, or Metastatic Adenoma (Cancer) of Unknown Primary Origin September 1998 October 2005
NCT00004006 Completed Phase 2 Combination Chemotherapy, Radiation Therapy, and Bone Marrow Transplantation in Treating Patients With Retinoblastoma November 1997 September 2005
NCT00004010 Completed Phase 2 Combination Chemotherapy and Radiation Therapy in Treating Children With Previously Untreated Stage II, Stage III, or Stage IV Hodgkin's Disease October 1999 June 2008
NCT00004024 Completed Phase 2 Biological Therapy Following Surgery and Radiation Therapy in Treating Patients With Primary or Recurrent Astrocytoma or Oligodendroglioma June 1997 January 2004
NCT00004031 Completed Phase 3 SWOG-9704 Chemoradiotherapy and Peripheral Stem Cell Transplantation Compared With Combination Chemotherapy in Treating Patients With Non-Hodgkin's Lymphoma July 1997 October 31, 2013
NCT00004054 Completed Phase 3 Hormone Therapy Plus Radiation Therapy With or Without Combination Chemotherapy in Treating Patients With Prostate Cancer January 2000 November 2013
NCT00004061 Completed Phase 2 Biological Therapy in Treating Patients Undergoing Radiation Therapy, Chemotherapy, and Peripheral Stem Cell Transplantation for Hematologic Cancer May 1999 December 2009
NCT00004068 Completed Phase 2 Irinotecan Followed by Radiation Therapy and Temozolomide in Treating Children With Newly Diagnosed Brain Tumor March 1999 April 2003
NCT00004073 Completed Phase 2 Suramin Plus Radiation Therapy in Treating Patients With Newly Diagnosed Glioblastoma Multiforme December 1999 June 2004
NCT00004089 Completed Phase 2 Chemotherapy Plus Radiation Therapy in Treating Patients With Previously Untreated Thyroid Cancer August 1999 April 2002
NCT00004125 Completed Phase 3 Combination Chemotherapy in Treating Women With Stage II or Stage IIIA Breast Cancer That Has Spread to the Lymph Nodes November 16, 1999 November 2016
NCT00004132 Completed Phase 2 Growth Factor to Prevent Oral Mucositis in Patients With Hematologic Cancer January 2000 May 2004
NCT00004146 Completed Phase 2 Carboxyamidotriazole + RT in Treating Patients Newly Diagnosed Supratentorial GBM March 2000 January 2010
NCT00004160 Completed Phase 1/Phase 2 Chemotherapy Plus Radiation Therapy in Treating Patients With Stage III Non-small Cell Lung Cancer That Cannot Be Surgically Removed February 2000 May 2004
NCT00004169 Completed Phase 2 Chemotherapy, Radiation Therapy, and Peripheral Stem Cell Transplantation in Treating Patients With Hodgkin's Disease November 1993 January 2007
NCT00004172 Completed Phase 2 Chemotherapy, Filgrastim, and Stem Cell Transplantation With Radiation Therapy in Treating Patients With Stage III or Stage IV Breast Cancer October 1999 October 2003
NCT00004174 Completed Phase 1 Combination Chemotherapy Followed By Peripheral Stem Cell Transplantation in Treating Patients With Advanced Breast Cancer October 1999 May 2008
NCT00004176 Completed Phase 2 Amifostine, Chemotherapy, and Radiation Therapy in Treating Patients With Limited-Stage Small Cell Lung Cancer October 1998 February 2001
NCT00004181 Completed Phase 2 Bone Marrow Transplantation in Treating Patients With Multiple Myeloma, Chronic Phase Chronic Myelogenous Leukemia, or Agnogenic Myeloid Metaplasia October 1999 August 2004
NCT00004186 Completed Phase 1/Phase 2 Combination Chemotherapy in Treating Patients With Small Cell Lung Cancer December 1996 December 2004
NCT00004188 Completed Phase 3 Combination Chemotherapy and Peripheral Stem Cell Transplantation in Treating Patients With Neuroblastoma February 2001
NCT00004202 Completed Phase 2 Combination Chemotherapy, Radiation Therapy, and RSR13 in Treating Patients With Stage III Non-small Cell Lung Cancer October 1998 January 2003
NCT00004224 Completed Phase 2 Combination Chemotherapy Followed by Radiation Therapy in Treating Children With Localized Ependymoma January 1999 March 2008
NCT00004225 Completed Phase 1 Gene Therapy Plus Radiation Therapy in Treating Patients With Non-Small Cell Lung Cancer January 2000
NCT00004228 Completed Phase 3 Combination Chemotx in Treating Children or Adolescents With Newly Diagnosed Stg III or Stg IV Lymphoblastic Lymphoma June 2000 March 31, 2015
NCT00004230 Completed Phase 3 Captopril in Treating Patients Undergoing Bone Marrow or Stem Cell Transplantation October 1999 March 2002
NCT00004234 Completed Phase 3 Oral Mucositis in Patients Receiving Radiation Therapy for Cancer of the Mouth, Pharynx, or Larynx August 2, 1999 February 10, 2009
NCT00004237 Completed Phase 2 Comparison of Three Combination Chemotherapy Regimens in Treating Women With Stage I or Stage II Breast Cancer October 1998 September 2005
NCT00004255 Completed Phase 2/Phase 3 Treatment of Bone Marrow to Prevent Graft-Versus-Host Disease in Patients With Acute or Chronic Leukemia Undergoing Bone Marrow Transplantation March 2000 May 2003
NCT00004256 Completed Phase 2 Sargramostim to Prevent Mucositis in Patients Receiving Radiation Therapy for Laryngeal Cancer October 1997 July 2006
NCT00004257 Completed Phase 1 Oxaliplatin and Fluorouracil Plus Radiation Therapy in Treating Patients With Primary Esophageal or Stomach Cancer January 2000 January 2004
NCT00004259 Completed Phase 3 Radiation Therapy Combined With Chemotherapy in Treating Patients With Anaplastic Astrocytoma or Mixed Gliomas June 2000 May 14, 2018
NCT00004891 Completed N/A PET and CT Scans in Patients With Locally Advanced Primary Rectal Cancer That Can Be Removed During Surgery September 1999
NCT00004896 Completed Phase 2 Busulfan and Cyclophosphamide Followed by Bone Marrow Transplantation in Treating Patients With Acute Myelogenous Leukemia or Myelodysplastic Syndrome October 1999 August 2004
NCT00004898 Completed Phase 1/Phase 2 Radiation Therapy and Chemotherapy Plus Peripheral Stem Cell Transplantation in Treating Patients With High-Grade Lymphoma or Acute Lymphoblastic Leukemia October 1999 July 2003
NCT00004900 Completed Phase 2 Chemotherapy Plus Peripheral Stem Cell Transplantation in Treating Women With Metastatic Breast Cancer October 1999 August 2004
NCT00004901 Completed Phase 1/Phase 2 Combination Chemotherapy Plus Radiation Therapy in Treating Patients With Advanced Mouth Cancer October 1999 July 2004
NCT00004905 Completed Phase 2 Combination Chemotherapy Plus Peripheral Stem Cell Transplantation in Treating Patients With Chronic Myelogenous Leukemia or Acute Leukemia October 1999 September 2004
NCT00004907 Completed Phase 1/Phase 2 Chemotherapy and Radiation Therapy Plus Bone Marrow or Peripheral Stem Cell Transplantation in Treating Patients With Relapsed or Refractory T-cell Lymphoma, Hodgkin's Lymphoma, or Non-Hodgkin's Lymphoma October 1999 August 2004
NCT00004908 Completed Phase 2 Radiation Therapy and Cyclophosphamide Plus Peripheral Stem Cell Transplantation in Treating Patients With Recurrent or Refractory Hodgkin's Disease or Non-Hodgkin's Lymphoma November 1999 June 2002
NCT00004917 Completed Phase 3 Radiation Therapy With or Without Epoetin Alfa in Treating Anemic Patients With Head and Neck Cancer June 2000 December 2016
NCT00005022 Completed Phase 1 Radiation Therapy Plus Combination Chemotherapy in Treating Patients With Small Cell Lung Cancer February 1998 June 2010
NCT00005044 Completed Phase 3 Hormone Therapy and Radiation Therapy in Treating Patients With Prostate Cancer February 2000 May 20, 2022
NCT00005062 Completed Phase 3 Radiation Therapy in Patients With Limited-Stage Small Cell Lung Cancer in Complete Remission September 1999 December 2005
NCT00005065 Completed Phase 1 Chemotherapy, Radiation Therapy, and Surgery in Treating Patients With Stage IIIA Non-small Cell Lung Cancer January 2000
NCT00005087 Completed Phase 2 Paclitaxel, Cisplatin, and Filgrastim Combined With Radiation Therapy in Treating Patients With Locally Recurrent Head and Neck Cancer March 2000 November 2013
NCT00005088 Completed Phase 2 Radiation Therapy and Cisplatin in Treating Patients With Advanced Head and Neck Cancer April 2000
NCT00005089 Completed Phase 2 S0014 Combination Chemotherapy Plus Rituximab and Radiation Therapy in Treating Patients With Stage I or Stage II Non-Hodgkin's Lymphoma April 2000 April 2014
NCT00005578 Completed Phase 3 Combination Chemotherapy With or Without Dexrazoxane in Treating Children With Hodgkin's Disease March 1997 June 2008
NCT00005583 Completed Phase 3 Radiation Therapy With or Without Chemotherapy in Treating Patients With High-Risk Endometrial Cancer January 2000 July 2010
NCT00005587 Completed Phase 3 Radiation Therapy After Surgery in Treating Women With Early Stage Breast Cancer January 1999 June 2004
NCT00005588 Completed Phase 3 Radiation Therapy After Surgery in Treating Women With Early Stage Breast Cancer January 1999 December 2004
NCT00005602 Completed Phase 1 Radiation Therapy Plus Carboplatin and Lobradimil in Treating Children With Newly Diagnosed Brain Stem Gliomas February 2001 September 2005
NCT00005615 Completed Phase 1/Phase 2 Post-Operative Adjuvant Radiotherapy With Concurrent Interferon-Alfa July 1997 December 2005
NCT00005638 Completed Phase 1 Combination Chemotherapy Plus Radiation Therapy in Treating Patients With Esophageal Cancer October 1999 April 2004
NCT00005801 Completed Phase 2 Total-Body Irradiation Plus Stem Cell Transplantation And White Blood Cell Infusion in Treating Older Patients With Acute Myeloid Leukemia November 1999 September 2001
NCT00005802 Completed Phase 1/Phase 2 Chemotherapy Followed by Donor White Blood Cells Plus Interleukin-2 in Treating Patients With Acute Myeloid or Lymphocytic Leukemia June 1999 March 2005
NCT00005804 Completed Phase 2 Bone Marrow Transplantation in Treating Patients With Hematologic Cancer October 1999 August 2002
NCT00005814 Completed Phase 2 Cetuximab, Cisplatin, and Radiation Therapy in Treating Patients With Advanced Stage III or Stage IV Head and Neck Cancer December 1999 October 2005
NCT00005822 Completed Phase 1 SU5416 and Doxorubicin in Treating Patients With Stage IIIB or Stage IV Inflammatory Breast Cancer April 2000 October 2003
NCT00005830 Completed Phase 1 Combination Chemotherapy Plus Radiation Therapy in Treating Patients With Stage III or Stage IV Endometrial Cancer July 2000
NCT00005838 Completed Phase 3 Combination Chemotherapy Plus Radiation Therapy With or Without AE-941 in Treating Patients With Stage III Non-small Cell Lung Cancer That Cannot Be Removed By Surgery March 2000
NCT00005840 Completed Phase 1 Combination Chemotherapy Plus Radiation Therapy in Treating Patients With Stage III or Stage IV Endometrial Cancer July 2000
NCT00005854 Completed Phase 2 Bone Marrow Transplantation in Treating Patients With Hematologic Cancer December 1999 October 2000
NCT00005866 Completed Phase 3 S9920 Busulfan Compared With Cyclophosphamide in Patients Undergoing Total-Body Irradiation Plus Peripheral Stem Cell Transplantation for Advanced Myelodysplastic Syndrome or Related Acute Myeloid Leukemia February 2000 March 2006
NCT00005887 Completed Phase 3 Radiation Therapy With or Without RSR13 in Treating Patients With Brain Metastases February 2000 January 2003
NCT00005926 Completed Phase 2 Gemcitabine, Herceptin and Radiation to Treat Cancer of the Pancreas June 2000 December 2000
NCT00005941 Completed Phase 2 Peripheral Stem Cell Transplant, White Blood Cell Infusions, Chemotherapy, and Radiation Therapy in Treating Patients With Recurrent Metastatic Cervical or Vaginal Cancer November 1999 June 2005
NCT00005945 Completed Phase 3 Comparison of Different Combination Chemotherapy Regimens in Treating Children With Acute Lymphoblastic Leukemia June 2000 June 2008
NCT00005978 Completed Phase 1 N99-01: Combination Chemotherapy, Radiation Therapy, and Stem Cell Transplantation in Treating Patients With Neuroblastoma May 2000
NCT00005985 Completed Phase 2 Filgrastim and Chemotherapy Followed by Peripheral Stem Cell Transplant in Treating Patients With Hodgkin's Lymphoma or Non-Hodgkin's Lymphoma August 2000 February 2007
NCT00005988 Completed Phase 1 Bone Marrow Transplantation With Specially Treated Bone Marrow in Treating Patients With Hematologic Cancer That Have Not Responded to Previous Therapy February 2000 March 8, 2002
NCT00006012 Completed Phase 1/Phase 2 Combination Chemotherapy and Radiation Therapy in Treating Patients With Limited-Stage Small Cell Lung Cancer February 2001 May 2006
NCT00006027 Completed Phase 3 Comparison of Radiation Therapy With or Without Combination Chemotherapy Following Surgery in Treating Patients With Stage I or Stage II Endometrial Cancer August 2000
NCT00006042 Completed Phase 1 Cyclophosphamide Plus Bone Marrow Transplantation in Treating Patients With Hematologic Cancer December 1999
NCT00006051 Completed Phase 2 Combination Chemotherapy Plus Radiation Therapy in Treating Patients With Head and Neck Cancer February 1999 September 2005
NCT00006107 Completed Phase 1 Chemotherapy and Radiation Therapy in Treating Patients With Stage III or Stage IV Head and Neck Cancer July 14, 2000 July 3, 2004
NCT00006111 Completed Phase 2 Surgery Plus Combination Chemotherapy and Radiation Therapy in Treating Patients With Cancer of the Urinary Tract April 1999 June 2008
NCT00006231 Completed Phase 3 Radiation Therapy in Preventing Metastatic Cancer in Patients Who Have Diagnostic Procedures to Identify Malignant Mesothelioma February 1998 December 2002
NCT00006233 Completed Phase 2 Combination Chemotherapy, Total-Body Irradiation, Peripheral Stem Cell Transplantation, and Lymphocyte Infusion in Treating Patients With Stage IV Melanoma January 2000 December 2003
NCT00006241 Completed Phase 2 Peripheral Stem Cell Transplantation in Treating Patients With Relapsed Low- or Intermediate-Grade Non-Hodgkin's Lymphoma March 2000 October 2000
NCT00006256 Completed Phase 2 Paclitaxel Plus Radiation Therapy in Treating Women With Stage II or Stage III Breast Cancer June 8, 2000 November 20, 2023
NCT00006258 Completed Phase 2 Combination Chemotherapy Followed by Radiation Therapy in Treating Patients With Medulloblastoma, Supratentorial Primitive Neuroectodermal Tumor, or Ependymoma November 1997 January 2005
NCT00006353 Completed Phase 3 Radiation Therapy With or Without Temozolomide in Treating Patients With Newly Diagnosed Glioblastoma Multiforme July 2000
NCT00006355 Completed Phase 1/Phase 2 Pyrazoloacridine Followed by Radiation Therapy in Treating Adults With Newly Diagnosed Supratentorial Glioblastoma Multiforme May 2000 October 2006
NCT00006359 Completed Phase 2 Androgen Suppression Plus Radiation Therapy in Treating Patients With Prostate Cancer September 2000 March 2012
NCT00006360 Completed Phase 1/Phase 2 Radiation Therapy in Treating Patients With Stage II or Stage III Oropharyngeal Cancer February 2001 December 2016
NCT00006365 Completed Phase 2 External-Beam Radiation Therapy Plus Implanted Radiation Therapy in Treating Patients With Prostate Cancer November 2000 November 2013
NCT00006366 Completed Phase 2 Radiation Therapy Plus Chemotherapy Followed by Surgery in Treating Patients With Locally Advanced Cancer of the Rectum February 2001
NCT00006378 Completed Phase 2 Combination Chemotherapy Plus Radiation Therapy in Treating Patients With Stage III Non-small Cell Lung Cancer December 1999 April 2003
NCT00006386 Completed Phase 2 Radiation Therapy Followed by Carmustine in Treating Patients Who Have Supratentorial Glioblastoma Multiforme March 2001 February 2009
NCT00006388 Completed Phase 2 Radiation Therapy and Tamoxifen in Treating Adults With Newly Diagnosed Supratentorial Glioblastoma Multiforme December 2000
NCT00006390 Completed Phase 2 Alemtuzumab Plus Peripheral Stem Cell Transplantation in Treating Patients With Chronic Lymphocytic Leukemia July 5, 2001
NCT00006452 Completed Phase 1 Gadolinium Texaphyrin Plus Radiation Therapy in Treating Patients With Supratentorial Glioblastoma Multiforme April 10, 2002 March 16, 2004
NCT00006469 Completed Phase 2 Combination Chemotherapy and Radiation Therapy Followed By Surgery in Treating Patients With Stage IIB or Stage IIIA Non-Small Cell Lung Cancer August 1999 January 30, 2006
NCT00006470 Completed Phase 2 Vaccine Therapy Plus Radiation Therapy in Treating Patients With Non-small Cell Lung Cancer That Has Been Completely Removed in Surgery March 2001
NCT00006481 Completed Phase 3 Biafine Cream to Reduce Side Effects of Radiation Therapy in Patients Receiving Treatment for Advanced Head and Neck Cancer October 2000
NCT00006487 Completed Phase 1 S0004: Combination Chemotherapy Plus Radiation Therapy in Treating Patients With Limited-stage Small Cell Lung Cancer October 2000 July 2004
NCT00006734 Completed Phase 3 Comparison of Combination Chemotherapy Regimens in Treating Patients With Ewing's Sarcoma or Neuroectodermal Tumor May 2001 June 30, 2023
NCT00007904 Completed Phase 2 Adjuvant Stage 2-3A Breast Cancer With Positive Lymph Nodes July 2000 September 2012
NCT00008151 Completed Phase 2 Gemtuzumab Ozogamicin, Fludarabine, and Total-body Irradiation Followed by Peripheral Stem Cell or Bone Marrow Transplantation in Treating Patients With Advanced Acute Myeloid Leukemia or Myelodysplastic Syndrome October 2000 July 2002
NCT00008398 Completed Phase 3 Sargramostim in Decreasing Mucositis in Patients Receiving Radiation Therapy for Head and Neck Cancer October 2000
NCT00009880 Completed Phase 2 Combination Chemotherapy Plus Radiation Therapy With or Without Fluorouracil in Treating Patients With Cancer of the Esophagus or Stomach April 2001
NCT00010036 Completed Phase 2 Carboplatin Plus Irinotecan in Treating Patients With Glioblastoma Multiforme May 1999
NCT00010166 Completed Phase 2 Gemcitabine and Radiation Therapy in Treating Patients With Cancer of the Pancreas December 1, 2000 October 3, 2003
NCT00010244 Completed Phase 3 Comparison of Radiation Therapy Regimens in Treating Patients With Localized Prostate Cancer September 1999 March 2018
NCT00011778 Completed Phase 1 PS-341 and Radiation to Treat Advanced Cancer of the Head and Neck February 22, 2001 February 8, 2013
NCT00011960 Completed Phase 2 Chemotherapy and Radiation Therapy With or Without Fluorouracil in Treating Patients With Cancer of the Stomach Who Have Undergone Surgery May 2001
NCT00011999 Completed Phase 2 Chemotherapy and Radiation Therapy Following Surgery in Treating Patients With Head and Neck Cancer March 2001 June 2010
NCT00012051 Completed Phase 3 Chemotherapy and Peripheral Stem Cell Transplant With or Without Monoclonal Antibody Therapy in Treating Patients With Non-Hodgkin's Lymphoma September 2000 October 2007
NCT00014118 Completed Phase 2 Chemotherapy and Radiation Therapy in Treating Patients With Stage III or Stage IV Larynx or Oropharynx Cancer June 6, 2001 May 2009
NCT00014612 Completed Phase 3 Comparison of Complete Axillary Lymph Node Dissection With Axillary Radiation Therapy in Treating Women With Invasive Breast Cancer February 2001 March 2013
NCT00016211 Completed Phase 3 Radiation Therapy to Prevent Brain Metastases in Patients With Previously Treated Extensive-Stage Small Cell Lung Cancer February 2001
NCT00016302 Completed N/A Combination Chemotherapy in Treating Patients With Newly Diagnosed Acute Lymphoblastic Leukemia April 2001
NCT00016315 Completed Phase 1 Gemcitabine, Carboplatin or Paclitaxel Plus Radiation Therapy in Treating Patients With Stage IIIA or IIIB Non-Small Cell Lung Cancer May 2001 June 2010
NCT00016913 Completed Phase 2 Chemotherapy, Hormone Therapy, and Radiation Therapy in Treating Patients With Locally Advanced Prostate Cancer May 2001 May 2008
NCT00017095 Completed Phase 3 Biomarker (p53 Gene) Analysis and Combination Chemotherapy Followed by Radiation Therapy and Surgery in Treating Women With Large Operable or Locally Advanced or Inflammatory Breast Cancer March 2001
NCT00017147 Completed Phase 3 S0001 RT and Carmustine With or Without O6BG in Patients With New Glioblastoma Multiforme or Gliosarcoma September 2001 November 2012
NCT00017225 Completed Phase 2 Chemotherapy and Radiation Therapy With or Without Peripheral Stem Cell Transplantation in Treating Patients With Neuroblastoma May 1997 February 2002
NCT00017368 Completed Phase 2 Combination Chemotherapy Plus Peripheral Stem Cell Transplantation in Treating Children With Newly Diagnosed Neuroblastoma April 2001 January 2012
NCT00018954 Completed Phase 2 Chemotherapy in Treating Patients With Acute Lymphoblastic Leukemia and Diffuse Non-Hodgkin's Lymphoma October 1992 October 2002
NCT00019058 Completed Phase 1 Radiation Therapy in Treating Patients With Glioblastoma April 1995
NCT00019071 Completed Phase 1 Chemotherapy Followed by Radiation Therapy in Treating Patients With Malignant Glioma March 1995
NCT00020709 Completed Phase 3 Combination Chemotherapy and Radiation Therapy With or Without Gefitinib in Treating Patients With Stage III Non-Small Cell Lung Cancer That Cannot Be Removed By Surgery June 2001
NCT00020891 Completed Phase 2 CT Scans in Guiding the Treatment of Patients With Prostate Cancer Who Are Undergoing Radiation Therapy March 2001
NCT00021125 Completed Phase 3 Radiation Therapy in Treating Patients With Head and Neck Cancer July 2000 June 2007
NCT00021320 Completed Phase 2 Combination Chemotherapy Plus Radiation Therapy in Treating Patients With Esophageal Cancer May 2000 April 2009
NCT00021333 Completed Phase 2 Paclitaxel and Cisplatin Plus Radiation Therapy Followed by Filgrastim in Treating Patients With Recurrent Head and Neck Cancer or Lung Cancer September 1999 May 2008
NCT00021398 Completed Phase 2 Radiation Therapy and Chemotherapy Followed by Surgery and Combination Chemotherapy in Treating Patients With Rectal Cancer July 1996 September 2018
NCT00021450 Completed Phase 3 Radiation Therapy With or Without Bicalutamide and Goserelin in Treating Patients With Prostate Cancer April 2001 January 2016
NCT00022126 Completed Phase 2 Combination Chemotherapy With or Without Donor Bone Marrow Transplantation in Treating Infants With Previously Untreated Acute Lymphoblastic Leukemia November 2002 April 2006
NCT00022139 Completed Phase 2 Radiation Therapy and Paclitaxel, Carboplatin, and Fluorouracil Followed by Esophagectomy in Treating Patients With Locally Advanced Cancer of the Esophagus or Gastroesophageal Junction January 2002 January 2009
NCT00022256 Completed Phase 2 Motexafin Gadolinium Plus Radiation Therapy to the Brain in Treating Patients With Newly Diagnosed Glioblastoma Multiforme April 2001 April 2003
NCT00022308 Completed Phase 1 Chemotherapy and Radiation Therapy in Treating Patients With Non-Small Cell Lung Cancer January 1999 September 2006
NCT00022737 Completed Phase 3 Combination Chemotherapy With or Without Peripheral Stem Cell Transplant in Treating Children With Acute Lymphoblastic Leukemia October 2002
NCT00023660 Completed Phase 1/Phase 2 Radiation Therapy Plus Celecoxib, Fluorouracil, and Cisplatin in Patients With Locally Advanced Cervical Cancer August 2001
NCT00023725 Completed Phase 1/Phase 2 Radiation Therapy With or Without SU5416 in Treating Patients With Soft Tissue Sarcoma August 2001 October 2003
NCT00023738 Completed Phase 1/Phase 2 Chemotherapy, SU5416, Radiation Therapy, and Surgery in Treating Patients With Soft Tissue Sarcoma August 2001 October 2003
NCT00023751 Completed Phase 2 Surgery With or Without Chemotherapy and Radiation Therapy in TreatingPatients With Stage I Rectal Cancer July 2001 April 2004
NCT00023829 Completed Phase 3 Adjuvant Radiation Therapy Plus Hormone Therapy Compared With Radiation Therapy Alone in Treating Patients With Stage II or Stage III Prostate Cancer August 2001 June 2004
NCT00023959 Completed Phase 1 Bevacizumab, Fluorouracil, and Hydroxyurea Plus Radiation Therapy in Treating Patients With Advanced Head and Neck Cancer July 2001
NCT00023998 Completed Phase 2 Chemotherapy With or Without Trastuzumab in Treating Patients With Metastatic Osteosarcoma July 2001 May 2007
NCT00024349 Completed Phase 3 Radiation Therapy With or Without Chemotherapy in Treating Patients With Stage II or Stage III Bladder Cancer June 2001 April 2012
NCT00025038 Completed Phase 2 Combination Chemotherapy Followed By Donor Bone Marrow or Umbilical Cord Blood Transplant in Treating Children With Newly Diagnosed Juvenile Myelomonocytic Leukemia June 2001
NCT00025077 Completed Phase 2 Combination Chemotherapy, Surgery or Radiation Therapy, and Peripheral Stem Cell Transplant in Treating Patients With Recurrent Medulloblastoma or Primitive Neuroectodermal and Pineal Tumors January 2000 April 2011
NCT00025090 Completed Phase 3 Radiation Therapy Plus Fluorouracil With or Without Additional Chemotherapy in Treating Patients With Primary Anal Cancer March 2001 August 2007
NCT00025168 Completed Phase 2 Combination Chemotherapy Plus Radiation Therapy in Treating Patients With Locally Advanced Unresectable Pancreatic Cancer November 1, 2001 August 29, 2003
NCT00025272 Completed Phase 2 Combination Chemotherapy in Treating Patients With Extensive-Stage Small Cell Lung Cancer November 1, 2001 January 18, 2005
NCT00025441 Completed Phase 2 Combination Chemotherapy in Treating Children With Metastatic Rhabdomyosarcoma or Other Malignant Mesenchymal Tumors November 1998 March 2010
NCT00025480 Completed Phase 1 Tipifarnib Plus Radiation Therapy After Combination Chemotherapy in Treating Patients With Stage III Non-Small Cell Lung Cancer August 2001
NCT00025545 Completed Phase 2 Filgrastim-Treated Donor Peripheral Stem Cell Transplantation in Treating Patients With Acute Leukemia</p> March 1996 October 2002
NCT00026104 Completed Phase 2 Combination Chemotherapy Plus Radiation Therapy With or Without Tipifarnib in Treating Patients With Locally Advanced Pancreatic Cancer November 2001
NCT00026130 Completed Phase 2 Combination Chemotherapy and Radiation Therapy in Treating Patients With Pancreatic Cancer September 2001 June 2010
NCT00026377 Completed Phase 1 SU5416 Plus Hormone Therapy and Radiation Therapy in Treating Patients With Prostate Cancer November 2001 April 2003
NCT00026403 Completed Phase 2 Combination Chemotherapy Plus Radiation Therapy in Treating Patients With Advanced Pancreatic Cancer September 2001 July 2009
NCT00027547 Completed Phase 1/Phase 2 Combination Chemotherapy and Total-Body Irradiation Followed by Peripheral Stem Cell or Bone Marrow Transplantation in Treating Patients With Acute Lymphoblastic Leukemia July 2001 July 2004
NCT00027612 Completed Phase 1/Phase 2 Irinotecan Plus Radiation Therapy Followed By Chemotherapy in Treating Patients With Glioblastoma Multiforme July 2002 July 2009
NCT00027846 Completed Phase 2 Observation or Radiation Therapy and/or Chemotherapy and Second Surgery in Treating Children Who Have Undergone Surgery for Ependymoma August 2003 March 31, 2016
NCT00027885 Completed Phase 2 Phase II Bevacizumab + Tax In Advanced Breast Cancer November 2001 August 2010
NCT00028665 Completed Phase 2 Cyclophosphamide W/or W/Out Rituximab and Peripheral Stem Cell Transplantation in Patients With Recurrent Non-Hodgkin's Lymphoma June 2000
NCT00028678 Completed Phase 2 Dalteparin and Radiation Therapy in Treating Patients With Newly Diagnosed Supratentorial Glioblastoma Multiforme July 11, 2002 June 2007
NCT00028730 Completed Phase 2 Total-Body Irradiation and Chemotherapy Followed By Donor Bone Marrow Transplant in Treating Young Patients With Hematologic Cancer August 2001 June 2008
NCT00028795 Completed Phase 2 Chemotherapy and Radiation Therapy After Surgery in Treating Children With Newly Diagnosed Astrocytoma, Glioblastoma Multiforme, Gliosarcoma, or Diffuse Intrinsic Pontine Glioma December 2002 March 2012
NCT00028938 Completed Phase 3 Chemotherapy and Radiation Therapy With or Without Epoetin Alfa in Treating Patients With Stage IIIA or Stage IIIB Non-Small Cell Lung Cancer January 1, 2002 November 10, 2002
NCT00030628 Completed Phase 3 Radiosurgery With or Without Whole-Brain Radiation Therapy in Treating Patients With Brain Metastases December 2001 October 2014
NCT00030680 Completed Phase 2 Radiation Therapy in Treating Patients With Aggressive Fibromatoses November 2001 March 2012
NCT00031668 Completed N/A Radiation Therapy in Relapsed or Refractory Non-Hodgkin's Lymphoma Who Have Undergone Stem Cell Transplantation January 31, 2001 February 10, 2009
NCT00031785 Completed Phase 3 Megestrol in Treating Patients Who Are Undergoing Radiation Therapy for Lung Cancer September 1, 2000 September 11, 2002
NCT00031967 Completed Phase 2 Melatonin and Radiation Therapy in Treating Patients With Brain Metastases May 2002
NCT00032006 Completed Phase 2 Hormone Therapy Followed By Internal Radiation Therapy in Treating Patients With Locally Recurrent Prostate Cancer February 2002 October 2003
NCT00032032 Completed Phase 1 Combination Chemotherapy Plus Radiation Therapy in Treating Patients With Non-Small Cell Lung Cancer May 2002 January 2010
NCT00032097 Completed Phase 1 Motexafin Gadolinium in Treating Patients With Glioblastoma Multiforme Who Are Undergoing Radiation Therapy to the Brain April 2002
NCT00033254 Completed Phase 3 Radiation Therapy With or Without Thalidomide in Treating Patients With Brain Metastases March 2002
NCT00033280 Completed Phase 2 Temozolomide Plus Radiation Therapy in Treating Patients With Newly Diagnosed Anaplastic Oligodendrogliomas or Mixed Anaplastic Oligoastrocytomas July 2002 May 14, 2018
NCT00033410 Completed Phase 1 Chemotherapy, Tirapazamine, and Radiation Therapy in Treating Patients With Non-Small Cell Lung Cancer March 2002
NCT00033436 Completed Phase 3 Radiation Therapy With or Without Carbogen and Niacinamide in Treating Patients With Bladder Cancer October 2000 November 2008
NCT00033553 Completed Phase 2 Combination Chemotherapy and Computer-Planned Radiation Therapy in Treating Patients With Unresectable Stage III Non-Small Cell Lung Cancer March 2002 June 2010
NCT00033657 Completed Phase 2 Radiation Therapy and Chemotherapy Before and After Surgery in Treating Patients With Esophageal Cancer August 15, 2002 October 2009
NCT00033696 Completed Phase 2 Combination Chemotherapy and Radiation Therapy in Treating Patients With Limited-Stage Small Cell Lung Cancer September 2001 April 2009
NCT00039195 Completed Phase 2 Chemotherapy and Rituximab With or Without Total-Body Irradiation and Peripheral Stem Cell Transplant in Treating Patients With Lymphoma November 2006 January 2010
NCT00039351 Completed Phase 2 Combination Chemotherapy in Treating Older Patients With Non-Hodgkin's Lymphoma March 2002
NCT00040365 Completed Phase 2 Amifostine to Protect the Rectum During External Beam Radiotherapy for Prostate Cancer June 2002 June 2011
NCT00040482 Completed Phase 2 High Dose Chemo/Radiotherapy and Hematopoietic Stem Cell Transplant for Patients With Multiple Sclerosis April 1999 August 2005
NCT00040690 Completed Phase 2 Combination Chemotherapy in Treating Patients With Burkitt's Lymphoma or Burkitt's Leukemia November 2008 December 2008
NCT00040794 Completed Phase 2 Combination Chemotherapy, Radiation Therapy, and Gefitinib in Treating Patients With Stage III Non-Small Cell Lung Cancer May 2002
NCT00040872 Completed Phase 2 Multiple Therapies in Treating Patients With Advanced Neuroblastoma June 2000 January 2007
NCT00042367 Completed N/A Study of Systemic and Spinal Chemotherapy Followed by Radiation for Infants With Brain Tumors April 4, 2000 June 2006
NCT00042991 Completed Phase 1/Phase 2 Gefitinib and Radiation Therapy in Treating Children With Newly Diagnosed Gliomas July 2002 March 2010
NCT00043108 Completed Phase 2 Combination Chemotherapy, Surgery, and Radiation Therapy in Treating Patients With Non-Small Cell Lung Cancer July 2002 February 2018
NCT00044954 Completed Phase 2 Total-Body Irradiation, Fludarabine, and Peripheral Stem Cell Transplantation in Treating Patients With Hematologic Cancer November 1999 November 2006
NCT00045565 Completed Phase 1 Arsenic Trioxide Plus Radiation Therapy in Treating Patients With Newly Diagnosed Malignant Glioma October 2002
NCT00046839 Completed Phase 1/Phase 2 Celecoxib and Radiation Therapy in Treating Patients With Locally Advanced Non-Small Cell Lung Cancer July 2002
NCT00046969 Completed Phase 4 Epoetin Beta in Treating Anemia in Patients With Cervical Cancer July 2002 June 2007
NCT00047099 Completed Phase 3 Combination Chemotherapy in Treating Women With Breast Cancer August 2001 March 2012
NCT00047112 Completed Phase 3 Surgery With or Without Radiation Therapy and Chemotherapy in Treating Patients With Esophageal Cancer May 2002 September 2010
NCT00047125 Completed Phase 3 Radiation Therapy in Treating Patients With Metastases to the Lymph Nodes in the Neck From an Unknown Primary Tumor July 2002
NCT00047320 Completed Phase 2 Neoadjuvant Chemotherapy With or Without Second-Look Surgery Followed by Radiation Therapy With or Without Peripheral Stem Cell Transplantation in Treating Patients With Intracranial Germ Cell Tumors January 2004 February 2009
NCT00048997 Completed Phase 3 Radiation Therapy in Preventing Central Nervous System (CNS) Metastases in Patients With Non-Small Cell Lung Cancer September 2002 December 2016
NCT00049283 Completed Phase 1 Erlotinib, Docetaxel, and Radiation Therapy in Treating Patients With Locally Advanced Head and Neck Cancer September 2002 February 2008
NCT00049348 Completed Phase 2 Chemotherapy and Radiation Therapy in Treating Patients With Locally Advanced Pancreatic Cancer October 13, 2003 May 2009
NCT00049361 Completed Phase 2 Radiation Therapy Plus Thalidomide and Temozolomide in Treating Patients With Newly Diagnosed Brain Metastases January 1, 2004 December 7, 2004
NCT00049387 Completed Phase 1 Tipifarnib, Temozolomide, and Radiation Therapy in Treating Patients With Newly Diagnosed Glioblastoma Multiforme or Gliosarcoma September 2002 June 2007
NCT00052208 Completed Phase 1/Phase 2 Gefitinib and Radiation Therapy in Treating Patients With Glioblastoma Multiforme March 2002
NCT00052351 Completed Phase 2 Vaccine Therapy Plus Sargramostim and Chemotherapy in Treating Women With Stage II or Stage III Breast Cancer September 2002 October 2007
NCT00052429 Completed Phase 1/Phase 2 High-Dose Radiation Therapy Plus Chemotherapy in Treating Patients With Advanced Nose or Throat Cancer September 2002 November 2010
NCT00052910 Completed Phase 3 Chemotherapy and Radiation Therapy After Surgery in Treating Patients With Stomach or Esophageal Cancer December 2002 December 2016
NCT00052923 Completed Phase 3 Stem Cell Transplantation With or Without Rituximab in Treating Patients With Relapsed or Progressive B-Cell Diffuse Large Cell Lymphoma March 2003
NCT00052936 Completed Phase 3 Combination Chemotherapy With or Without Rituximab in Treating Older Patients With Non-Hodgkin's Lymphoma January 2001 August 5, 2010
NCT00053183 Completed Phase 1 Surgery Followed by Radiation Therapy in Treating Patients With Newly Diagnosed Glioblastoma Multiforme October 2003
NCT00053768 Completed Phase 3 Combination Chemotherapy Followed By Radiation Therapy in Treating Patients With Aggressive Non-Hodgkin's Lymphoma April 2002 December 5, 2006
NCT00053898 Completed Phase 3 Anastrozole or Tamoxifen in Treating Postmenopausal Women With Ductal Carcinoma in Situ Who Are Undergoing Lumpectomy and Radiation Therapy January 2003 May 2016
NCT00054054 Completed Phase 2 S0216, Combination Chemotherapy and RT in Treating Patients With Stage III or Stage IV Head and Neck Cancer April 2003
NCT00054327 Completed Phase 2 Donor Stem Cell Transplant in Treating Patients With Hematologic Cancer November 2000 September 2011
NCT00055601 Completed Phase 2 Combination Chemotherapy and Radiation Therapy With/Without Surgery In Patients With Stage II/III Bladder Cancer December 2002 May 14, 2018
NCT00055653 Completed Phase 2 Donor Umbilical Cord Blood Transplantation in Treating Patients With Leukemia, Lymphoma, or Nonmalignant Hematologic Disorders January 2003 September 2005
NCT00055731 Completed Phase 3 Hormone Therapy With or Without Docetaxel And Estramustine in Treating Patients With Prostate Cancer That is Locally Advanced or At High Risk of Relapse November 14, 2002 December 31, 2022
NCT00055835 Completed Phase 2 S0121, Neoadjuvant Carboplatin, Paclitaxel, and Gemcitabine Followed by Cisplatin and Radiation Therapy in Treating Patients With Locally Advanced or Recurrent Carcinoma of the Urothelium November 2002 June 2006
NCT00057876 Completed Phase 3 Gemcitabine With or Without Radiation Therapy in Treating Patients With Pancreatic Cancer August 29, 2003 May 2009
NCT00058097 Completed Phase 2 Tipifarnib and Radiation Therapy in Treating Patients With Newly Diagnosed Glioblastoma Multiforme August 2003
NCT00058370 Completed N/A Intrathecal Radioimmunotherapy, Radiation Therapy, and Chemotherapy After Surgery in Treating Patients With Medulloblastoma February 2003 June 2019
NCT00059761 Completed Phase 1 Chemotherapy Combined With Radiation Therapy in Treating Patients With Limited-Stage Small Cell Lung Cancer March 2003 November 2013
NCT00059826 Completed Phase 2 Adjuvant Chemoradiotherapy and Interferon Alfa in Treating Patients With Resected Pancreatic Cancer March 2003 February 2011
NCT00060255 Completed Phase 2 High-Dose Chemotherapy, Total-Body Irradiation, and Autologous Stem Cell Transplantation or Bone Marrow Transplantation in Treating Patients With Hematologic Cancer or Solid Tumors December 1991 February 2013
NCT00060333 Completed Phase 2 Adjuvant Radiation Therapy in Treating Patients With Resected Desmoplastic Melanoma July 2003 April 2016
NCT00061893 Completed Phase 2 Vinblastine, Celecoxib, and Combination Chemotherapy in Treating Patients With Newly-Diagnosed Metastatic Ewing's Sarcoma Family of Tumors April 2004 December 2013
NCT00062140 Completed Phase 1 Total-Body Irradiation, Cyclophosphamide, and Stem Cell Transplantation in Treating Patients With Hematologic Cancer April 2003 July 2004
NCT00062270 Completed Phase 1/Phase 2 Neoadjuvant Chemoradiotherapy With or Without Gefitinib in Treating Patients With Stage IIIA or Stage IIIB Non-Small Cell Lung Cancer May 2003 September 2004
NCT00062309 Completed Phase 3 Comparison of Two Radiation Therapy Regimens in Treating Patients With Stage II or Stage III Prostate Cancer June 2002
NCT00062322 Completed Phase 1 Neoadjuvant Chemoradiotherapy Followed By Surgery in Treating Patients With Limited-Stage Small Cell Lung Cancer February 2003 October 2009
NCT00062439 Completed Phase 2 S0220: Chemoradiotherapy Followed By Surgery and Docetaxel in Treating Patients With Pancoast Tumors July 2003 December 2010
NCT00063947 Completed Phase 1 Erlotinib, Gemcitabine, and Radiation Therapy in Treating Patients With Locally Advanced Unresectable Pancreatic Cancer May 2003
NCT00064207 Completed Phase 2/Phase 3 Gemcitabine and Radiation Therapy Compared With Gemcitabine Alone in Treating Patients Who Have Undergone Surgery for Pancreatic Cancer May 2003
NCT00066222 Completed Phase 2 Cisplatin, Etoposide, and Radiation Therapy in Treating Patients With Limited-Stage Small Cell Lung Cancer June 2003 November 2013
NCT00066742 Completed Phase 2 Tirapazamine Combined With Chemo and RT in Limited-Stage Small Cell Lung Cancer September 2003 August 2009
NCT00067015 Completed Phase 3 Radiation Therapy With or Without Bicalutamide and Goserelin in Treating Patients With Prostate Cancer May 2003 September 2008
NCT00068250 Completed Phase 1/Phase 2 Combination Chemotherapy, Monoclonal Antibody, and Radiation Therapy in Treating Patients With Primary Central Nervous System Lymphoma July 2003 December 2016
NCT00068263 Completed Phase 1/Phase 2 3-Dimensional Conformal Radiation Therapy In Treating Women With Stage I or Stage II Breast Cancer Previously Treated With Lumpectomy and Axillary Node Dissection August 2003 December 2016
NCT00068549 Completed Phase 1 Radiation Therapy Plus Cisplatin and Gemcitabine in Treating Patients With Cervical Cancer October 2003
NCT00068575 Completed Phase 2 Chemotherapy, Interferon Alfa, and Radiation Therapy in Treating Patients Who Have Undergone Surgery For Pancreatic Cancer May 2002 December 2010
NCT00069953 Completed Phase 2 Combination Chemotherapy Followed By Chemoradiotherapy, With or Without Surgery, in Treating Patients With Resectable Locally Advanced Cancer of the Esophagus or Gastroesophageal Junction September 2003 December 2016
NCT00070018 Completed Phase 2 S0313 Cyclophosphamide, Doxorubicin, Vincristine, Prednisone, and Radiation Therapy Followed By Rituximab and Yttrium Y 90 Ibritumomab Tiuxetan in Treating Patients With Stage I or Stage II Non-Hodgkin's Lymphoma February 2004 January 8, 2015
NCT00070200 Completed Phase 1 Induction Chemotherapy Using Cyclophosphamide and Topotecan in Treating Patients Who Are Undergoing Autologous Peripheral Stem Cell Transplantation for Newly Diagnosed or Progressive Neuroblastoma March 2004 December 2013
NCT00072527 Completed Phase 2 Cisplatin and Irinotecan Followed by Carboplatin, Etoposide, and Radiation Therapy in Treating Patients With Limited-Stage Small Cell Lung Cancer November 2003 January 2013
NCT00074152 Completed Phase 3 Adjuvant Chemotherapy in Treating Women Who Have Undergone Resection for Relapsed Breast Cancer; Chemotherapy as Adjuvant for LOcally Recurrent Breast Cancer July 2002 August 22, 2016
NCT00075582 Completed Phase 3 Vincristine, Dactinomycin, and Cyclophosphamide With or Without Radiation Therapy in Treating Patients With Newly Diagnosed Low-Risk Rhabdomyosarcoma September 4, 2004 September 30, 2021
NCT00075725 Completed Phase 3 Dexamethasone Compared With Prednisone During Induction Therapy and Methotrexate With or Without Leucovorin During Maintenance Therapy in Treating Patients With Newly Diagnosed High-Risk Acute Lymphoblastic Leukemia December 29, 2003 March 31, 2021
NCT00077051 Completed Phase 1 Cytochlor and Tetrahydrouridine as Radiosensitizers and Cisplatin Combined With Radiation Therapy in Treating Patients With Advanced Squamous Cell Carcinoma of the Oral Cavity (Mouth) or Oropharynx (Throat) April 2004 July 2007
NCT00077116 Completed Phase 2 Idarubicin, Cytarabine, and Gemtuzumab Ozogamicin in Treating Patients With Previously Untreated High-Risk Myelodysplastic Syndrome or Acute Myeloid Leukemia Secondary to Myelodysplastic Syndrome November 2003
NCT00077519 Completed Phase 1 Tipifarnib and Radiation Therapy in Treating Patients With Unresectable Locally Advanced Pancreatic Cancer January 2004 December 31, 2019
NCT00079339 Completed Phase 1/Phase 2 Tipifarnib and Radiation Therapy in Treating Young Patients With Brainstem Glioma January 2004 November 2009
NCT00079417 Completed Phase 3 Neoadjuvant Carboplatin and Vincristine and Standard Local Ophthalmic Therapy in Treating Patients With Intraocular Retinoblastoma December 26, 2005 March 31, 2017
NCT00080912 Completed N/A Single vs Multiple-Fraction Therapy in Treating Patients With Previously Irradiated Painful Bone Metastases January 22, 2004 January 16, 2014
NCT00080938 Completed Phase 2 Temozolomide and Radiation Therapy in Treating Patients With Brain Metastasis Secondary to Non-Small Cell Lung Cancer December 20, 2005 February 2009
NCT00081289 Completed Phase 2 Neoadjuvant Chemoradiotherapy and Adjuvant Chemotherapy in Treating Patients Who Are Undergoing Surgical Resection for Locally Advanced Rectal Cancer March 2004 December 2016
NCT00081302 Completed Phase 2 Cetuximab, Paclitaxel, Carboplatin, and Radiation Therapy in Treating Patients With Unresectable Stage IIIA or Stage IIIB Non-Small Cell Lung Cancer March 2004 November 2013
NCT00083057 Completed Phase 1 Gefitinib, Paclitaxel, and Radiation Therapy in Treating Patients With Advanced or Recurrent Squamous Cell Carcinoma of the Head and Neck May 2004 November 2010
NCT00084318 Completed Phase 2 Adjuvant Cetuximab and Chemoradiotherapy Using Either Cisplatin or Docetaxel in Treating Patients With Resected Stage III or Stage IV Squamous Cell Carcinoma or Lymphoepithelioma of the Head and Neck April 2004 December 2016
NCT00002459 Completed Phase 3 Radiation Therapy or No Further Treatment Following Surgery in Treating Patients With Cancer of the Uterus April 1988
NCT00002461 Completed Phase 2 Combination Chemotherapy Followed by Bone Marrow or Peripheral Stem Cell Transplantation in Treating Patients With Refractory Hodgkin's Disease or Non-Hodgkin's Lymphoma April 1988 July 1991
NCT00002466 Completed Phase 2 Combination Chemotherapy and Radiation Therapy in Treating Patients With Peripheral Neuroectodermal Tumors, Ewing's Sarcoma, Wilms' Tumor, or Bone Cancer May 1990 May 2005
NCT00002472 Completed Phase 2 Cisplatin and Etoposide Prior to Radiation Therapy in Treating Patients With CNS Tumors March 1991 August 2005
NCT00002476 Completed Phase 3 Radiation Therapy With or Without Chemotherapy in Treating Patients With Advanced Head and Neck Cancer January 1990 January 2010
NCT00002480 Completed Phase 1 Radiation Therapy in Treating Patients With Prostate Cancer February 1991 August 2005
NCT00002484 Completed Phase 1 Radiation Therapy Using 3-Dimensional Treatment Planning in Patients With Non-small Cell Lung Cancer October 1991
NCT00002490 Completed Phase 3 Radiation Therapy, Chemotherapy, or Observation in Treating Patients With Bladder Cancer September 1991
NCT00002492 Completed Phase 2 Combination Chemotherapy in Treating Patients With Soft Tissue Sarcoma November 1991 February 2000
NCT00002507 Completed Phase 3 Radiation Therapy and Chemotherapy in Treating Patients With Head and Neck Cancer November 1992 October 2002
NCT00002510 Completed Phase 1/Phase 2 Chemotherapy and Radiation Therapy Followed by Peripheral Stem Cell Transplantation in Treating Patients With Non-Hodgkin's Lymphoma April 1992 June 2001
NCT00002514 Completed Phase 3 Stem Cell Transplantation Compared With Standard Chemotherapy in Treating Patients With Acute Lymphoblastic Leukemia in First Remission May 7, 1993
NCT00002517 Completed Phase 3 Combination Chemotherapy in Treating Children With Newly Diagnosed Acute Myeloid Leukemia or Myelodysplastic Syndrome March 1993
NCT00002519 Completed Phase 1 Paclitaxel Plus Radiation Therapy in Treating Patients With Untreated Stage III Non-small Cell Lung Cancer January 1997 January 2000
NCT00002521 Completed Phase 2 Combination Chemotherapy and Bone Marrow and/or Peripheral Stem Cell Transplantation in Treating Patients With Non-Hodgkin's Lymphoma February 1993 February 2000
NCT00002522 Completed Phase 2 Combination Chemotherapy Followed by Bone Marrow or Peripheral Stem Cell Transplantation in Treating Patients With Relapsed or Refractory Hodgkin's Lymphoma February 1993 February 2002
NCT00002523 Completed Phase 3 Radiation Therapy, Surgery, and Chemotherapy in Treating Patients With Rectal Cancer That Can Be Surgically Removed April 1993 January 2016
NCT00002524 Completed Phase 2 Combination Chemotherapy in Treating Patients With AIDS-Related Lymphoma June 1993 October 2005
NCT00002528 Completed Phase 3 Surgery With or Without Lymph Node Removal in Treating Older Women With Stage I or Stage IIA Breast Cancer May 1993 August 2010
NCT00002533 Completed Phase 2/Phase 3 Fluconazole in Preventing Mucositis in Patients Undergoing Radiation Therapy for Head and Neck Cancer February 1993 August 2006
NCT00002536 Completed Phase 3 Surgery With or Without Chemotherapy in Treating Patients With Stage IB Cervical Cancer December 1996
NCT00002537 Completed Phase 1 Radiation Therapy Plus Topotecan in Treating Patients With Non-small Cell Lung Cancer September 1993
NCT00002542 Completed Phase 3 Tamoxifen in Treating Women With High-Risk Breast Cancer July 20, 1993 January 11, 2011
NCT00002546 Completed Phase 3 Radiation Therapy Compared With Combination Chemotherapy in Treating Patients With Cancer of the Uterus December 1993
NCT00002548 Completed Phase 3 SWOG-9321 Melphalan, TBI, and Transplant vs Combo Chemo in Untreated Myeloma January 1994 November 2006
NCT00002550 Completed Phase 3 Chemotherapy Plus Radiation Therapy With or Without Surgery in Treating Patients With Stage IIIA Non-small Cell Lung Cancer March 1994 November 2013
NCT00002551 Completed Phase 3 SWOG-9304 Chemotherapy Plus Radiation Therapy in Treating Patients With Rectal Cancer That Has Been Surgically Removed March 1994 October 2008
NCT00002552 Completed Phase 2 Chemotherapy Plus Bone Marrow Transplantation in Treating Patients With Refractory Non-Hodgkin's Lymphoma, Hodgkin's Disease, or Multiple Myeloma October 1993 October 2003
NCT00002561 Completed Phase 3 Radiation Therapy and Chemotherapy in Treating Patients With Hodgkin's Disease January 25, 1994 January 6, 2012
NCT00002569 Completed Phase 3 Radiation Therapy With or Without Chemotherapy in Treating Patients With Anaplastic Oligodendroglioma July 1994 May 21, 2018
NCT00002571 Completed Phase 2 SWOG-9320 Combination Chemotherapy, Radiation Therapy, and Antiviral Therapy in Treating Patients With AIDS-Related Lymphoma June 1994 July 2011
NCT00002577 Completed Phase 1/Phase 2 Radiation Therapy in Treating Patients With Non-small Cell Lung Cancer July 1995
NCT00002579 Completed Phase 3 Tamoxifen Following Combination Chemotherapy in Treating Women With Operable Invasive Breast Cancer March 1993
NCT00002580 Completed Phase 3 Tamoxifen, Ovarian Ablation, and/or Combination Chemotherapy in Treating Premenopausal Women With Stage I, Stage II, or Stage IIIA Invasive Breast Cancer June 1993
NCT00002581 Completed Phase 3 Tamoxifen With or Without Combination Chemotherapy in Treating Postmenopausal Women With Operable Invasive Breast Cancer June 1993
NCT00002582 Completed Phase 3 Tamoxifen, Ovarian Ablation, and/or Chemotherapy in Treating Women With Stage I, Stage II, or Stage IIIA Breast Cancer June 1993 April 2007
NCT00002590 Completed Phase 2 Combination Chemotherapy in Treating Children With Lymphoma July 1994 March 2007
NCT00002596 Completed Phase 3 Combination Chemotherapy With or Without Bone Marrow or Stem Cell Transplantation in Treating Men With Untreated Germ Cell Tumors September 1994 July 2006
NCT00002597 Completed Phase 3 Radiation Therapy With or Without Antiandrogen Therapy in Treating Patients With Stage I or Stage II Prostate Cancer October 1994 May 14, 2018
NCT00002598 Completed Phase 2 Combination Chemotherapy and Interferon Alfa in Treating Patients With Chronic Myelogenous Leukemia June 1994 June 2004
NCT00002608 Completed Phase 2 Combination Chemotherapy and Tamoxifen in Treating Patients With Solid Tumors May 1994 April 2005
NCT00002610 Completed Phase 3 Chemotherapy With or Without Surgery, Radiation Therapy, or Stem Cell Transplantation in Treating Young Patients With Kidney Tumors January 1996 February 2006
NCT00002611 Completed Phase 3 Combination Chemotherapy Alone or With Radiation Therapy in Treating Children With Kidney Cancer July 1995 August 2003
NCT00002623 Completed Phase 3 Chemotherapy Followed by Surgery or Radiation Therapy in Treating Patients With Stage III Non-small Cell Lung Cancer December 1994
NCT00002624 Completed Phase 2 Video-Assisted Surgery Followed by Radiation Therapy in Treating Patients With Stage I Non-small Cell Lung Cancer and Poor Heart and Lung Function December 1994 August 2005
NCT00002633 Completed Phase 3 Hormone Therapy With or Without Surgery or Radiation Therapy in Treating Patients With Prostate Cancer February 8, 1995 January 6, 2012
NCT00002638 Completed Phase 2 Combination Chemotherapy Followed by Peripheral Stem Cell Transplantation in Treating Children With Relapsed Acute Lymphocytic Leukemia March 1995 March 2005
NCT00002641 Completed Phase 3 Surgery With or Without Chemotherapy in Treating Patients With Soft Tissue Sarcoma February 1995 June 2012
NCT00002649 Completed Phase 3 Interleukin-2 or Observation Following Radiation Therapy, Combination Chemotherapy, and Peripheral Stem Cell Transplantation in Treating Patients With Recurrent Non-Hodgkin's Lymphoma May 1995
NCT00002657 Completed Phase 2 SWOG-9239 Reduction of Immunosuppression Plus Interferon Alfa and Combination Chemotherapy in Treating Patients With Malignant Tumors That Develop After Organ Transplant May 1995 July 2011
NCT00002665 Completed Phase 2 SWOG-9400 Combination Chemotherapy With or Without Bone Marrow Transplantation in Treating Patients With Previously Untreated Acute Lymphocytic Leukemia July 1995 December 2003
NCT00002679 Completed Phase 2 Adjuvant High-Dose, Sequential Chemotherapy in Treating Patients With Resected Breast Cancer February 1994 January 2002
NCT00002680 Completed Phase 2 Sequential High-Dose Chemotherapy and Stem Cell Transplantation in Treating Patients With Chemotherapy-Sensitive Metastatic Breast Cancer February 1994 December 2000
NCT00002689 Completed Phase 2 Radiation Therapy Plus Chemotherapy in Treating Patients With Pancreatic Cancer September 1995 June 2007
NCT00002697 Completed Phase 2 Combination Chemotherapy Plus Radiation Therapy Followed by Peripheral Stem Cell Transplantation in Treating Patients With Non-Hodgkin's Lymphoma September 1995 June 2003
NCT00002700 Completed Phase 3 Chemotherapy With or Without Bone Marrow Transplantation in Treating Patients With Acute Lymphoblastic Leukemia August 1995
NCT00002708 Completed Phase 3 Radiation Therapy With or Without Radiosurgery in Treating Patients With Brain Metastases January 1996 December 2004
NCT00002714 Completed Phase 2 Combination Chemotherapy Plus Radiation Therapy in Treating Patients With Early-Stage Hodgkin's Disease April 1995 September 2001
NCT00002718 Completed Phase 2 T-cell Depleted Bone Marrow and G-CSF Stimulated Peripheral Stem Cell Transplantation From Related Donors in Treating Patients With Leukemia, Lymphoblastic Lymphoma, Myelodysplastic Syndrome, or Aplastic Anemia November 1995 October 2008
NCT00002727 Completed Phase 3 Radiation Therapy in Treating Patients With Stage II Cancer of the Vocal Cord April 1996 December 2016
NCT00002766 Completed Phase 3 Comparison of Two Combination Chemotherapy Regimens in Treating Adults With Previously Untreated Leukemia or Lymphoma March 1996 September 2011
NCT00002788 Completed Phase 1 High-Dose Chemotherapy Followed by Total-Body Irradiation and Peripheral Stem Cell Transplantation in Treating Patients With Chronic Lymphocytic Leukemia October 1995 September 2002
NCT00002801 Completed Phase 1 Combination Chemotherapy and Radiation Therapy in Treating Patients With Colorectal Cancer April 1996 December 2009
NCT00002807 Completed N/A Radiation or Observation Only in Endometrial Cancer Who Have Undergone Surgery July 4, 1996 December 21, 2009
NCT00002809 Completed Phase 2 Bone Marrow Transplant Plus Cyclophosphamide and Total-Body Irradiation in Treating Patients With Hematologic Cancer August 1996 December 2003
NCT00002812 Completed Phase 3 Combination Chemotherapy in Treating Children With Acute Lymphocytic Leukemia September 1996
NCT00002822 Completed Phase 3 Combination Chemotherapy Followed by Radiation Therapy in Patients With Small Cell Lung Cancer March 1996 November 2005
NCT00002823 Completed Phase 3 Combination Chemotherapy Compared With No Treatment Following Surgery in Treating Patients With Non-small Cell Lung Cancer February 1995
NCT00002829 Completed Phase 2 Bone Marrow Transplantation in Treating Patients With Lymphoma February 1994 April 2002
NCT00002835 Completed Phase 3 Combination Chemotherapy in Treating Patients With Lymphoma October 30, 1995 February 4, 2004
NCT00002839 Completed Phase 3 Combination Chemotherapy Plus Radiation Therapy To Preserve the Larynx in Patients With Cancer of the Hypopharynx or Larynx July 1996
NCT00002840 Completed Phase 3 Radiation Therapy With and Without Combination Chemotherapy in Patients With Resected Anaplastic Oligodendroglioma August 1996
NCT00002874 Completed Phase 3 Radiation Therapy With or Without Bicalutamide for Recurrent pT3N0 Prostate Cancer After Radical Prostatectomy February 1998 May 20, 2022
NCT00002898 Completed Phase 3 Surgery Followed by Chemotherapy in Treating Young Patients With Soft Tissue Sarcoma January 1995 December 2009
NCT00002916 Completed Phase 2 Surgery and Vaccine Therapy in Treating Patients With Early Cervical Cancer November 1996
NCT00002932 Completed Phase 2 Cisplatin and Radiation Therapy in Treating Patients With Stage IV Cancer of the Head and Neck May 1997 March 2005
NCT00002945 Completed Phase 3 High Dose Chemotherapy, Peripheral Stem Cell Transplantation, and Interleukin-2 in Treating Patients With Acute Myeloid Leukemia December 1996 August 2011
NCT00002949 Completed Phase 1 Vinorelbine and Paclitaxel Plus Radiation Therapy in Treating Patients With Advanced Cancer Arising in the Pelvis July 1996 May 2001
NCT00002951 Completed Phase 2 Chemotherapy Plus Radiation Therapy in Treating Patients With Head and Neck Cancer June 1996 July 2006
NCT00002982 Completed Phase 2 Combination Chemotherapy and Peripheral Stem Cell Transplantation in Treating Older Patients With Refractory or Relapsed Intermediate-Grade Non-Hodgkin's Lymphoma January 1997 October 2005
NCT00002984 Completed Phase 1/Phase 2 Combination Chemotherapy Plus Radiation Therapy in Treating Patients With Advanced or Metastatic Cancer of the Esophagus March 1997 January 2007
NCT00002995 Completed Phase 3 Combination Chemotherapy With or Without Radiation Therapy in Treating Patients With Newly Diagnosed Rhabdomyosarcoma August 1997 January 2011
NCT00003013 Completed Phase 3 Chemotherapy Plus Surgery in Treating Women With Breast Cancer October 1996 March 2009
NCT00003014 Completed Phase 3 Radiation Therapy Compared With Chemotherapy in Treating Patients With Stage I Testicular Cancer April 1998 July 2005
NCT00003026 Completed Phase 3 Hormone Therapy in Treating Patients With Advanced Prostate Cancer April 1997
NCT00003035 Completed Phase 2 Doxorubicin and Paclitaxel in Treating Women With Locally Advanced Breast Cancer March 1997 June 2001
NCT00003049 Completed Phase 3 Surgery Followed by Radiation Therapy and Chemotherapy in Treating Patients With Cancer of the Pancreas May 1997 July 2007
NCT00003050 Completed Phase 2 Radiation Therapy Plus Paclitaxel in Treating Patients With Stage IIB or Stage III Breast Cancer April 1997 March 2000
NCT00003052 Completed Phase 3 Combination Chemotherapy With or Without Hyperthermia Therapy in Treating Patients With Soft Tissue Sarcoma July 1997 June 2010
NCT00003061 Completed Phase 2 Combination Chemotherapy Plus Radiation Therapy in Treating Patients With Primary CNS Lymphoma July 1997
NCT00003078 Completed Phase 3 Radiation Therapy With or Without Cisplatin or Fluorouracil in Treating Patients With Cancer of the Cervix October 1997
NCT00003081 Completed Phase 1 Combination Chemotherapy, Peripheral Stem Cell Transplantation, and Radiation Therapy in Treating Patients With Ewing's Sarcoma, Peripheral Primitive Neuroectodermal Tumor, or Rhabdomyosarcoma March 1998 January 2002
NCT00003087 Completed Phase 2 Combination Chemotherapy, Radiation Therapy and Surgery in Treating Patients With Cancer of the Esophagus August 1997 February 2005
NCT00003089 Completed Phase 2 Chemotherapy, Amifostine, and Radiation Therapy in Treating Patients With Non-small Cell Lung Cancer July 1997 February 2004
NCT00003104 Completed Phase 2 Computer Planned Radiation Therapy in Treating Patients With Prostate Cancer June 1997 October 2005
NCT00003111 Completed Phase 2 Combination Chemotherapy Followed by Surgery in Treating Patients With Stage IIIA Non-small Cell Lung Cancer April 1997 April 2004
NCT00003114 Completed Phase 2 Combination Chemotherapy in Treating Patients With AIDS-Related Hodgkin's Disease July 1997 February 2003
NCT00003118 Completed Phase 3 Surgery With or Without Chemotherapy and Radiation Therapy in Treating Patients With Cancer of the Esophagus October 1997 March 2000
NCT00003119 Completed Phase 3 Surgery in Treating Children With Neuroblastoma March 1998 March 2006
NCT00003124 Completed Phase 2 Hormone Therapy Plus Radiation Therapy in Treating Patients With Prostate Cancer May 1997 January 2007
NCT00003157 Completed Phase 1 Radiation Therapy and Chemotherapy in Treating Patients With Cancer of the Pancreas or Stomach February 1998 May 2003
NCT00003158 Completed Phase 2 S9712: Radiation Therapy and Combination Chemotherapy in Treating Patients With Stage III Non-small Cell Lung Cancer February 1998 December 2007
NCT00003162 Completed Phase 3 Radiation Therapy in Treating Patients With Bone Metastases From Breast or Prostate Cancer February 1998
NCT00003187 Completed Phase 2/Phase 3 Bone Marrow Transplantation in Treating Patients With Leukemia, Myelodysplasia, or Lymphoblastic Lymphoma May 1995 February 2005
NCT00003193 Completed Phase 1/Phase 2 Paclitaxel and Radiation Therapy Plus Chemoprotection With Amifostine in Treating Patients With Stage III or Stage IV Head and Neck Cancer January 1998 September 2005
NCT00003195 Completed Phase 2 Total-Body Irradiation, Busulfan, and Interferon Alfa Followed by Peripheral Stem Cell or Bone Marrow Transplantation in Treating Patients With Multiple Myeloma December 1997 November 2000
NCT00003199 Completed Phase 2 Combination Chemotherapy and Peripheral Blood Stem Cell Transplant Followed By Aldesleukin and Sargramostim in Treating Patients With Inflammatory Stage IIIB or Metastatic Stage IV Breast Cancer November 1997 December 2009
NCT00003200 Completed Phase 1 Chemotherapy Plus Radiation Therapy in Treating Patients With Squamous Cell Cancer of the Head and Neck October 1995 June 2008
NCT00003202 Completed Phase 1/Phase 2 Gemcitabine Plus Radiation Therapy or Combination Chemotherapy in Treating Patients With Non-small Cell Lung Cancer January 1998 July 2006
NCT00003203 Completed Phase 2 Carboplatin and Vincristine Plus Radiation Therapy Followed By Adjuvant Chemotherapy in Treating Young Patients With Newly Diagnosed CNS Embryonal Tumors March 1998 March 2012
NCT00003209 Completed Phase 3 Radiation Therapy With or Without Chemotherapy After Surgery in Treating Patients With Stage IB or Stage IIA Cervical Cancer December 1997
NCT00003211 Completed Phase 2 Chemotherapy, Radiation Therapy, and Peripheral Stem Cell Transplantation in Treating Children With Newly Diagnosed Medulloblastoma or Supratentorial Primitive Neuroectodermal Tumor October 1996 June 2007
NCT00003215 Completed Phase 3 Combination Chemotherapy Plus Peripheral Stem Cell Transplantation in Treating Patients With Newly Diagnosed Aggressive Non-Hodgkin's Lymphoma April 1997 March 2004
NCT00003216 Completed Phase 3 Fluorouracil, Gemcitabine, and Radiation Therapy in Treating Patients With Cancer of the Pancreas July 1998
NCT00003231 Completed Phase 2 Combination Chemotherapy Followed by Surgery in Treating Patients With Non-small Cell Lung Cancer April 1997 September 2000
NCT00003235 Completed Phase 3 Combination Chemotherapy Plus Radiation Therapy in Treating Patients With Stage III Non-small Cell Lung Cancer That Can Not Be Surgically Removed June 1, 1998
NCT00003263 Completed Phase 1 Cisplatin, Interferon Alfa, Surgery, and Radiation Therapy in Treating Patients With Malignant Pleural Mesothelioma August 1996 November 2000
NCT00003270 Completed Phase 2 Chemotherapy, Radiation Therapy, and Umbilical Cord Blood Transplantation in Treating Patients With Hematologic Cancer September 4, 1997 October 16, 2017
NCT00003278 Completed Phase 2 Radiation Therapy and High-Dose Corticosteroids in Treating Older Patients With Primary CNS Non-Hodgkin's Lymphoma March 1998 June 2003
NCT00003281 Completed Phase 2 Topotecan and Paclitaxel in Treating Patients With Recurrent or Refractory Small Cell Lung Cancer April 1998 March 2006
NCT00003290 Completed Phase 3 Radiation Therapy in Treating Patients With Prostate Cancer January 1998 August 2004
NCT00003298 Completed Phase 2 Chemotherapy, Surgery, and Radiation Therapy in Treating Patients With Gastric Cancer June 1, 1999 May 2011
NCT00003307 Completed Phase 2 Radiation Therapy Plus Amifostine in Treating Patients With Primary Prostate Cancer March 1998 June 2001
NCT00003309 Completed Phase 2 Combination Chemotherapy Plus Radiation Therapy in Treating Adult Patients With Brain Cancer May 4, 1999
NCT00003313 Completed Phase 3 Amifostine in Treating Patients With Stage II or Stage III Non-small Cell Lung Cancer September 1998 June 2010
NCT00003317 Completed Phase 3 Combination Chemotherapy With or Without Radiation Therapy in Treating Patients With Stage IIIA Non-small Cell Lung Cancer May 1998 August 2005
NCT00003320 Completed N/A Radiation Therapy Following Surgery to Remove Brain Metastases March 1997
NCT00003324 Completed N/A Radiation Therapy With or Without Surgery in Treating Patients Who Have Brain Metastases December 1997
NCT00003328 Completed Phase 3 Radiation Therapy Plus Porfiromycin in Treating Patients With Stage III or Stage IV Head and Neck Cancer December 1997
NCT00003332 Completed Phase 1/Phase 2 Combination Chemotherapy Followed by Chemotherapy and Radiation Therapy and/or Surgery in Treating Patients Who Have Pancreatic Cancer July 1997
NCT00003335 Completed Phase 2 Umbilical Cord Blood Transplantation in Treating Patients With High-Risk Hematologic Cancer January 1998 January 2012
NCT00003336 Completed Phase 2 Pilot Study Of Unrelated UCB Transplant for Non-Malignant Hematologic Conditions January 1998 February 2006
NCT00003344 Completed Phase 1/Phase 2 Radiation Therapy Plus Irinotecan in Treating Patients With Colon Cancer August 1998 January 2000
NCT00003364 Completed Phase 3 Radiation Therapy Plus Combination Chemotherapy In Treating Patients With Limited Stage Small Cell Lung Cancer January 1993 August 2006
NCT00084539 Completed Phase 2 Adjuvant Hypofractionated Intensity-Modulated Radiation Therapy With Incorporated Boost in Treating Patients With Early-Stage Breast Cancer November 2003
NCT00084552 Completed N/A Intensity-Modulated Radiation Therapy With or Without Decreased Radiation Dose to Erectile Tissue in Treating Patients With Stage II Prostate Cancer December 11, 2003 May 5, 2016
NCT00084591 Completed Phase 1 Intensity-Modulated Radiation Therapy With Incorporated Boost and Capecitabine Before Surgery in Treating Patients With Locally Advanced Rectal Cancer December 2003 February 2007
NCT00084773 Completed N/A Neoadjuvant Cetuximab, Fluorouracil, and Pelvic Irradiation in Treating Patients With Locally Advanced or Locally Recurrent Rectal Cancer March 2004 March 2010
NCT00084838 Completed Phase 2 Chemotherapy Combined With Radiation Therapy for Newly Diagnosed CNS AT/RT February 2003 March 2013
NCT00085098 Completed Phase 3 Radiation Therapy Compared With Chemotherapy and Radiation Therapy in Treating Patients With Newly Diagnosed Primary Central Nervous System (CNS) Germ Cell Tumor January 2007 May 2009
NCT00085202 Completed Phase 3 Treatment of Patients With Newly Diagnosed Medulloblastoma, Supratentorial Primitive Neuroectodermal Tumor, or Atypical Teratoid Rhabdoid Tumor August 2003 December 31, 2023
NCT00085254 Completed Phase 1/Phase 2 Cilengitide, Temozolomide, and Radiation Therapy in Treating Patients With Newly Diagnosed Glioblastoma Multiforme April 2005 November 2012
NCT00086931 Completed Phase 1/Phase 2 Oxaliplatin, Capecitabine, and Radiation Therapy in Treating Patients With Locally Advanced Cancer of the Rectum September 2003 May 2010
NCT00086996 Completed Phase 2 S0356 Oxaliplatin, 5-FU, Radiation Therapy (RT), Surgery for Pts With Stage II or III Cancer of Esophagus or Gastroesophageal (GE) Junction September 2004 August 2011
NCT00089024 Completed Phase 2 Combination Chemotherapy, and Radiation Therapy in Treating Patients With Locally Advanced Pancreatic Cancer February 25, 2004 December 1, 2014
NCT00089297 Completed Phase 2 Cetuximab, Chemotherapy, and Radiation Therapy for Operable Stage III or IV Head and Neck Cancer January 6, 2005 February 2011
NCT00089427 Completed Phase 1 IL13-PE38QQR Infusion After Tumor Resection, Followed by Radiation Therapy With or Without Temozolomide in Patients With Newly Diagnosed Malignant Glioma July 2004
NCT00091039 Completed N/A Vaccine Therapy, Chemotherapy, and Radiation Therapy in Treating Patients With Stage III Non-Small Cell Lung Cancer That Cannot Be Removed With Surgery August 2004 February 2006
NCT00091052 Completed Phase 1/Phase 2 Radiation Therapy and Sargramostim in Treating Patients With Advanced Solid Tumors July 2004 June 2006
NCT00091351 Completed Phase 3 Surgery With or Without Radiation Therapy in Treating Patients With Primary Soft Tissue Sarcoma of the Retroperitoneum or Pelvis August 2004 February 2006
NCT00093509 Completed Phase 1/Phase 2 MRI Sarcoma Non Invasive Thermometry November 1999 October 2009
NCT00094081 Completed Phase 3 Concomitant Radiation and Cisplatin With and Without Tirapazamine in Treatment of Advanced Head and Neck Cancer October 2002 September 2006
NCT00095771 Completed Phase 1 Arsenic Trioxide and Radiation Therapy in Treating Young Patients With Newly Diagnosed Gliomas November 2004 January 2011
NCT00096070 Completed Phase 2 Radiotherapy Combined With Oxaliplatin and Fluorouracil Followed By Gemcitabine in Treating Patients With Locally Advanced, Unresectable Pancreatic Cancer December 2004
NCT00096135 Completed N/A Combination Chemotherapy and Radiation Therapy in Treating Patients With Acute Lymphoblastic Leukemia That Has Relapsed in the CNS or Testes November 2004
NCT00096174 Completed Phase 2 Phase II Study of Concurrent C225, Cisplatin and Radiation in Stage IV Squamous Cell Carcinoma of the Head and Neck April 8, 2005 July 2016
NCT00096226 Completed Phase 2 Paclitaxel, Carboplatin, and Radiation Therapy in Treating Patients Who Are Undergoing Surgery for Stage III Non-Small Cell Lung Cancer September 2004 May 16, 2016
NCT00096382 Completed Phase 2 Cyclophosphamide, Fludarabine, and Total-Body Irradiation Followed By Cellular Adoptive Immunotherapy, Autologous Stem Cell Transplantation, and Interleukin-2 in Treating Patients With Metastatic Melanoma September 2004 January 2009
NCT00098995 Completed Phase 1 Tirapazamine, Cisplatin, and Radiation Therapy in Treating Patients With Stage IB, Stage II, Stage III, or Stage IVA Cervical Cancer December 2004 January 2010
NCT00099125 Completed Phase 2 Radiation Therapy, Temozolomide, and Irinotecan in Treating Patients With Newly Diagnosed Glioblastoma Multiforme November 2004 November 2013
NCT00100802 Completed Phase 2 Radiation Therapy, Temozolomide, and Lomustine in Treating Young Patients With Newly Diagnosed Gliomas March 21, 2005 June 30, 2017
NCT00104702 Completed Phase 2 Radiation Therapy in Treating Older Women Who Are Undergoing Surgery for Stage I or Stage II Breast Cancer July 2004 March 2011
NCT00104741 Completed Phase 3 Triptorelin, Flutamide, and External-Beam Radiation Therapy or External-Beam Radiation Therapy Alone in Treating Patients With Stage II or Stage III Prostate Cancer September 10, 2003 October 15, 2015
NCT00105560 Completed N/A Proton Beam Radiation Therapy in Treating Young Patients Who Have Undergone Biopsy or Surgery for Medulloblastoma or Pineoblastoma May 2002 December 2020
NCT00107497 Completed N/A Radiation Therapy in Treating Women With Localized Breast Cancer October 5, 2004 March 9, 2017
NCT00109837 Completed Phase 2 S0333 Combination Chemotherapy in Treating Patients With Newly Diagnosed Acute Lymphoblastic Leukemia April 2005 November 2014
NCT00110058 Completed Phase 2 Fludarabine and Radiation Therapy in Treating Patients Who Are Undergoing Donor Stem Cell Transplant for Chronic Phase or Accelerated Phase Chronic Myelogenous Leukemia February 2005 July 2006
NCT00112567 Completed Phase 1/Phase 2 Total-Body Irradiation, Thiotepa, and Fludarabine in Treating Young Patients Who Are Undergoing a Donor Stem Cell Transplant for Hematologic Cancer April 2003 July 2007
NCT00112697 Completed Phase 2 Radiation Therapy and Docetaxel With Either Fluorouracil or Cisplatin as First-Line Therapy in Treating Patients With Metastatic Pancreatic Cancer That Cannot Be Removed By Surgery October 6, 2003 March 1, 2012
NCT00113230 Completed Phase 2 Neoadjuvant Chemoradiation With RHUMAB VEGF (Avastin) for Rectal Cancer February 2005 January 2009
NCT00113347 Completed Phase 1 Erlotinib and Docetaxel With Concomitant Boost Radiation Therapy (XRT) for Head and Neck Squamous Cell Carcinoma (HNSCC) April 2005 April 2011
NCT00114140 Completed Phase 2 Temozolomide and Radiation Therapy in Treating Patients With Gliomas January 2005 May 20, 2022
NCT00114153 Completed Phase 1 Carboplatin, Capecitabine, and Radiation Therapy in Treating Patients With Stage III or Stage IV Head and Neck Cancer June 2003
NCT00114179 Completed Phase 2 Capecitabine, Bevacizumab, and Radiation Therapy Followed By Gemcitabine and Bevacizumab in Treating Patients With Locally Advanced Pancreatic Cancer That Cannot Be Removed By Surgery January 2005 May 2007
NCT00114231 Completed Phase 2 Capecitabine, Oxaliplatin, and Radiation Therapy in Treating Patients Who Are Undergoing Surgery for Stage I Rectal Cancer May 2006 December 2014
NCT00117962 Completed Phase 2 Pemetrexed Disodium, Carboplatin, and Radiation Therapy With or Without Cetuximab in Treating Patients With Stage III Non-Small Cell Lung Cancer September 2005 September 2012
NCT00119262 Completed Phase 2 Bevacizumab and Combination Chemotherapy in Patients With Lymph Node Positive Breast Cancer October 2005 September 2009
NCT00119340 Completed Phase 1/Phase 2 Fludarabine, Total-Body Irradiation, and Donor Stem Cell Transplant Followed By Cyclosporine and Mycophenolate Mofetil in Treating Patients With Chronic Myelogenous Leukemia April 2005 November 2007
NCT00124618 Completed Phase 2 Cetuximab and Radiation Therapy in Treating Patients With Stage III Non-Small Cell Lung Cancer January 2006 March 2015
NCT00128700 Completed Phase 1/Phase 2 Temozolomide and Radiation Therapy With or Without Vatalanib in Treating Patients With Newly Diagnosed Glioblastoma Multiforme June 2005
NCT00134004 Completed Phase 2 Fludarabine, Cyclophosphamide, and Total-Body Irradiation in Treating Patients Who Are Undergoing a Donor Bone Marrow Transplant for Hematologic Cancer October 2004 January 2015
NCT00136474 Completed Phase 2 Amifostine for Head and Neck Irradiation in Lymphoma May 2003 March 2009
NCT00137852 Completed Phase 2 Cisplatin, CPT-11 and Celecoxib With Radiation Therapy and Surgery for Operable Esophageal Cancer January 2002 September 2017
NCT00142480 Completed Phase 2 Capecitabine, Oxaliplatin, Bevacizumab and Radiation Therapy in Patients With Biliary Tract and Gallbladder Cancer December 2004 April 2011
NCT00165126 Completed Dosimetric Analysis of Vaginal Cuff Brachytherapy in Endometrial Carcinoma January 2004 July 2008
NCT00165490 Completed Phase 2 Combination Chemotherapy, Radiation Therapy and Surgery for Esophageal Cancer August 2004 November 2014
NCT00178256 Completed Phase 1/Phase 2 Pulsed Paclitaxel And Daily Thoracic Radiotherapy For Inoperable (Stage I/II) Or Unresectable Lung Cancer June 1998 December 2012
NCT00178269 Completed Phase 2 Low-Dose Taxotere® (Docetaxel) With Concurrent Radiotherapy For Localized, Inoperable Carcinoma Of The Uterine Cervix January 2005
NCT00178295 Completed Radiation-Induced Cytokine Cascades and Their Correlation With Central Nervous System Injury November 1999
NCT00182793 Completed Phase 2 Combination Chemotherapy With or Without Trastuzumab Followed By an Autologous Stem Cell Transplant and Radiation Therapy in Treating Patients With Stage III or Stage IV Breast Cancer July 2005 October 2014
NCT00182819 Completed Phase 3 Radiation Therapy or Temozolomide in Treating Patients With Gliomas July 2005 May 2014
NCT00183846 Completed Phase 1 Study of Irinotecan Administered as a Continuous Infusion and Radiation Therapy for Upper Gastrointestinal Cancers December 2000 July 2009
NCT00187070 Completed N/A Large Cell Lymphoma Pilot Study III December 1997 July 2001
NCT00187122 Completed N/A Treatment for Patients With Stage III or IV Non-Hodgkin Lymphoma March 1993 June 2004
NCT00187226 Completed Phase 2 A Study for Image-Guided Radiation Therapy in Pediatric Brain Tumors and Side Effects June 1997 February 1, 2022
NCT00187486 Completed Phase 2 Safety and Efficacy Study of Tarceva, Temodar, and Radiation Therapy in Patients With Newly Diagnosed Brain Tumors August 2004 March 2011
NCT00191139 Completed Phase 2 Gemcitabine or Gemcitabine Plus Docetaxel After Cisplatin, Etoposide and Radiation in Non Small Cell Lung Cancer (NSCLC) March 2003 February 2009
NCT00193128 Completed Phase 1/Phase 2 Preoperative Therapy With Oxaliplatin/Docetaxel/Capecitabine and Radiation in Resectable Esophagus Cancer April 2004 January 2009
NCT00193973 Completed Phase 2 Idarubicin Based Combined Modality Therapy in Primary CNS Lymphoma July 2001 August 2013
NCT00206752 Completed N/A Study of Unilateral Neck Irradiation in Patients With SCC of the Head and Neck August 2004 February 2015
NCT00225420 Completed Phase 1/Phase 2 Docetaxel, Androgen Ablation, and External-Beam Radiation Therapy in Patients With High-Risk Localized Prostate Cancer August 2005 August 2012
NCT00226239 Completed Phase 2 Docetaxel, Cetuximab and Cisplatin Followed by Radiation, Cetuximab and Cisplatin in Head and Neck Cancer October 2005 July 2013
NCT00227630 Completed Phase 2 Pemetrexed Disodium and Cisplatin Followed By Surgery and Radiation Therapy in Treating Patients With Malignant Pleural Mesothelioma July 2005
NCT00227747 Completed Phase 3 Radiation Therapy and Capecitabine With or Without Oxaliplatin in Treating Patients Who Are Undergoing Surgery for Stage II or Stage III Rectal Cancer November 8, 2005 July 15, 2013
NCT00231842 Completed Phase 2 Adjuvant Radiation Therapy With Ifosfamide in Patients With Mixed Mesodermal Tumors of the Uterus February 2003 July 2011
NCT00233987 Completed Phase 2 S0410 Tandem Stem Cell Transplantation in Treating Patients With Progressive or Recurrent Hodgkin's Lymphoma October 2005 December 2017
NCT00238147 Completed Phase 1 Combination Chemotherapy and Radiation Therapy in Treating Patients Who Are Undergoing Surgery for Locally Advanced Esophageal Cancer September 2004 August 2008
NCT00238251 Completed Phase 2 Radiation Therapy Combined With Either Gefitinib or Temozolomide in Pats With NSCLC and Brain Metastases May 2005 November 2010
NCT00238264 Completed Phase 2 Radiation Therapy in Treating Young Patients With Gliomas November 2006 December 31, 2018
NCT00238368 Completed Phase 2 Fludeoxyglucose F 18 Positron Emission Tomography in Predicting Risk of Relapse in Patients With Non-Hodgkin's Lymphoma Who Are Undergoing Combination Chemotherapy With or Without Autologous Stem Cell or Bone Marrow Transplant February 2004 September 17, 2007
NCT00238420 Completed Phase 1/Phase 2 Paclitaxel and Radiation Therapy With or Without Trastuzumab in Treating Patients Who Have Undergone Surgery for Bladder Cancer July 26, 2005 May 20, 2022
NCT00242190 Completed Phase 1/Phase 2 Gemcitabine, Oxaliplatin and Radiation Therapy in Pancreatic Cancer June 2004 February 2010
NCT00243048 Completed Phase 2 Isoflavones and Radiation Therapy in Treating Patients With Localized Prostate Cancer May 2002 October 2007
NCT00243113 Completed Phase 2 Docetaxel and Radiation Therapy in Treating Patients With Stage II or Stage III Cancer of the Larynx or Hypopharynx June 2004 November 2008
NCT00246181 Completed Phase 1/Phase 2 Phase I and II Study Of Stereotactic Body Radiotherapy in Medically Unresectable Patients With Stage 1 NSCLC December 1999 August 2012
NCT00251355 Completed Phase 1 Gemcitabine, 5-Fluorouracil, and Radiation Therapy in the Treatment of Non-Metastatic Pancreatic Cancer January 1998 August 2008
NCT00253435 Completed Phase 2 N2001-02: I-MIBG With Intensive Chemotherapy and Autologous Stem Cell Rescue for High-Risk Neuroblastoma September 2005 December 2013
NCT00253448 Completed Phase 2 Stereotactic Radiosurgery and Radiation Therapy in Treating Patients With Glioblastoma Multiforme December 2002 July 2011
NCT00253487 Completed N/A Combination Chemotherapy and Radiation Therapy in Treating Younger Patients Who Are Undergoing an Autologous Stem Cell Transplant for Newly Diagnosed Gliomas August 2005 August 2012
NCT00253591 Completed Phase 2/Phase 3 Radiation Therapy With or Without Vinorelbine and Cisplatin in Treating Patients With Stage I, Stage II, or Stage III Non-Small Cell Lung Cancer June 2005 December 2009
NCT00255710 Completed Phase 1 Cyclophosphamide and/or Mycophenolate Mofetil With or Without Tacrolimus in Treating Patients Who Are Undergoing a Donor Bone Marrow or Peripheral Stem Cell Transplant for Hematologic Cancer July 2002
NCT00255814 Completed Phase 1 Radiation Therapy in Treating Patients With Liver Metastases November 2005 November 2013
NCT00258323 Completed Phase 2 Radiotherapy,Chemotherapy,Before and After Surgery in Advanced Esophageal or Gastroesophageal Junction Cancer October 2005 February 2010
NCT00258362 Completed Phase 2 Carboplatin, Docetaxel, and Radiation Therapy in Treating Patients With Stage III/IV, or Recurrent Endometrial Cancer July 2005 December 2009
NCT00258453 Completed N/A Observation of Young Patients Who Are Undergoing Surgery for Craniopharyngioma May 2001 September 2009
NCT00262730 Completed Phase 2 Radiation Therapy and Temozolomide Followed by Temozolomide and Poly ICLC in Treating Patients With Newly Diagnosed GBM January 2006 April 2010
NCT00264953 Completed Phase 3 HD11 for Intermediate Stages May 1998
NCT00265031 Completed Phase 3 HD12 for Advanced Stages January 1999
NCT00265889 Completed Phase 2 Autologous Stem Cell Transplant in Treating Patients With Progressive or Recurrent Hodgkin's Lymphoma February 2002 April 2010
NCT00266097 Completed Phase 1 Oxaliplatin, Gemcitabine, Erlotinib, and Radiation Therapy in Treating Patients With Unresectable and/or Metastatic Pancreatic Cancer or Biliary Tract Cancer August 2004 September 2011
NCT00274755 Completed Phase 2 Magnetic Resonance Imaging and Magnetic Resonance Spectroscopic Imaging in Evaluating Patients Who Are Undergoing Treatment for Gliomas November 2003
NCT00274833 Completed Phase 2 Radiation Therapy, Temozolomide, and Erlotinib in Treating Patients With Newly Diagnosed Glioblastoma Multiforme October 2005 September 2012
NCT00274937 Completed Phase 3 Radiation Therapy, Amifostine, and Chemotherapy in Treating Young Patients With Newly Diagnosed Nasopharyngeal Cancer February 20, 2006 September 30, 2022
NCT00275015 Completed Phase 2 Cyclophosphamide and Total Body Irradiation in Treating Patients Who Are Undergoing an Autologous Peripheral Stem Cell Transplant For Chronic Lymphocytic Leukemia January 1998 April 2012
NCT00276640 Completed N/A Radiation Therapy or Combination Chemotherapy in Treating Patients With Clinically or Radiologically Progressive Low-Grade Gliomas April 1, 2004 May 31, 2017
NCT00276809 Completed Phase 2 Combination Chemotherapy, Total-Body Irradiation, and Alemtuzumab in Treating Patients Undergoing an Autologous Stem Cell Transplant for Stage I, Stage II, Stage III, or Stage IV Chronic Lymphocytic Leukemia June 2001 September 2004
NCT00278148 Completed Phase 1/Phase 2 Erlotinib, Paclitaxel, and Carboplatin Combined With Radiation Therapy for Stage III Non-Small Cell Lung Cancer October 2005 February 2011
NCT00278304 Completed Phase 2 Radiation Therapy in Treating Patients With Cervical Cancer September 2005 June 2006
NCT00278408 Completed Phase 3 Rituximab and Combination Chemotherapy With or Without Radiation Therapy in Treating Patients With B-Cell Non-Hodgkin's Lymphoma November 2005 February 2018
NCT00280176 Completed Phase 1 Bortezomib, Fluorouracil, and External-Beam Radiation Therapy in Treating Patients With Stage II, Stage III, or Stage IV Rectal Cancer April 2003 September 2010
NCT00280761 Completed Biomarkers in Patients With Rectal Cancer Undergoing Chemotherapy and Radiation Therapy December 2003 September 19, 2021
NCT00281788 Completed Phase 1 Combination Chemotherapy and Radiation Therapy in Treating Patients With Esophageal Cancer or Gastroesophageal Junction Cancer September 2003 July 2007
NCT00281840 Completed Phase 2 Bevacizumab, Docetaxel, and Radiation Therapy in Treating Patients With Stage III or Stage IV Head and Neck Cancer September 2005 December 2012
NCT00281983 Completed Phase 1/Phase 2 Fludarabine and Cyclophosphamide in Treating Patients Who Are Undergoing Donor Stem Cell Transplant for Chronic Lymphocytic Leukemia or Waldenstrom's Macroglobulinemia June 2000 July 2010
NCT00287911 Completed Phase 1 Topotecan, Cisplatin, and Radiation Therapy in Treating Patients With Advanced Cervical Cancer February 2005 December 2009
NCT00288080 Completed Phase 3 Hormone Therapy and Radiation Therapy or Hormone Therapy and Radiation Therapy Followed by Docetaxel and Prednisone in Treating Patients With Localized Prostate Cancer December 2005 May 20, 2022
NCT00290641 Completed N/A Chemotherapy and Total-Body Irradiation Followed by Donor Umbilical Cord Blood Transplant, Cyclosporine, and Mycophenolate Mofetil in Treating Patients With Hematologic Cancer April 2001 January 2006
NCT00290667 Completed Phase 2 Rituximab and Combination Chemotherapy in Treating Older Patients With Previously Untreated B-Cell Lymphoma February 2004 November 2015
NCT00291707 Completed Phase 1 Trial of Cetuximab and Pemetrexed With Radiation in Head and Neck Cancer March 2006 January 2009
NCT00293358 Completed Phase 3 Combination Chemotherapy and Radiation Therapy in Treating Patients With Germ Cell Tumors in the Brain January 1997 December 2006
NCT00296608 Completed Phase 3 Radiation Therapy With or Without Chemotherapy Before Surgery in Treating Patients With Stage II or Stage III Rectal Cancer April 1993 August 2008
NCT00301028 Completed Phase 2 Cetuximab, Carboplatin, and Paclitaxel Followed by Radiation Therapy, With or Without Cisplatin, in Treating Patients With Metastatic Head and Neck Cancer April 2006 September 2011
NCT00301041 Completed Early Phase 1 Radiation Therapy in Treating Women With Invasive Breast Cancer April 2004 May 2004
NCT00301808 Completed Phase 2 Cisplatin, Pemetrexed Disodium, and Radiation Therapy Followed by Docetaxel in Treating Patients With Stage III Non-Small Cell Lung Cancer November 2005 October 2012
NCT00302003 Completed Phase 3 Combination Chemotherapy Followed by Radiation Therapy in Treating Young Patients With Newly Diagnosed Hodgkin's Lymphoma February 2006 June 30, 2019
NCT00302159 Completed Phase 2 Valproic Acid With Temozolomide and Radiation Therapy to Treat Brain Tumors March 2006 November 2014
NCT00303810 Completed N/A Radiation Therapy and Combination Chemotherapy in Treating Young Patients With Medulloblastoma, Supratentorial Primitive Neuroectodermal Tumor, or Ependymoma January 2001
NCT00304083 Completed Phase 2 Combination Chemotherapy in Treating Patients With Stage III or Stage IV Malignant Peripheral Nerve Sheath Tumors December 2005 June 2014
NCT00305708 Completed Phase 1/Phase 2 Busulfan, Antithymocyte Globulin, and Fludarabine Followed By a Donor Stem Cell Transplant in Treating Young Patients With Blood Disorders, Bone Marrow Disorders, Chronic Myelogenous Leukemia in First Chronic Phase, or Acute Myeloid Leukemia in First Remission August 2000 July 2004
NCT00305877 Completed Phase 2 Bevacizumab or Cetuximab And Gemcitabine Hydrochloride, Capecitabine, and Radiation Therapy in Treating Patients With Pacreatic Cancer That Has Been Completely Removed By Surgery February 2006 February 2012
NCT00308516 Completed Phase 2 5-Fluorouracil, Bevacizumab, and Radiation Followed by Modified FOLFOX6 and Bevacizumab in Stage II/III Rectal Cancer March 2006 February 2012
NCT00308529 Completed Phase 2 Irinotecan, Carboplatin, Bevacizumab, and Radiation Therapy in the Treatment of Limited Stage Small Cell Lung Cancer March 2006 January 2009
NCT00310154 Completed Phase 1 Gefitinib, Docetaxel, and Radiation Therapy in Treating Patients With Stage III Non-Small Cell Lung Cancer November 2003 August 2010
NCT00310167 Completed Phase 3 Low-Dose Radiation Therapy in Treating Patients With Follicular or Marginal Zone Non-Hodgkin's Lymphoma October 2005 January 2017
NCT00316862 Completed Phase 2 Cisplatin, Irinotecan, and Radiation Therapy in Treating Patients With Esophageal Cancer or Gastroesophageal Junction Cancer That Can Be Removed By Surgery February 2006 October 15, 2014
NCT00319735 Completed Phase 2 Cetuximab and Radiation Therapy for Surgically Resectable Esophageal and Gastroesophageal (GE) Junction Carcinomas April 2006 January 2009
NCT00321685 Completed Phase 2 Bevacizumab, Radiation Therapy, and Combination Chemotherapy in Treating Patients Who Are Undergoing Surgery for Locally Advanced Nonmetastatic Rectal Cancer July 25, 2006 February 11, 2019
NCT00324415 Completed Phase 2 Combined Modality Therapy for Patients With With HIV and Stage I, Stage II, or Stage III Anal Cancer September 2006 May 2016
NCT00328614 Completed Phase 1 Samarium-153 With Neoadjuvant Hormonal and Radiation Therapy for Locally Advanced Prostate Cancer March 2003 June 2011
NCT00328783 Completed N/A Using the Active Breathing Control Device to Reduce Radiation Side Effects to Critical Structures in Breast Cancer October 2002 July 2011
NCT00329797 Completed Phase 3 Zoledronate in Preventing Osteoporosis and Bone Fractures in Patients With Locally Advanced Nonmetastatic Prostate Cancer Undergoing Radiation Therapy and Hormone Therapy March 2006 November 2014
NCT00333294 Completed Phase 2 Phase II Iressa + Irradiation Followed by Chemo in NSCLC September 2004 January 2006
NCT00334997 Completed Phase 2 Endoscopic Surgery or Radiation Therapy in Treating Patients With Stage 0, Stage I, or Stage II Laryngeal Cancer of the Glottis September 2005 July 2006
NCT00335543 Completed Phase 2 Gemcitabine, Cisplatin, and Radiation Therapy Followed By Surgery or Surgery Alone in Treating Patients With Localized Pancreatic Cancer That Can Be Removed By Surgery June 2003 October 2009
NCT00335556 Completed Phase 2 Combination Chemotherapy, Radiation Therapy, and/or Surgery in Treating Patients With High-Risk Kidney Tumors June 2006
NCT00336648 Completed Phase 2 Preop Chemoradiation Resectable Pancreas June 2006 July 2008
NCT00336960 Completed Phase 2 Celecoxib, Fluorouracil, and Radiation Therapy in Treating Patients With Stage II or Stage III Rectal Cancer That Can Be Removed By Surgery July 2002 March 2008
NCT00354679 Completed Phase 2 Irinotecan, Cisplatin, Bevacizumab, Radiation Therapy, and Surgery in Treating Patients With Locally Advanced Esophageal Cancer April 2006 June 2015
NCT00354744 Completed Phase 3 High-Dose Combination Chemotherapy and Radiation Therapy in Treating Patients With Newly Diagnosed Metastatic Rhabdomyosarcoma or Ectomesenchymoma July 2006 June 30, 2019
NCT00354835 Completed Phase 3 Combination Chemotherapy and Radiation Therapy in Treating Patients With Newly Diagnosed Rhabdomyosarcoma December 26, 2006 December 31, 2022
NCT00356031 Completed Phase 2 Bevacizumab and Radiation Therapy for Sarcomas July 2006 March 2010
NCT00357253 Completed Phase 1 Capecitabine and Radiation Therapy in Treating Young Patients With Newly Diagnosed, Nonmetastatic Brain Stem Glioma or High-Grade Glioma January 2006 March 2010
NCT00365287 Completed Phase 1/Phase 2 Combination Chemotherapy and Total-Body Irradiation Before Donor Umbilical Cord Blood Transplant in Treating Patients With Advanced Hematologic Cancer, Metastatic Breast Cancer, or Kidney Cancer June 2000 December 2005
NCT00365872 Completed Phase 2 External Beam Radiation With Intratumoral Injection of Dendritic Cells As Neo-Adjuvant Treatment for Sarcoma May 2006 June 2012
NCT00373191 Completed Effect of Surgery, Radiation Therapy, Chemotherapy, and Hormone Therapy on Biomarkers in Women With Stage I, Stage II, Stage III Breast Cancer, or Ductal Carcinoma In Situ That Can Be Removed By Surgery May 2006 December 2013
NCT00377156 Completed Phase 3 Stereotactic Radiation Therapy With or Without Whole-Brain Radiation Therapy in Treating Patients With Brain Metastases July 2006 December 15, 2019
NCT00379509 Completed Phase 1 Lapatinib and Radiation Therapy in Treating Patients With Locally Recurrent or Chemotherapy-Refractory Locally Advanced or Metastatic Breast Cancer April 2006 August 2012
NCT00385853 Completed Phase 1 PTK787/ZK 222584 in Combination With Temozolomide and Radiation in Patients With Glioblastoma Taking Enzyme-Inducing Anti-Epileptic Drugs September 2006 September 2011
NCT00387374 Completed Phase 2 Radiation Therapy, Bevacizumab, Paclitaxel, and Carboplatin in Treating Patients With Unresectable Stage IIIB or Stage IV Non-Small Cell Lung Cancer at High Risk for Hemoptysis Caused by Bevacizumab October 2006
NCT00387699 Completed Phase 2 Bevacizumab, Cisplatin, Etoposide, and Radiation Therapy in Treating Patients With Limited-Stage Small Cell Lung Cancer October 2006 April 2014
NCT00389584 Completed Phase 1/Phase 2 Irinotecan and Whole-Brain Radiation Therapy in Treating Patients With Brain Metastases From Solid Tumors December 2002 November 2006
NCT00390403 Completed Phase 1 Gossypol (AT-101) and Temozolomide With or Without Radiation Therapy in Treating Patients With Newly Diagnosed Glioblastoma Multiforme February 2007
NCT00392704 Completed Phase 2 Treatment of Head & Neck Cancer With Chemotherapy and Radiation December 2006 May 2012
NCT00393068 Completed Phase 2 Chemotherapy, Radiation Therapy and Immunotherapy Prior to Surgery in Operable Esophageal Cancer February 2007 August 2011
NCT00398554 Completed Phase 2 Combination Chemotherapy in Treating Young Male Patients With Hodgkin's Lymphoma June 2005 March 2013
NCT00400946 Completed Phase 3 Treatment of Acute Lymphoblastic Leukemia in Children April 2005 June 2019
NCT00402116 Completed Phase 1/Phase 2 Phase 1/2 Study of Enzastaurin in Newly Diagnosed Glioblastoma Multiforme (GBM) and Gliosarcoma (GS) Patients September 2006 December 2009
NCT00403065 Completed Phase 3 Dexamethasone and Supportive Care With or Without Whole-Brain Radiation Therapy in Treating Patients With Non-Small Cell Lung Cancer That Has Spread to the Brain and Cannot Be Removed By Surgery October 2006 March 2013
NCT00408564 Completed Phase 2 Cetuximab, Gemcitabine, and Oxaliplatin Followed By Surgery or External-Beam Radiation Therapy and Capecitabine in Treating Patients With Locally Advanced, Nonmetastatic Pancreatic Cancer That Cannot Be Removed By Surgery January 2006 April 2013
NCT00416832 Completed Phase 2 Combination Chemotherapy and Radiation Therapy in Treating Young Patients With Hodgkin's Lymphoma November 2002 December 2005
NCT00416858 Completed Phase 3 Radiation Therapy and Combination Chemotherapy With or Without Surgery in Treating Patients With Locally Advanced Esophageal Cancer That Can Be Removed By Surgery April 2007
NCT00423475 Completed Phase 3 Radiation Therapy With or Without Goserelin in Treating Patients Who Have Undergone Surgery for Recurrent or Refractory Prostate Cancer October 2006
NCT00430118 Completed Phase 3 Combination Chemotherapy Based on Risk of Relapse in Treating Young Patients With Acute Lymphoblastic Leukemia July 2000 January 2012
NCT00433459 Completed Phase 3 Combination Chemotherapy in Treating Young Patients With Hodgkin's Lymphoma January 2007 January 2013
NCT00436397 Completed N/A A New Radiation Therapy Planning System in Patients Undergoing Radiation Therapy for Cancer June 2002 August 2005
NCT00441142 Completed Phase 1/Phase 2 Zactima With Temodar During Radiation Treatment for Newly Diagnosed Stage IV Brain Tumors May 25, 2007 October 10, 2017
NCT00442455 Completed Phase 3 Erlotinib,Radiation and Cisplatin in Patients With Complete Resected Squamous Cell Carcinoma of the Head and Neck January 2006 August 2015
NCT00449020 Completed Phase 2 Carboplatin, Irinotecan, and Radiation Therapy Followed By Docetaxel in Treating Patients With Newly Diagnosed Stage III Non-Small Cell Lung Cancer January 2004 January 2008
NCT00450736 Completed Phase 1 Celecoxib and Radiation Therapy in Treating Patients With Stage II or Stage III Soft Tissue Sarcoma of the Arm, Hand, Leg, or Foot That Has Been Removed by Surgery March 2004 May 2009
NCT00458848 Completed Phase 2 Chemotherapy With or Without Imatinib and/or Peripheral Stem Cell Transplant in Acute Lymphoblastic Leukemia October 2004 March 2014
NCT00460174 Completed Phase 2 Gemcitabine, Bevacizumab, and Abdominal Radiation Therapy in Treating Patients With Localized Pancreatic Cancer October 10, 2005 July 16, 2010
NCT00462501 Completed N/A Combination Chemotherapy and Bevacizumab With or Without Radiation Therapy in Treating Patients With Locally Advanced Rectal Cancer March 2007 February 2014
NCT00467116 Completed Phase 1 PhI Study of Erbitux & Gemcitabine w/Radiation Therapy for Locally Adv. Pancreas Ca October 2005 October 2007
NCT00470184 Completed Phase 2 Oxaliplatin, Capecitabine, and Radiation Therapy in Patients Undergoing Surgery for Stage II, III, IV Esophageal Cancer November 2006
NCT00482014 Completed Phase 1/Phase 2 A Study of Pemetrexed Plus Carboplatin, or Pemetrexed Plus Cisplatin With Radiation Therapy Followed by Pemetrexed in Patients With Inoperable Non-Small-Cell Lung Cancer May 2007 October 2011
NCT00498953 Completed Phase 1/Phase 2 Combination Chemotherapy and Radiation Therapy With or Without Lapatinib in Treating Patients With Locally Advanced Cancer of the Larynx or Hypopharynx May 2007 March 2009
NCT00499083 Completed Phase 2 Paclitaxel, Cyclophosphamide & Doxorubicin, Autologous Dendritic Cells & Surgery in Stage II/III Breast Cancer (Women) May 1, 2006 January 28, 2010
NCT00499447 Completed N/A Radiofrequency Ablation and External-Beam Radiation Therapy in Treating Patients With Stage I Non-Small Cell Lung Cancer That Cannot Be Removed by Surgery May 2007 March 2010
NCT00502411 Completed Phase 1 Post-Operative Chemoradiation for Extremity & Trunk Soft Tissue Sarcoma January 2003 April 2015
NCT00521183 Completed Phase 1 Cytochlor, Tetrahydrouridine, and External-Beam Radiation Therapy in Treating Patients With Cancer That Has Spread to the Brain June 2007 May 2014
NCT00524121 Completed Phase 2 Erlotinib and Radiation Therapy in Treating Older Patients With Stage I, Stage II, Stage III, or Stage IV Esophageal Cancer March 2006 October 2011
NCT00525915 Completed Phase 2 Oxaliplatin-Based Chemotherapy and Chemoradiotherapy or Chemoradiotherapy in Esophageal or Gastroesophageal Carcinoma April 2005 March 2013
NCT00528866 Completed Phase 2 Radiation Therapy, Androgen Suppression, and Docetaxel in Treating Patients With High-Risk Prostate Cancer Who Have Undergone Radical Prostatectomy April 2008 May 14, 2018
NCT00529100 Completed Phase 1/Phase 2 Concurrent Pemetrexed, Cisplatin and Radiation Therapy in Patients With Stage IIIA/B Non Small Cell Lung Cancer December 2005 September 2012
NCT00535795 Completed Phase 3 Phase III: Assess Conventional RT w/ Conventional Plus Accelerated Boost RT in the Treatment of Nasopharyngeal CA September 2007 September 2015
NCT00541047 Completed Phase 3 RADICALS - Radiotherapy and Androgen Deprivation In Combination After Local Surgery November 2007 July 27, 2022
NCT00543842 Completed Phase 1 Bevacizumab, Erlotinib, and Capecitabine for Locally Advanced Rectal Cancer December 2007 December 2013
NCT00544193 Completed Phase 1 Gemcitabine and Radiation Therapy in Treating Patients With Locally Advanced Upper Gastrointestinal Cancer December 1997 August 2012
NCT00544570 Completed N/A High-Dose Chemotherapy in Treating Patients Undergoing Stem Cell Transplant for Recurrent or Refractory Hodgkin's Lymphoma April 1998 December 2007
NCT00544817 Completed Phase 2 Radiation Therapy and Temozolomide Followed by Temozolomide Plus Sorafenib for Glioblastoma Multiforme April 2007 August 2010
NCT00553462 Completed Phase 2 Carboplatin and Paclitaxel Albumin-Stabilized Nanoparticle Formulation Followed by Radiation Therapy and Erlotinib in Treating Patients With Stage III Non-Small Cell Lung Cancer That Cannot Be Removed By Surgery March 2008 June 15, 2017
NCT00554463 Completed Phase 2 G-CSF and Pegfilgrastim in Treating Neutropenia in Patients Undergoing Radiation Therapy and Chemotherapy for Limited Stage Small Cell Lung Cancer January 2008 August 3, 2011
NCT00556621 Completed Phase 1/Phase 2 Gemcitabine, Cisplatin, and Radiation Therapy in Treating Patients With Stage II or Stage III Bladder Cancer June 2005 August 2009
NCT00559156 Completed Phase 2 Arginine/Omega-3 Fatty Acids/Nucleotides Nutritional Supplement in Treating Patients With Stage III or Stage IV Head and Neck Cancer Undergoing Chemotherapy and Radiation Therapy June 2005
NCT00562718 Completed Phase 2 Capecitabine and Radiation Therapy in Treating Patients With Nonmetastatic Breast Cancer After Surgery September 2004 November 2009
NCT00563784 Completed Phase 2 TARCEVA (Erlotinib) in Combination With Chemoradiation in Patients With Stage IIIA/B Non-Small Cell Lung Cancer (NSCLC) November 2007 May 30, 2018
NCT00581971 Completed Phase 1/Phase 2 Radiosensitization With Celecoxib and Chemoradiation for Head and Neck Cancer September 2002 March 2012
NCT00589056 Completed Phase 1/Phase 2 Nelfinavir, Radiation Therapy, Cisplatin, and Etoposide in Treating Patients With Stage III Non-Small Cell Lung Cancer That Cannot Be Removed By Surgery June 2007 March 2012
NCT00589121 Completed Phase 2 Image-Guided Radiation Therapy in Treating Patients With Primary Soft Tissue Sarcoma of the Shoulder, Arm, Hip, or Leg March 2008 May 21, 2018
NCT00589875 Completed Phase 2 Phase 2a Study of CAN-2409 With Standard Radiation Therapy for Malignant Glioma March 2007 August 2016
NCT00601627 Completed Phase 2 Panitumumab, Chemotherapy, and External-Beam Radiation Therapy in Treating Patients With Locally Advanced Pancreatic Cancer That Cannot be Removed by Surgery June 2009 May 2013
NCT00601692 Completed Phase 1 Irinotecan, Radiation Therapy, and Docetaxel With or Without Cisplatin in Treating Patients With Locally Advanced Esophageal Cancer April 2003 December 2009
NCT00602602 Completed Phase 2 Bevacizumab, Combination Chemotherapy, and Radiation Therapy in Treating Patients Undergoing Surgery For Locally Advanced Pancreatic Cancer March 2007 September 2011
NCT00602628 Completed N/A Radiation Therapy Planning Techniques in Reducing Damage to Normal Tissue in Women Undergoing Breast-Conserving Surgery for Ductal Carcinoma of the Breast November 2007 January 2009
NCT00608205 Completed Phase 3 Radiation Therapy Cisplatin With or Without Fluorouracil Patients With Stage III or Stage IV Head and Neck Cancer January 2008 August 2016
NCT00613080 Completed Phase 2 Combination Chemotherapy and Intensity-Modulated Radiation Therapy in Treating Patients Undergoing Surgery for Locally Advanced Rectal Cancer April 2008 December 2016
NCT00614653 Completed Phase 1 Bevacizumab, Erlotinib and Capecitabine for Advanced Pancreatic Cancer January 2008 July 2016
NCT00618813 Completed N/A Two Regimens of Combination Chemotherapy in Treating Younger Patients With Newly Diagnosed Localized Ewing Sarcoma Family of Tumors March 2008
NCT00629863 Completed N/A Endoscopic Ultrasound in Diagnosing Cancer in Patients With Localized Stomach Cancer or Esophageal Cancer September 2004 January 2010
NCT00634725 Completed Phase 3 Gemcitabine With or Without Capecitabine and/or Radiation Therapy or Gemcitabine With or Without Erlotinib in Treating Patients With Locally Advanced Pancreatic Cancer That Cannot Be Removed by Surgery February 2008 September 2014
NCT00639366 Completed Phase 3 Radiation Therapy to the Head in Preventing Brain Metastases in Women Receiving Trastuzumab and Chemotherapy for Metastatic or Locally Advanced Breast Cancer February 2007 October 2010
NCT00647582 Completed Phase 2 Radiation Therapy During and After Lumpectomy in Treating Women With Stage I or Stage II Breast Cancer October 2002 December 21, 2013
NCT00650923 Completed Phase 1 Aflibercept, Radiation Therapy, and Temozolomide in Treating Patients With Newly Diagnosed or Recurrent Glioblastoma Multiforme, Gliosarcoma, or Other Malignant Glioma July 2008 December 2013
NCT00655876 Completed Phase 3 Paclitaxel, Cisplatin, and Radiation Therapy With or Without Cetuximab in Treating Patients With Locally Advanced Esophageal Cancer June 2008 May 20, 2022
NCT00660270 Completed Phase 2 Chemotherapy and Radiation Following Pancreatic Surgery May 2002 February 2009
NCT00662233 Completed Early Phase 1 Combination Chemotherapy in Treating Patients With Sarcoma October 1991 October 21, 2013
NCT00666484 Completed Phase 2 Combination Chemotherapy in Treating Younger Patients With Hodgkin Lymphoma March 2008 September 2012
NCT00669162 Completed Phase 1/Phase 2 Postoperative Radiation Therapy, Hormonal Therapy and Concurrent Docetaxel for High Risk Pathologic Prostate Cancer August 2012 April 2017
NCT00671034 Completed Phase 3 Calaspargase Pegol or Pegaspargase and Combination Chemotherapy in Treating Younger Patients With Newly Diagnosed High-Risk Acute Lymphoblastic Leukemia July 21, 2008 March 31, 2021
NCT00686166 Completed Phase 2 S0713: Oxaliplatin, Capecitabine, Cetuximab, and RT Followed By Surgery in Pts W/Stage II or III Rectal Cancer February 2009 March 2018
NCT00701857 Completed Phase 1 Pemetrexed, Cisplatin, and Radiation Therapy in Treating Patients With Esophageal or Gastroesophageal Junction Cancer February 2008 September 2015
NCT00703976 Completed Phase 2 Radiation, Cetuximab and Pemetrexed With or Without Bevacizumab in Locally Advanced Head and Neck Cancer October 2008 September 2014
NCT00707278 Completed Phase 1 Radiation Therapy and Capecitabine/Oxaliplatin Chemotherapy in the Treatment of Locally Advanced Pancreas Adenocarcinoma September 2005 August 2011
NCT00720109 Completed Phase 2/Phase 3 Dasatinib and Combination Chemotherapy in Treating Young Patients With Newly Diagnosed Acute Lymphoblastic Leukemia July 14, 2008 March 31, 2020
NCT00720304 Completed Phase 2 Erlotinib, Docetaxel, and Radiation Therapy in Stage III or Stage IV Squamous Cell Carcinoma of the Head and Neck November 2007 November 2015
NCT00720564 Completed Phase 1 Radiation Therapy, Arsenic Trioxide, and Temozolomide in Treating Patients With Newly Diagnosed High-Grade Glioma April 2008 February 2009
NCT00727584 Completed N/A Radiation Therapy in Treating Patients With Metastatic Spinal Cord Compression November 2007 August 2009
NCT00727831 Completed Phase 1/Phase 2 Methotrexate, Glucarpidase, and Leucovorin in Treating Patients With Newly Diagnosed Primary Central Nervous System Lymphoma July 2008 July 2011
NCT00732563 Completed N/A Fludeoxyglucose F 18 in Detecting Lymph Node Metastasis in Patients With Stage I or Stage II Non-Small Cell Lung Cancer That Can Be Removed by Surgery July 16, 2008 July 26, 2017
NCT00735306 Completed Phase 1 Phase I/II Trial of Radiation, Avastin and Tarceva for Pancreatic Adenocarcinoma July 2008 October 2011
NCT00738452 Completed Phase 1 Radiolabeled Monoclonal Antibody Therapy in Treating Patients With Stage I-IIIB Non-Small Cell Lung Cancer After Completion of Radiation Therapy Alone or Combined Radiation Therapy and Chemotherapy August 6, 2008 February 7, 2018
NCT00751816 Completed Head & Neck Cancer Survivorship: Physical and Functional Status June 2008 January 2009
NCT00757172 Completed Phase 2 Panitumumab, Docetaxel, Cisplatin, Radiation Therapy, and Surgery in Treating Patients With Newly Diagnosed, Locally Advanced Esophageal Cancer or Cancer of the Gastroesophageal Junction January 2009 December 2014
NCT00757549 Completed Early Phase 1 3'-Deoxy-3'-[18F] Fluorothymidine and Fludeoxyglucose F 18 PET Scans in Evaluating Response to Cetuximab, Cisplatin, and Radiation Therapy in Patients With Advanced Cancer of the Oropharynx, Larynx, or Hypopharynx September 2008 October 25, 2017
NCT00770471 Completed Phase 1 ABT-888, Radiation Therapy, and Temozolomide in Treating Patients With Newly Diagnosed Glioblastoma Multiforme July 13, 2009 March 1, 2012
NCT00771641 Completed Phase 3 Fractionated Radiation Therapy in Treating Advanced Squamous Cell Carcinoma of the Head and Neck November 2013
NCT00796796 Completed Phase 1 Temsirolimus and Radiation for Non-Small Cell Lung Cancer March 2009 July 2011
NCT00798655 Completed Phase 2 Trial of Postoperative Radiation, Cisplatin, and Panitumumab in Locally Advanced Head and Neck Cancer November 2007 November 9, 2016
NCT00805961 Completed Phase 2 RT, Temozolomide, and Bevacizumab Followed by Bevacizumab/Everolimus in First-line Treatment of GBM January 2009 May 2013
NCT00820963 Completed Phase 3 Standard Radiation Therapy, Higher-Dose Radiation Therapy, or Chemotherapy in Treating Older Patients With Glioblastoma Multiforme July 2006
NCT00836186 Completed N/A Cytokine Expression During Radiation for Breast Cancer November 13, 2009 November 1, 2019
NCT00838929 Completed Phase 1 Study of the Combination of Vorinostat and Radiation Therapy for the Treatment of Patients With Brain Metastases March 2009 March 2015
NCT00849082 Completed Phase 3 Radiation Therapy With or Without Goserelin and Cyproterone in Treating Patients With Prostate Cancer May 1987
NCT00861094 Completed Phase 2/Phase 3 Radiation Therapy + Combination Chemotherapy as 1st-Line Therapy for Patients With Inoperable Esophageal Cancer March 2008 December 2012
NCT00867347 Completed Phase 3 Radiation Therapy or Surgery in Treating Patients Receiving Chemotherapy for Bladder Cancer July 2007 April 2017
NCT00869401 Completed Phase 1/Phase 2 Dasatinib or Placebo, Radiation Therapy, and Temozolomide in Treating Patients With Newly Diagnosed Glioblastoma Multiforme June 2009 November 15, 2019
NCT00869570 Completed Phase 1/Phase 2 External-Beam Radiation Therapy, Capecitabine, and Sorafenib in Treating Patients With Locally Advanced Rectal Cancer March 2009 September 2016
NCT00871923 Completed Phase 2 Tarceva With Whole Brain Radiation Therapy - Brain Mets From Non-Small Cell Lung Cancer March 26, 2009 December 4, 2019
NCT00872625 Completed Phase 1 Radiation Therapy and Docetaxel Followed by Standard Therapy in Treating Women With Breast Cancer April 2007 December 2010
NCT00875849 Completed Phase 2 Chemotherapy, Radiation Therapy, and Cetuximab in Treating Patients With the Head and Neck Cancer March 2008 December 2013
NCT00879437 Completed Phase 2 Valproic Acid, Radiation, and Bevacizumab in Children With High Grade Gliomas or Diffuse Intrinsic Pontine Glioma September 1, 2009 October 2, 2017
NCT00884598 Completed Phase 1 Cilengitide and Whole-Brain Radiation Therapy in Treating Patients With Brain Metastases From Lung Cancer December 2008 October 2012
NCT00897793 Completed Growth Factor Levels in the Blood of Patients Undergoing Radiation Therapy for Epithelial Cancer January 2006 July 2010
NCT00898352 Completed Phase 3 Radiation Therapy or Surgery in Treating Patients With Previously Untreated Vulva Cancer With Positive Groin Lymph Nodes
NCT00916578 Completed Phase 2 Xeloda (Capecitabine) and External Beam Radiation June 5, 2009 June 6, 2017
NCT00929591 Completed Phase 3 SWOG-8814 Tamoxifen With or Without Combination Chemotherapy in Postmenopausal Women Who Have Undergone Surgery for Breast Cancer May 1989 March 2010
NCT00938470 Completed Phase 2 Docetaxel, Oxaliplatin, Capecitabine, Fluorouracil, and Radiation Therapy in Treating Patients With Locally Advanced Cancer of the Esophagus or Gastroesophageal Junction January 2010 March 2018
NCT00943826 Completed Phase 3 A Study of Bevacizumab (Avastin®) in Combination With Temozolomide and Radiotherapy in Participants With Newly Diagnosed Glioblastoma June 29, 2009 September 9, 2015
NCT00946673 Completed Phase 1 Phase I Vorinostat Concurrent With Stereotactic Radiosurgery (SRS) in Brain Metastases From Non-Small Cell Lung Cancer June 2009 July 2015
NCT00960492 Completed Phase 1 Safety Study of XL184 (Cabozantinib) in Combination With Temozolomide and Radiation Therapy in the Initial Treatment of Adults With Glioblastoma September 2009 October 2013
NCT00964977 Completed Phase 3 Effectiveness of Adjuvant Radiotherapy in Small Oropharyngeal Squamous Cell Cancer and Single Lymph Node Metastasis. October 2009 December 2021
NCT00968643 Completed Phase 3 Spinal Cord Compression. ICORG 05-03, V6 January 2006
NCT00972881 Completed Phase 1/Phase 2 Capecitabine, Irinotecan Hydrochloride, Cetuximab, and Radiation Therapy in Treating Patients Undergoing Surgery for Locally Advanced Rectal Cancer April 2009 December 31, 2016
NCT00978549 Completed Phase 3 Symptom Control With or Without Docetaxel in Treating Patients With Relapsed Esophageal Cancer or Stomach Cancer April 2008 October 2010
NCT00983359 Completed N/A Stereotactic Radiation Therapy in Treating Patients With Brain Metastases April 2007 August 2012
NCT01055197 Completed Phase 2 Radiation Therapy in Treating Patients With Extensive Stage Small Cell Lung Cancer March 2010 December 2016
NCT01062399 Completed Phase 1/Phase 2 Everolimus, Temozolomide, and Radiation Therapy in Treating Patients With Newly Diagnosed Glioblastoma Multiforme December 2010 May 20, 2022
NCT01064921 Completed Phase 1 Ph I Vorinostat in the Treatment of Advanced Staged Oropharyngeal Squamous Cell Carcinoma January 19, 2010 November 8, 2017
NCT01102088 Completed Phase 1 Simultaneous Integrated Boost (SIB) in Esophageal Cancer April 2010 June 8, 2019
NCT01117441 Completed Phase 3 International Collaborative Treatment Protocol For Children And Adolescents With Acute Lymphoblastic Leukemia June 2010 December 31, 2021
NCT01118026 Completed Phase 2 Response-Based Therapy Assessed By PET Scan in Treating Patients With Bulky Stage I and Stage II Classical Hodgkin Lymphoma September 2010 September 29, 2021
NCT01118377 Completed Phase 2 A Study of Capecitabine (Xeloda®) and Concomitant Radiation Therapy in Children With Newly Diagnosed Brainstem Gliomas May 2007 April 2013
NCT01132807 Completed Phase 2 Chemotherapy Based on Positron Emission Tomography Scan in Treating Patients With Stage I or Stage II Hodgkin Lymphoma May 2010 January 2018
NCT01134861 Completed Phase 3 Radiation Therapy Plus Chemotherapy in Treating Patients With Non-small Cell Lung Cancer July 1994 March 2012
NCT01142102 Completed N/A Feasibility of Online Adaptive Radiotherapy for Muscle Invasive Bladder Cancer October 2010 June 2015
NCT01186978 Completed N/A Reduced Radiation in Patients With Diffuse Large B-cell Lymphoma September 20, 2010 June 4, 2019
NCT01196390 Completed Phase 3 Radiation Therapy, Paclitaxel, and Carboplatin With or Without Trastuzumab in Treating Patients With Esophageal Cancer February 14, 2011 August 15, 2023
NCT01222221 Completed Phase 1 Vaccine Therapy, Temozolomide, and Radiation Therapy in Treating Patients With Newly Diagnosed Glioblastoma Multiforme July 2010 February 2015
NCT01227707 Completed Phase 2 A Study of Avastin (Bevacizumab) Plus Xeloda (Capecitabine) in Patients With Locally Advanced Rectal Cancer. November 2005 August 2010
NCT01230983 Completed Phase 3 Combination Chemotherapy in Treating Patients With Acute Lymphoblastic Leukemia or Advanced Lymphoblastic Non-Hodgkin's Lymphoma June 1996 October 2004
NCT01233843 Completed Phase 3 Chemoradiotherapy HNSCC, Randomized Study, Docetaxel,Cisplatin, 5FU,Erbitux. May 18, 2009 November 6, 2018
NCT01242800 Completed N/A Early Surgery or Standard Palliative Therapy in Treating Patients With Stage IV Breast Cancer May 16, 2011 December 21, 2022
NCT01263171 Completed Phase 2 Oxaliplatin, Leucovorin, and Fluorouracil Before and After Radiation Therapy and Surgery in Treating Patients With Rectal Cancer That Can Be Removed by Surgery April 2012 November 2015
NCT01264432 Completed Phase 1 Veliparib and Radiation Therapy in Treating Patients With Advanced Solid Malignancies With Peritoneal Carcinomatosis, Epithelial Ovarian, Fallopian, or Primary Peritoneal Cancer January 1, 2011 November 15, 2016
NCT01269424 Completed Phase 1 BG & TMZ Therapy of Glioblastoma Multiforme November 22, 2011 September 26, 2022
NCT01288534 Completed Phase 2 Hypofractionated Stereotactic Body Radiation Therapy (SBRT) January 2011 January 2016
NCT01333033 Completed Phase 2 PET Scan Imaging in Assessing Response in Patients With Esophageal Cancer Receiving Combination Chemotherapy July 2011 April 1, 2023
NCT01345370 Completed Comparison of Different Methods to Test MGMT Status in Glioblastoma Patients March 2009 June 2015
NCT01384799 Completed Phase 1 Phase I Study of CUDC-101 With Cisplatin and Radiation in Subjects With Head & Neck Cancer November 2011 October 2013
NCT01401062 Completed Phase 2 Fresolimumab and Radiotherapy in Metastatic Breast Cancer July 2011 June 2014
NCT01443676 Completed Phase 2 Avastin Plus Radiotherapy in Elderly Patients With Glioblastoma October 2011 August 2016
NCT01445405 Completed Phase 1 Radiation Therapy and Bortezomib and Cetuximab With or Without Cisplatin to Treat Head and Neck Cancer February 5, 2008 August 27, 2010
NCT01449279 Completed Phase 2 Pilot Ipilimumab in Stage IV Melanoma Receiving Palliative Radiation Therapy October 2011 December 1, 2016
NCT01459497 Completed Phase 3 Hypofractionated Image-Guided Radiation Therapy (IGRT) in Patients With Stage II-III Non-Small Cell Lung Cancer October 2012 October 19, 2023
NCT01469247 Completed Phase 1/Phase 2 Diffuse Intrinsic Pontine Glioma (DIPG) Reirradiation (ReRT) December 7, 2011 September 20, 2022
NCT01481545 Completed Phase 2 Bevacizumab With Pelvic Radiotherapy And Primary Chemotherapy in Patients With Poor-Risk Rectal Cancer December 2006 December 2016
NCT01486602 Completed Phase 1 Specialized Radiation Therapy and Chemotherapy in Treating Patients With Stage III Non-Small Cell Lung Cancer That Cannot Be Removed by Surgery March 2012 January 16, 2018
NCT01496131 Completed Phase 2 Tecemotide (L-BLP25) in Prostate Cancer October 24, 2011 November 25, 2016
NCT01526603 Completed N/A High Dose Chemotherapy and Autologous Transplant for Neuroblastoma March 28, 2012 May 30, 2023
NCT01534637 Completed Phase 2 Aprepitant in Preventing Nausea and Vomiting in Patients Undergoing Chemotherapy and Radiation Therapy for Pancreatic Cancer August 2006 August 2012
NCT01540994 Completed Phase 1/Phase 2 Stereotactic Body Radiation Therapy (SBRT) for Prostate Cancer January 2011 April 5, 2019
NCT01560949 Completed Phase 2 Preoperative Folfirinox, Radiation Therapy for Resectable Adenocarcinoma of the Pancreas June 14, 2012 February 20, 2019
NCT01561014 Completed Phase 1 Oxaliplatin, Fluorouracil, Erlotinib Hydrochloride, and Radiation Therapy Before Surgery and Erlotinib Hydrochloride After Surgery in Treating Patients With Locally Advanced Cancer of the Esophagus or Gastroesophageal Junction April 2007 March 2009
NCT01591135 Completed Phase 3 A Phase III Study of Comparing Paclitaxel Plus 5-Fluorouracil Versus Cisplatin Plus 5-Fluorouracil in Chemoradiotherapy for Locally Advanced Esophageal Carcinoma April 2012 August 2018
NCT01666808 Completed Phase 2/Phase 3 FACBC Outcomes for Post Prostatectomy September 2012 April 18, 2022
NCT01674842 Completed Phase 1 Cisplatin + RT for Triple Negative Breast Cancer October 2012 June 8, 2021
NCT01711541 Completed Phase 1/Phase 2 Combination Chemotherapy With or Without Veliparib in Treating Patients With Stage IV Head and Neck Cancer October 22, 2012 May 15, 2023
NCT01717053 Completed Phase 2 Abiraterone, Radiotherapy and Short-Term Androgen Deprivation in Unfavorable Localized Prostate Cancer January 17, 2014 August 31, 2021
NCT01730950 Completed Phase 2 Bevacizumab With or Without Radiation Therapy in Treating Patients With Recurrent Glioblastoma December 20, 2012 December 22, 2022
NCT01740258 Completed Phase 2 Bevacizumab Beyond Progression (BBP) January 2013 November 14, 2019
NCT01740648 Completed Phase 1 Trametinib, Fluorouracil, and Radiation Therapy Before Surgery in Treating Patients With Stage II-III Rectal Cancer November 26, 2012 September 29, 2021
NCT01758731 Completed Phase 1 Study of Olaparib With Radiation Therapy and Cetuximab in Advanced Head and Neck Cancer With Heavy Smoking History October 22, 2012 October 31, 2018
NCT01783587 Completed Phase 1 Safety Study of Afatinib and Postoperative Radiation Therapy to Treat Head and Neck Cancer February 2013 June 1, 2018
NCT01790503 Completed Phase 1/Phase 2 A Phase 1b/2 Study of PLX3397 + Radiation Therapy + Temozolomide in Patients With Newly Diagnosed Glioblastoma July 18, 2013 March 4, 2020
NCT01819233 Completed N/A Caloric Restriction in Treating Patients With Stage 0-I Breast Cancer Undergoing Surgery and Radiation Therapy March 8, 2013 September 2019
NCT01831531 Completed Phase 2 Study of S-1 in Combination With Radiotherapy in Esophageal Cancer March 2013 October 2018
NCT01833208 Completed N/A Radiation Therapy in Treating Patients With Metastatic Hormone-Resistant Prostate Cancer Receiving Sipuleucel-T July 3, 2013 January 23, 2021
NCT01835626 Completed Phase 2 Phase II Study of Radiation Therapy and Vismodegib for Advanced Head/Neck Basal Cell Carcinoma May 2013 September 10, 2019
NCT01869192 Completed Phase 2 Phase II Trial for Large ER-Negative Breast Cancers March 5, 2003 August 21, 2010
NCT01893294 Completed Phase 1 Gemcitabine Hydrochloride in Treating Patients With Locally Advanced Pancreatic Cancer April 2013 October 30, 2015
NCT01903018 Completed Phase 2 A Study to Assess Radiation Induced Mucositis in Patients of Head and Neck Cancer Administered Chemo-Radiation With or Without P276-00 July 2012 September 2014
NCT01922076 Completed Phase 1 Adavosertib and Local Radiation Therapy in Treating Children With Newly Diagnosed Diffuse Intrinsic Pontine Gliomas September 3, 2013 September 30, 2022
NCT01958372 Completed Phase 1 Radiation Therapy, Chemotherapy, and Soy Isoflavones in Treating Patients With Stage IIIA-IIIB Non-Small Cell Lung Cancer August 2014 November 11, 2019
NCT01977677 Completed Phase 1/Phase 2 Plerixafor After Radiation Therapy and Temozolomide in Treating Patients With Newly Diagnosed High Grade Glioma November 2014 September 2018
NCT01979211 Completed Phase 2 Post-operative Radiation With Cetuximab for Locally Advanced Cutaneous Squamous Cell Carcinoma of the Head and Neck October 2013 January 19, 2022
NCT01985958 Completed N/A A Pilot Study to Evaluate Radiotherapy-Induced Anti-Tumor Immunity in Metastatic Carcinoma of the Pancreas July 2013 December 2019
NCT02037230 Completed Phase 1/Phase 2 Dose Escalation Trial of AZD1775 and Gemcitabine (+Radiation) for Unresectable Adenocarcinoma of the Pancreas January 2014 August 2018
NCT02046304 Completed Phase 1 PP-Gemcitabine & External Beam Radiation-Sarcomas December 2001 March 2015
NCT02057939 Completed Phase 2 Salvage Therapeutic Radiation With Enzalutamide and ADT in Men With Recurrent Prostate Cancer (STREAM) April 2014 June 5, 2019
NCT02104193 Completed Phase 2 Simvastatin Effect on Radiation Therapy of Brain Metastases April 2014 December 2015
NCT02122081 Completed Phase 1 Organ-Sparing Marrow-Targeted Irradiation Before Stem Cell Transplant in Treating Patients With High-Risk Hematologic Malignancies July 27, 2015 September 6, 2022
NCT02180698 Completed Phase 1 TLR4 Agonist GLA-SE and Radiation Therapy in Treating Patients With Soft Tissue Sarcoma That Is Metastatic or Cannot Be Removed by Surgery November 17, 2014 October 7, 2016
NCT02184533 Completed Phase 1 Sodium Selenite and Radiation Therapy in Treating Patients With Metastatic Cancer July 2014 May 2018
NCT02203565 Completed Phase 2 Dakin's Solution in Preventing Radiation Dermatitis in Patients With Breast Cancer Undergoing Radiation Therapy July 2014 July 7, 2016
NCT02241499 Completed Phase 2 Palliative Short-course Hypofractionated Radiotherapy Followed by Chemotherapy in Adenocarcinoma of the Esophagus or Esophagogastric Junction Trial - a Phase II Clinical Trial Protocol. October 2014 May 2019
NCT02243358 Completed Phase 2 Phase II Study of Chemo-Radiotherapy in Patients With Resectable and Borderline Resectable Pancreatic Cancer February 2014 January 14, 2020
NCT02254772 Completed Phase 1/Phase 2 A Phase I/II Study of Intratumoral Injection of SD-101 September 2014 January 26, 2017
NCT02274350 Completed The Herlev Hospital Post Radiation Therapy for Localized Prostate Cancer Database for Sexual Side Effects May 2015 November 2015
NCT02280252 Completed Phase 2 Study of Concurrent Paclitaxel and Radiation: Correlation of Tumor Profiles With Pathologic Response March 2005 December 20, 2018
NCT02318095 Completed N/A Gemcitabine/Nab-Paclitaxel With HIGRT in Resectable Pancreatic Cancer February 17, 2015 November 14, 2022
NCT02325401 Completed Phase 1 Dose-finding Study of Metformin With Chemoradiation in Locally Advanced Head and Neck Squamous Cell Carcinoma May 11, 2015 February 21, 2020
NCT02337426 Completed Phase 1 Dimethyl Fumarate, Temozolomide, and Radiation Therapy in Treating Patients With Newly Diagnosed Glioblastoma Multiforme February 13, 2015 November 9, 2017
NCT02379845 Completed Phase 2/Phase 3 NBTXR3 Crystalline Nanoparticles and Radiation Therapy in Treating Randomized Patients in Two Arms With Soft Tissue Sarcoma of the Extremity and Trunk Wall March 3, 2015 September 20, 2020
NCT02389751 Completed Phase 1 Ganetespib in Combination With Paclitaxel, Carboplatin, and Radiation Therapy in Treating Patients With Stage II-III Esophageal Cancer April 10, 2015 July 16, 2019
NCT02394535 Completed Phase 1 Nab-Paclitaxel, Capecitabine, and Radiation Therapy Following Induction Chemotherapy in Treating Patients With Locally Advanced Pancreatic Cancer November 12, 2015 August 31, 2022
NCT02397486 Completed Phase 2 The Impact of Pentoxifylline and Vitamin E on Radiotherapy-induced Toxicity in Head & Neck Cancer Patients May 2, 2015 June 30, 2018
NCT02459652 Completed Phase 2 Neoadjuvant S-1 and Concurrent Radiotherapy for Borderline Resectable Pancreatic Cancer December 28, 2012 July 17, 2018
NCT02472275 Completed Phase 1 PLX3397, Radiation Therapy, and Antihormone Therapy in Treating Patients With Intermediate- or High-Risk Prostate Cancer June 2015 August 5, 2019
NCT02474186 Completed Phase 2 Phase II Study for Solid Metastatic Tumors April 2003 July 2015
NCT02501954 Completed Phase 3 Trial of Cisplatin Plus Radiation Followed by Carbo and Taxol Vs. Sandwich Therapy of Carbo and Taxol Followed Radiation Then Further Carbo and Taxol March 2015 November 2023
NCT02528942 Completed N/A Feasibility Study Incorporating Lung Function Imaging Into Radiation Therapy for Lung Cancer Patients April 22, 2016 January 25, 2021
NCT02730546 Completed Phase 1/Phase 2 Pembrolizumab, Combination Chemotherapy, and Radiation Therapy Before Surgery in Treating Adult Patients With Locally Advanced Gastroesophageal Junction or Gastric Cardia Cancer That Can Be Removed by Surgery June 24, 2016 October 31, 2023
NCT02759575 Completed Phase 1/Phase 2 A Study of Chemoradiation Plus Pembrolizumab for Locally Advanced Laryngeal Squamous Cell Carcinoma April 2016 February 2021
NCT02769299 Completed Cardiotoxicity of Radiation Therapy (CTRT) June 2, 2015 November 26, 2018
NCT02773238 Completed Phase 2 FLARE RT for Patients With Stage IIB-IIIB Non-small Cell Lung Cancer: Personalizing Radiation Therapy Using PET/CT and SPECT/CT Imaging May 20, 2016 December 1, 2023
NCT02805530 Completed N/A Radical Treatment of Synchronous Oligometastatic Non-Small Cell Lung Carcinoma June 2015 January 2019
NCT02911350 Completed Phase 1 Safety Study of Combination of Hormone Therapy, Paclitaxel and Radiation Therapy to Treat Prostate Cancer May 2000 December 2016
NCT02927964 Completed Phase 1/Phase 2 TLR9 Agonist SD-101, Ibrutinib, and Radiation Therapy in Treating Patients With Relapsed or Refractory Grade 1-3A Follicular Lymphoma November 7, 2016 May 18, 2023
NCT02958787 Completed Phase 2 Vessel Sparing Prostate Radiation Therapy November 2004 October 2009
NCT02970617 Completed N/A Ringing a Bell on the Final Day of Radiation Therapy in Improving the Memory of Distress in Cancer Patients August 15, 2016 November 15, 2018
NCT02990468 Completed Phase 1/Phase 2 A Trial of Concurrent Radiation Therapy, Cisplatin, and BMX-001 in Locally Advanced Head and Neck Cancer April 19, 2017 March 31, 2022
NCT03095209 Completed Observation Study of Patients With Non-Small Cell Lung Cancer and Esophageal Cancer Treated With Chemo-Radiation Followed by Surgery February 24, 2017 January 18, 2021
NCT03109080 Completed Phase 1 Olaparib & Radiation Therapy for Patients Triple Negative Breast Cancer (TNBC) July 24, 2017 November 29, 2021
NCT03151642 Completed A PILOT STUDY OF DIFFUSION WEIGHTED MRI TO ASSESS ESOPHAGEAL TUMOR RESONSE TO NEOADJUVANT CHEMORADIATION April 5, 2017 April 23, 2021
NCT03165994 Completed Phase 2 APX005M With Concurrent Chemoradiation for Resectable Esophageal and Gastroesophageal Junction Cancers October 6, 2017 February 21, 2023
NCT03224104 Completed Phase 1 Study of TG02 in Elderly Newly Diagnosed or Adult Relapsed Patients With Anaplastic Astrocytoma or Glioblastoma June 12, 2018 May 5, 2022
NCT03267888 Completed Phase 1 Pembrolizumab and Radiation Therapy in Patients With Relapsed or Refractory Multiple Myeloma May 29, 2018 September 2, 2022
NCT03281811 Completed Early Phase 1 Photodynamic Therapy in Treating Patients With Refractory Mycosis Fungoides November 13, 2017 August 12, 2020
NCT03297710 Completed Phase 1 TAS-102 and Radiation Therapy in Treating Patients With Rectal Cancer That Is Locally Recurrent, Metastatic, or Cannot Be Removed by Surgery December 11, 2017 April 30, 2021
NCT03320421 Completed N/A Hypofractionated Radiation Therapy With Concomitant Boost in Treating Women After Breast Conserving Surgery January 1, 2017 January 1, 2019
NCT03324802 Completed Phase 3 Hypofractionated Radiation Therapy in Preventing Recurrence in Patients With Breast Cancer After Surgery February 7, 2018 August 28, 2023
NCT03335540 Completed Phase 1 An Adaptive Study to Match Patients With Solid Tumors to Various Immunotherapy Combinations Based Upon a Broad Biomarker Assessment May 7, 2018 August 25, 2021
NCT03338959 Completed Phase 1/Phase 2 Pembrolizumab and Radiation Therapy in Treating Patients With Intermediate or High-Grade Soft Tissue Sarcoma March 28, 2018 August 4, 2023
NCT03438318 Completed Phase 1 Study Evaluating CMP-001 in Combination With Atezolizumab in Participants With Non-Small Cell Lung Cancer March 15, 2018 December 11, 2019
NCT03477110 Completed Early Phase 1 Temozolomide, Radiation Therapy, and Tumor Treating Fields Therapy in Treating Participants With Glioblastoma May 4, 2018 January 26, 2024
NCT03515538 Completed Phase 2 Safety and Efficacy of RRx-001 in the Attenuation of Oral Mucositis in Patients Receiving Chemoradiation for the Treatment of Oral Cancers July 12, 2018 October 8, 2020
NCT03523351 Completed Phase 1/Phase 2 Study of Palliative Radiation Therapy vs. no Palliative Radiation Therapy for Patients With High Risk Bone Metastases That Are Not Causing Significant Pain May 1, 2018 April 18, 2024
NCT03524170 Completed Phase 1 Radiation Therapy and M7824 in Treating Patients With Metastatic Hormone Receptor Positive, HER2 Negative Breast Cancer April 30, 2018 February 10, 2022
NCT03617913 Completed Phase 2 Avelumab in Combination With Fluorouracil and Mitomycin or Cisplatin and Radiation Therapy in Treating Participants With Muscle-Invasive Bladder Cancer September 19, 2018 July 27, 2020
NCT03677531 Completed Phase 1 Video Distraction to Decrease Use of Sedation in Pediatric Participants During Radiation Therapy May 31, 2018 September 25, 2019
NCT03691493 Completed Phase 2 Radiation Therapy, Palbociclib, and Hormone Therapy in Treating Breast Cancer Patients With Bone Metastasis February 8, 2019 October 13, 2022
NCT03696355 Completed Phase 1 Study of GDC-0084 in Pediatric Patients With Newly Diagnosed Diffuse Intrinsic Pontine Glioma or Diffuse Midline Gliomas November 19, 2018 September 4, 2022
NCT03798639 Completed Phase 1 Nivolumab and Radiation Therapy or Ipilimumab as Adjuvant Therapy in Treating Patients With Merkel Cell Cancer January 7, 2019 December 2, 2022
NCT03824366 Completed N/A Same-session MR-only Simulation and Treatment With MRI-guided Adaptive Palliative RadioTherapy April 23, 2019 January 14, 2022
NCT04050085 Completed Phase 1 SD-101, Nivolumab, and Radiation Therapy in Treating Patients With Chemotherapy-Refractory Metastatic Pancreatic Cancer August 15, 2019 May 14, 2022
NCT04091867 Completed Phase 1 sEphB4-HSA With RT+Chemo or Cetux in Patients With Intermediate to High Risk LAHNSCC January 6, 2020 October 25, 2022
NCT04451603 Completed LiverMultiScan Analysis of MRI Scans in HCC October 19, 2018 December 31, 2023
NCT04465162 Completed Phase 2 Radiation Therapy Alone for the Treatment of Stage 1 and 2 Mucosa-Associated Lymphoid Tissue (MALT) Lymphoma June 7, 2000 March 15, 2021
NCT04541355 Completed Phase 2 Sodium Thiosulfate in Preventing Ototoxicity for Squamous Cell Cancer Patients Undergoing Chemoradiation With Cisplatin October 14, 2020 July 31, 2023
NCT04636762 Completed Phase 2 A Study of Concurrent Chemoradiation With Atezolizumab in Participants With Untreated Extensive-Stage (ES) Small Cell Lung Cancer (SCLC) June 1, 2020 May 1, 2022
NCT04782726 Completed N/A Radiation Therapy Plan Quality Improvement Using Ideal Theoretical Isodose Distribution December 16, 2021 January 20, 2023
NCT01968538 Enrolling by invitation Metabolomic Study for Localized Prostate Cancer January 2009 December 2024
NCT06310369 Not yet recruiting Phase 2 Radiotherapy for BCG-unresponsive Non-muscle-invasive Carcinoma in Situ (CIS) Bladder Cancer March 1, 2025 March 1, 2030
NCT04176081 Not yet recruiting Phase 2 Study of Radiation Therapy in Combination With Darolutamide + Degarelix in Intermediate Risk Prostate Cancer July 2, 2024 December 2028
NCT06025747 Not yet recruiting Phase 1 Evaluation of Abemaciclib and Radiation Therapy Before Surgery for the Treatment of High-Risk Adipocytic Retroperitoneal Sarcoma July 1, 2024 March 3, 2026
NCT06305715 Not yet recruiting Phase 2 Radiation Prior to TKI to Delay Progression in Advanced Driver-Mutated Non-small Cell Lung Cancers (RadiaNCe Lung X) July 15, 2024 June 15, 2028
NCT05962242 Not yet recruiting Phase 2 HPV DNA-Guided Radiotherapy De-intensification of Head and Neck Squamous Cell Carcinoma January 1, 2024 November 1, 2029
NCT06236997 Not yet recruiting Phase 2 Adebrelimab and Concurrent Radiochemotherapy as First-line Treatment for Extensive-stage Small-cell Lung Cancer February 10, 2024 December 31, 2027
NCT06434350 Not yet recruiting Phase 1/Phase 2 Enfortumab Vedotin With Radiation for Locally Advanced Bladder Cancer (CONSOLIDATE) November 29, 2024 September 24, 2027
NCT06124157 Not yet recruiting Phase 3 A Study Comparing the Combination of Dasatinib and Chemotherapy Treatment With or Without Blinatumomab for Children, Adolescents, and Young Adults With Philadelphia Chromosome Positive (Ph+) or Philadelphia Chromosome-Like (Ph-Like) ABL-Class B-Cell Acute Lymphoblastic Leukemia (B-ALL) July 22, 2024 December 1, 2030
NCT05296005 Not yet recruiting Phase 1 Neoadjuvant Therapy for the Treatment of Gastroesophageal Junction and Gastric Cancers May 31, 2022 December 31, 2024
NCT04157478 Not yet recruiting Phase 2 Addition of Anlotinib Hydrochloride to the Stupp Regimen Versus the Stupp Regimen Alone for Newly Diagnosed Glioblastoma January 2020 December 2024
NCT03541486 Not yet recruiting Phase 2 A Clinical Trial Evaluating the Effect of Pharmacological Ascorbate on Radiation Therapy for Pancreatic Cancer Patients December 31, 2025 December 31, 2030
NCT05986318 Not yet recruiting Phase 2 Reducing Respiratory Symptoms of Pulmonary Irradiation in Interstitial Lung Disease May 1, 2024 December 31, 2032
NCT06099951 Not yet recruiting Phase 2 Total Neoadjuvant Treatment for pMMR Locally Advanced Low Rectal Cancer: Anti-PD-1 Antibody With FOLFOXIRI and Preoperative Radiation Therapy November 1, 2023 September 1, 2027
NCT05608369 Not yet recruiting Phase 2 Vorinostat in Combination With Chemoradiation in Locally Advanced HPV Negative HNSCC June 1, 2024 February 1, 2026
NCT06448286 Not yet recruiting Phase 3 PH Weighted Chemical Exchange Saturation Transfer MRI-Based Surgical Resection to Improve Survival in Patients With Glioblastoma June 1, 2024 June 1, 2027
NCT06330545 Not yet recruiting N/A Radiation Therapy for Dupuytren's Contracture Following Non-Surgical Release April 2024 April 2032
NCT06344130 Not yet recruiting Phase 1 Hypofractionation Trial of Re-irradiation in Good Prognosis Recurrent Glioblastoma June 23, 2024 December 31, 2027
NCT05721755 Recruiting Phase 3 Combining Radiation Therapy With Immunotherapy for the Treatment of Metastatic Squamous Cell Carcinoma of the Head and Neck June 8, 2023 March 31, 2030
NCT05190172 Recruiting N/A PRO-GLIO: PROton Versus Photon Therapy in IDH-mutated Diffuse Grade II and III GLIOmas January 14, 2022 December 31, 2041
NCT03919071 Recruiting Phase 2 Dabrafenib Combined With Trametinib After Radiation Therapy in Treating Patients With Newly-Diagnosed High-Grade Glioma February 20, 2020 September 30, 2027
NCT02098252 Recruiting N/A Treatment of Brain AVMs (TOBAS) Study May 2014 January 2036
NCT04567771 Recruiting N/A Comparison of Proton or Intensity Modulated Radiation Therapy After Surgery for Endometrial or Cervical Cancer December 4, 2020 October 15, 2024
NCT02927912 Recruiting Phase 2 Intraoperative Electron Beam Radiotherapy Boost in Treating Patients With Stage I-II Breast Cancer Undergoing Surgery With Reconstruction October 16, 2017 December 31, 2024
NCT02106988 Recruiting Phase 2 Concurrent Chemotherapy and Radiation Therapy for Newly Diagnosed Nasal NK Cell Lymphoma January 16, 2015 January 31, 2034
NCT02912312 Recruiting Phase 2 Hypofractionated vs. Conventional Regional Nodal Radiation Therapy for Patients With Invasive Breast Cancer February 23, 2017 February 28, 2031
NCT03914625 Recruiting Phase 3 A Study to Investigate Blinatumomab in Combination With Chemotherapy in Patients With Newly Diagnosed B-Lymphoblastic Leukemia July 3, 2019 June 30, 2029
NCT02905591 Recruiting Phase 2 A Phase 2 Study Adding Ascorbate to Chemotherapy and Radiation Therapy for NSCLC November 16, 2018 December 31, 2027
NCT05704985 Recruiting Phase 1 Evaluating Safety and Biomarkers Using DK210 (EGFR) for Locally Advanced or Metastatic EGFR+ Tumors April 3, 2023 February 2025
NCT05198830 Recruiting Phase 2 Testing the Addition of an Anti-Cancer Drug, TRC102, to the Usual Chemotherapy Treatment (Pemetrexed, Cisplatin or Carboplatin) During Radiation Therapy for Stage III Non-Squamous Non-Small Cell Lung Cancer December 15, 2022 December 31, 2025
NCT05607017 Recruiting Early Phase 1 Losartan in Prevention of Radiation-Induced Heart Failure January 1, 2024 December 1, 2024
NCT05568550 Recruiting Phase 2 Pembro With Radiation With or Without Olaparib July 27, 2023 July 2, 2029
NCT05560009 Recruiting An Imaging Agent (Fluorodopa F 18) With Positron Emission Tomography/Magnetic Resonance Imaging for Assessing Treatment Response in Patients With High-Grade Soft Tissue Sarcomas November 10, 2022 July 1, 2025
NCT05236036 Recruiting Phase 1 Mycophenolate Mofetil in Combination With Standard of Care for the Treatment of Glioblastoma August 8, 2022 January 3, 2027
NCT05513443 Recruiting N/A Prostate Cancer IRE Study (PRIS) September 1, 2022 September 1, 2025
NCT05245682 Recruiting Early Phase 1 Tolinapant and Radiation for Cisplatin-Ineligible, Previously Untreated, Locally Advanced Head and Neck Cancer February 17, 2022 October 21, 2025
NCT05268614 Recruiting Phase 2 Risk Adapted De-Intensification of Radio-Chemotherapy for Oropharyngeal Squamous Cell Carcinoma May 16, 2022 June 2032
NCT04248452 Recruiting Phase 3 Testing the Addition of Radiotherapy to the Usual Treatment (Chemotherapy) for Patients With Esophageal and Gastric Cancer That Has Spread to a Limited Number of Other Places in the Body May 26, 2020 March 31, 2028
NCT05294120 Recruiting Phase 2 A Study on Radiation Therapy Guided by the Reflectance Confocal Microscopy (RCM)/Optical Coherence Tomography (OCT) Device in People With Basal Cell Carcinoma March 3, 2022 March 2025
NCT04402788 Recruiting Phase 2/Phase 3 Testing the Addition of Radiation Therapy to the Usual Immune Therapy Treatment (Atezolizumab) for Extensive Stage Small Cell Lung Cancer, The RAPTOR Trial January 7, 2021 April 30, 2027
NCT03875716 Recruiting N/A Study of De_Intensified Postoperative Radiation Therapy for HPV Associated Oropharyngeal Squamous Cell Carcinoma May 20, 2019 December 31, 2027
NCT03858205 Recruiting N/A Low-Dose Radiotherapy in Treating Painful Bone Metastases in Patients With Multiple Myeloma March 11, 2019 March 11, 2026
NCT05304585 Recruiting Phase 3 Chemotherapy for the Treatment of Patients With Newly Diagnosed Very Low-Risk and Low Risk Fusion Negative Rhabdomyosarcoma August 4, 2022 December 31, 2030
NCT05491226 Recruiting Phase 2 Reinvigorating TNBC Response to Immunotherapy With Combination Myeloid Inhibition and Radiation November 17, 2023 December 1, 2025
NCT02287428 Recruiting Phase 1 Personalized NeoAntigen Cancer Vaccine w RT Plus Pembrolizumab for Patients With Newly Diagnosed GBM November 2014 June 2026
NCT05336383 Recruiting Phase 2 Phase II Study of Salvage Radiation Treatment After B-cell Maturation Antigen Chimeric Antigen Receptor T-cell Therapy for Relapsed Refractory Multiple Myeloma May 31, 2022 December 7, 2024
NCT04588545 Recruiting Phase 1/Phase 2 Radiation Therapy Followed by Intrathecal Trastuzumab/Pertuzumab in HER2+ Breast Leptomeningeal Disease December 10, 2020 November 1, 2024
NCT03801902 Recruiting Phase 1 Testing the Safety of Adding Either Monalizumab (IPH2201) or Oleclumab (MEDI9447) to Durvalumab (MEDI4736) Plus Standard Radiation Therapy for Locally Advanced Non-small Cell Lung Cancer (NSCLC), The ARCHON-1 Trial October 28, 2019 March 31, 2025
NCT05387915 Recruiting Phase 2 Biomarker-Driven Radiation Therapy Dose Reduction After Transoral Robotic Surgery for the Treatment of HPV-Positive Oropharyngeal Cancer June 6, 2022 May 5, 2026
NCT02344121 Recruiting Intra- and Inter-fraction Changes in Radiation Therapy January 2015 January 1, 2030
NCT04594187 Recruiting Phase 2 Nodal Radiation Therapy for Sentinel Lymph Node Positive Melanoma August 26, 2021 February 24, 2025
NCT02468024 Recruiting Phase 3 JoLT-Ca Sublobar Resection (SR) Versus Stereotactic Ablative Radiotherapy (SAbR) for Lung Cancer July 2015 December 2024
NCT05488366 Recruiting Early Phase 1 Immunotherapy Combined With Radiotherapy for Metastatic Sarcoma August 3, 2022 August 2024
NCT04266249 Recruiting Phase 2 CompassHER2-pCR: Decreasing Chemotherapy for Breast Cancer Patients After Pre-surgery Chemo and Targeted Therapy March 13, 2020 December 31, 2038
NCT05443971 Recruiting Phase 2 Durvalumab and Grid Therapy for Non-small Cell Lung Cancer in Progression During or After Treatment With PACIFIC Regimen July 3, 2023 June 30, 2025
NCT05417386 Recruiting Phase 1 FOLFIRINOX + NIS793 in Pancreatic Cancer August 9, 2022 May 1, 2025
NCT05406232 Recruiting Temporal Immunologic Changes With Hypofractionated Radiation-Induced DNA Damage in Breast Cancer September 15, 2023 December 31, 2026
NCT05411094 Recruiting Phase 1 Testing the Safety of the Anti-Cancer Drugs Durvalumab and Olaparib During Radiation Therapy for Locally Advanced Unresectable Pancreatic Cancer May 22, 2023 March 31, 2025
NCT04594772 Recruiting Phase 2 Adaptive Approach to Neoadjuvant Therapy to Maximize Resection Rates for Pancreatic Adenocarcinoma March 17, 2021 January 1, 2026
NCT06295744 Recruiting N/A Outcomes and Cosmesis With Whole Breast Irradiation and Boost April 17, 2024 February 2032
NCT03746080 Recruiting Phase 2 Whole Brain Radiation Therapy With Standard Temozolomide Chemo-Radiotherapy and Plerixafor in Treating Patients With Glioblastoma December 4, 2018 July 2027
NCT03739411 Recruiting Phase 1 Hyperpolarized Imaging in Diagnosing Participants With Glioma December 9, 2015 June 30, 2024
NCT04614909 Recruiting Early Phase 1 Study of Pamiparib in Newly Diagnosed and rGBM January 11, 2021 December 2024
NCT04097067 Recruiting N/A ISRT 20 Gy for Indolent Localized Gastrointestinal (GI)-Lymphoma September 1, 2019 August 31, 2025
NCT04616248 Recruiting Phase 1 In Situ Immunomodulation With CDX-301, Radiation Therapy, CDX-1140 and Poly-ICLC in Patients w/ Unresectable and Metastatic Solid Tumors January 9, 2023 January 9, 2026
NCT04175431 Recruiting Phase 2 Prostate Specific Membrane Antigen (PSMA) or (FACBC) PET/CT Site-Directed Therapy for Treatment of Prostate Cancer, Flu-BLAST-PC Study September 30, 2020 July 1, 2029
NCT04427566 Recruiting Phase 2 Low Dose Whole Lung Radiation Therapy for Patients With COVID-19 and Respiratory Compromise July 23, 2020 December 31, 2021
NCT06244004 Recruiting Phase 2 FDG-PET-Guided Metastasis Directed Radiation Therapy for the Treatment of Metastatic Hormone Sensitive Prostate Cancer, The PRTY Trial February 18, 2024 February 18, 2028
NCT04623931 Recruiting Phase 2 Chemotherapy and Radiation Therapy for the Treatment of IDH Wildtype Gliomas or Non-histological (Molecular) Glioblastomas January 30, 2020 December 31, 2026
NCT04428671 Recruiting Phase 1 Cemiplimab Before and After Surgery for the Treatment of High Risk Cutaneous Squamous Cell Cancer May 15, 2020 October 1, 2030
NCT04430699 Recruiting Phase 2 Cisplatin+Pembrolizumab+RT in Vulvar Cancer July 29, 2020 January 30, 2028
NCT04643366 Recruiting Phase 2 Total Neoadjuvant Therapy With mFOLFOX and Short-course Radiation in Resectable Rectal Cancer January 28, 2021 January 31, 2033
NCT04322318 Recruiting Phase 2 A Study of Combination Chemotherapy for Patients With Newly Diagnosed DAWT and Relapsed FHWT October 19, 2020 July 1, 2027
NCT04658537 Recruiting N/A Advanced Techniques for Single-fraction Palliative Radiotherapy Versus ASPIRE-single June 29, 2021 December 31, 2024
NCT03687957 Recruiting Phase 1/Phase 2 rhIL-7-hyFc on Increasing Lymphocyte Counts in Patients With Newly Diagnosed Non-severe Lymphopenic Gliomas Following Radiation and Temzolomide January 4, 2019 January 31, 2032
NCT03678025 Recruiting Phase 3 Standard Systemic Therapy With or Without Definitive Treatment in Treating Participants With Metastatic Prostate Cancer September 24, 2018 October 1, 2031
NCT04075305 Recruiting The MOMENTUM Study: The Multiple Outcome Evaluation of Radiation Therapy Using the MR-Linac Study February 1, 2019 May 1, 2025
NCT04359199 Recruiting QUantitative Assessment of Swallowing After Radiation (QUASAR) September 1, 2020 December 31, 2024
NCT06208826 Recruiting Phase 2 A Single-center Phase II Study to Investigate the Immune Maintenance Therapy Pattern in Patients With Locally Advanced Head and Neck Squamous Cell Carcinoma Who Have Achieved MPR After Neoadjuvant Immunotherapy Combined With Chemotherapy September 1, 2023 September 1, 2028
NCT04375891 Recruiting N/A Radiation Therapy Alone Versus Radiation Therapy Plus Radiofrequency Ablation (RFA)/Vertebral Augmentation May 22, 2020 May 2026
NCT04684368 Recruiting Phase 2 A Study of a New Way to Treat Children and Young Adults With a Brain Tumor Called NGGCT July 13, 2021 December 21, 2029
NCT04728230 Recruiting Phase 1/Phase 2 Olaparib and Durvalumab With Carboplatin, Etoposide, and/or Radiation Therapy for the Treatment of Extensive-Stage Small Cell Lung Cancer, PRIO Trial January 5, 2021 December 31, 2025
NCT04745390 Recruiting N/A Standard Versus Radiobiologically-Guided Dose Selected SBRT in Liver Cancer August 1, 2021 April 2027
NCT06177925 Recruiting Phase 2 A Phase Ⅱ Clinical Study of Adebrelimab Combined With Chemotherapy and Concurrent Radiotherapy for Extensive-Stage Oligometastatic SCLC December 10, 2023 September 30, 2026
NCT03598257 Recruiting Phase 2 Radiation Therapy With or Without Olaparib in Treating Patients With Inflammatory Breast Cancer January 18, 2019 June 1, 2027
NCT01473628 Recruiting Phase 1/Phase 2 Radiation Therapy and Rituximab in Treating Patients With Stage I-II Grade 1 or Grade 2 Follicular Lymphoma May 20, 2013 May 20, 2027
NCT04759586 Recruiting Phase 3 Nivolumab in Combination With Chemo-Immunotherapy for the Treatment of Newly Diagnosed Primary Mediastinal B-Cell Lymphoma October 5, 2021 September 30, 2027
NCT04837209 Recruiting Phase 2 Radiation, Immunotherapy and PARP Inhibitor in Triple Negative Breast Cancer July 21, 2021 December 1, 2029
NCT05099003 Recruiting Phase 1/Phase 2 A Study of the Drug Selinexor With Radiation Therapy in Patients With Newly-Diagnosed Diffuse Intrinsic Pontine (DIPG) Glioma and High-Grade Glioma (HGG) May 31, 2022 June 30, 2027
NCT05100095 Recruiting Phase 2 Hypofractionated Radiation Therapy for Merkel Cell Carcinoma December 14, 2021 September 1, 2028
NCT03161522 Recruiting Phase 2 Chemotherapy With or Without Radiation or Surgery in Treating Participants With Oligometastatic Esophageal or Gastric Cancer February 19, 2018 December 31, 2026
NCT05982691 Recruiting Development of Asian Consortium for Data Collection and Clinical Trial of CNS Tumors August 5, 2022 December 31, 2032
NCT01973179 Recruiting Re-irradiation of Recurrent Head and Neck Cancer July 2015 December 2026
NCT04545957 Recruiting N/A Jump: MR Simulation For Radiation Therapy Master Protocol October 14, 2020 October 22, 2026
NCT03107780 Recruiting Phase 1 Testing the Ability of AMG 232 (KRT 232) to Get Into the Tumor in Patients With Brain Cancer July 9, 2018 December 31, 2024
NCT03104439 Recruiting Phase 2 Nivolumab and Ipilimumab and Radiation Therapy in MSS and MSI High Colorectal and Pancreatic Cancer May 10, 2017 October 2026
NCT05124912 Recruiting N/A REMASTer: REcurrent Brain Metastases After SRS Trial May 10, 2022 October 2028
NCT05879653 Recruiting Phase 2 Pembrolizumab and EV With Radiation Therapy for MIBC Patients (PEVRAD) October 1, 2023 September 30, 2027
NCT05879250 Recruiting Phase 2 WP1066 and Radiation Therapy in Treating Patients With Newly Diagnosed Glioblastoma May 22, 2024 December 27, 2028
NCT05136846 Recruiting Phase 1 Papaverine in Combination With Chemoradiation for the Treatment of Stage II-III Non-small Cell Lung Cancer December 6, 2021 December 31, 2025
NCT05838599 Recruiting Early Phase 1 Combining Topical Imiquimod With Local Radiotherapy for Treatment of Mycosis Fungoides July 24, 2023 February 1, 2026
NCT02970448 Recruiting Early Phase 1 Expedited Laser Interstitial Thermal Therapy + Chemoradiation For Newly Diagnosed High Grade Gliomas August 24, 2017 June 1, 2024
NCT05781321 Recruiting Phase 2 Short Course Radiotherapy for the Treatment of Patients With Glioblastoma, SAGA Study March 23, 2023 March 2, 2028
NCT04555577 Recruiting Phase 1 Peposertib and Radiation Therapy, Followed by Temozolomide for the Treatment of Patients With Newly Diagnosed MGMT Unmethylated Glioblastoma or Gliosarcoma September 20, 2020 October 30, 2025
NCT04134260 Recruiting Phase 3 Testing the Addition of the Drug Apalutamide to the Usual Hormone Therapy and Radiation Therapy After Surgery for Prostate Cancer March 5, 2020 November 1, 2026
NCT05172245 Recruiting Phase 1 Testing the Addition of Ipatasertib to Usual Chemotherapy and Radiation for Head and Neck Cancer September 19, 2022 June 1, 2026
NCT03921684 Recruiting Phase 2 Trial of Nivolumab With FOLFOX After Chemoradiation in Rectal Cancer Patients April 2019 October 2025
NCT03921008 Recruiting Phase 1/Phase 2 Induction Paclitaxel Followed by Concurrent Paclitaxel and Radiation Therapy for Cutaneous Angiosarcoma May 21, 2019 August 31, 2027
NCT04525989 Recruiting N/A Preoperative Short-Course Radiation Therapy With PROtons Compared to Photons In High-Risk RECTal Cancer (PRORECT) April 20, 2021 March 2028
NCT03180268 Recruiting Phase 3 Observation or Radiation Therapy in Treating Patients With Newly Diagnosed Grade II Meningioma That Has Been Completely Removed by Surgery June 14, 2017 August 31, 2027
NCT04539808 Recruiting Phase 2 NeoOPTIMIZE: Early Switching of mFOLFIRINOX or Gemcitabine/Nab-Paclitaxel Before Surgery for the Treatment of Resectable, Borderline Resectable, or Locally-Advanced Unresectable Pancreatic Cancer May 27, 2021 October 5, 2025
NCT06369610 Recruiting Phase 2 Risk Stratified De-escalated Hormone Therapy With Radiation Therapy for the Treatment Prostate Cancer April 22, 2024 April 22, 2027
NCT05076513 Recruiting Early Phase 1 Trial of Niraparib in Participants With Newly-diagnosed Glioblastoma and Recurrent Glioma October 29, 2021 February 2025
NCT05083754 Recruiting Phase 1 Carmustine Wafer in Combination With Retifanlimab and Radiation With/Without Temozolomide in Subjects With Glioblastoma August 31, 2022 January 2027
NCT06306924 Recruiting UNC Metastatic Cancer Radiation Therapy Registry April 21, 2024 May 2033
NCT06172296 Recruiting Phase 3 Dinutuximab With Chemotherapy, Surgery and Stem Cell Transplantation for the Treatment of Children With Newly Diagnosed High Risk Neuroblastoma April 19, 2024 December 31, 2029
NCT06140407 Recruiting Phase 2 Pembrolizumab After Radiation Therapy and Chemotherapy in Limited Stage Small Cell Lung Cancer May 8, 2024 May 31, 2029
NCT04879940 Recruiting Phase 2 Phase II Study to Evaluate the Safety and Efficacy of Prostatic Artery Embolization February 23, 2022 August 1, 2024
NCT04892173 Recruiting Phase 3 NBTXR3 With or Without Cetuximab in LA-HNSCC January 5, 2022 January 2026
NCT06129747 Recruiting Phase 2 Repeat Breast Conserving Surgery Followed by Daily Partial Breast Irradiation in Ipsilateral Breast November 30, 2023 August 9, 2029
NCT04894188 Recruiting N/A Neoadjuvant Hormone and Radiation Therapy Followed by Radical Prostatectomy in Patients With High-Risk Prostate Cancer January 27, 2022 July 1, 2041
NCT04902040 Recruiting Phase 1/Phase 2 Plinabulin in Combination With Radiation/Immunotherapy in Patients With Select Advanced Cancers After Progression on PD-1 or PD-L1 Targeted Antibodies April 14, 2021 June 1, 2025
NCT03423628 Recruiting Phase 1 A Study to Assess the Safety and Tolerability of AZD1390 Given With Radiation Therapy in Patients With Brain Cancer April 2, 2018 April 22, 2026
NCT03398161 Recruiting Phase 2 Ultra Low Dose Radiation Therapy in Treating Patients With Mycosis Fungoides January 6, 2018 December 31, 2024
NCT03391869 Recruiting Phase 3 Nivolumab and Ipilimumab With or Without Local Consolidation Therapy in Treating Patients With Stage IV Non-Small Cell Lung Cancer December 29, 2017 December 31, 2025
NCT04947254 Recruiting Phase 2 Androgen Ablation Therapy With or Without Niraparib After Radiation Therapy for the Treatment of High-Risk Localized or Locally Advanced Prostate Cancer August 5, 2021 June 7, 2026
NCT04229459 Recruiting Phase 2 Trial of Nivolumab and Cetuximab After Chemoradiation in Esophageal Squamous Cell Carcinoma Patients. December 30, 2019 June 2027
NCT04030260 Recruiting Phase 2 Regorafenib and PD-1 Antibody in Combination With Radiotherapy for pMMR/MSS Metastatic Colorectal Cancer July 19, 2019 July 19, 2023
NCT03383094 Recruiting Phase 2 Chemoradiation vs Immunotherapy and Radiation for Head and Neck Cancer March 15, 2018 June 2025
NCT06116786 Recruiting Phase 1 A Study of JNJ-86974680 in Participants With Advanced Non-small Cell Lung Cancer November 27, 2023 July 27, 2028
NCT04984343 Recruiting Phase 2 Randomized Trial of Five or Two MRI-Guided Adaptive Radiotherapy Treatments for Prostate Cancer February 11, 2022 December 31, 2027
NCT04025372 Recruiting Phase 2 INTREPId (INTermediate Risk Erection PreservatIon Trial) June 1, 2020 March 1, 2028
NCT04994132 Recruiting Phase 3 A Study to Compare Early Use of Vinorelbine and Maintenance Therapy for Patients With High Risk Rhabdomyosarcoma September 14, 2021 September 30, 2027
NCT04997018 Recruiting Phase 2 A Study of MRI-guided High-dose Radiation Therapy in Prostate Cancer August 4, 2021 August 4, 2026
NCT06065449 Recruiting Phase 3 A Phase III Randomized Trial Comparing Stereotactic Body Radiation Therapy (SBRT) vs Conventional Palliative Radiation Therapy for Painful Bone Metastases January 24, 2024 June 27, 2027
NCT06064097 Recruiting Phase 2 A Study Using Nivolumab, in Combination With Chemotherapy Drugs to Treat Nasopharyngeal Carcinoma (NPC) January 17, 2025 August 31, 2026
NCT06037863 Recruiting N/A Evaluation of the Impact of Empty Versus Full Bladder in Patients With Prostate Cancer, RELIEF Trial September 19, 2023 September 19, 2028
NCT04477200 Recruiting Phase 1 Mycophenolate Mofetil Combined With Radiation Therapy in Glioblastoma August 5, 2020 October 2027
NCT03987386 Recruiting Phase 3 Conventional or Hypofractionated Radiation Therapy in Treating Patients With Prostate Cancer May 30, 2019 November 1, 2025
NCT04151940 Recruiting N/A PET/CT Changes During Chemoimmunotherapy and Radiation Therapy in Patients With Stage IV Non-small Cell Lung Cancer September 26, 2019 November 30, 2026
NCT05009992 Recruiting Phase 2 Combination Therapy for the Treatment of Diffuse Midline Gliomas October 20, 2021 June 30, 2029
NCT03968406 Recruiting Phase 1 Talazoparib and Radiation Therapy in Treating Patients With Locally Recurrent Gynecologic Cancers September 26, 2019 October 1, 2024
NCT04505267 Recruiting Phase 1 NBTXR3 and Radiation Therapy for the Treatment of Inoperable Recurrent Non-small Cell Lung Cancer February 10, 2021 March 31, 2026
NCT03959085 Recruiting Phase 3 Inotuzumab Ozogamicin and Post-Induction Chemotherapy in Treating Patients With High-Risk B-ALL, Mixed Phenotype Acute Leukemia, and B-LLy October 31, 2019 March 31, 2030
NCT05024097 Recruiting Phase 2 A Phase I-II Study to Test the Safety and Efficacy of PD1 (AB122) and Adenosine Receptor (AB928) Antagonists With Chemotherapy After Short-Course Radiation for Rectal Cancer. March 31, 2022 December 2027
NCT05030298 Recruiting Phase 1/Phase 2 Preoperative Radiosurgery for the Treatment of High Grade Glioma, The NeoGlioma Study May 23, 2023 September 15, 2025
NCT03945721 Recruiting Phase 1 A Phase I Study of Niraparib Administered Concurrently With Postoperative RT in Triple Negative Breast Cancer Patients July 11, 2019 December 31, 2026
NCT03257163 Recruiting Phase 2 Pembrolizumab, Capecitabine, and Radiation Therapy in Treating Patients With Mismatch-Repair Deficient and Epstein-Barr Virus Positive Gastric Cancer September 29, 2017 December 31, 2025
NCT04513717 Recruiting Phase 3 Two Studies for Patients With High Risk Prostate Cancer Testing Less Intense Treatment for Patients With a Low Gene Risk Score and Testing a More Intense Treatment for Patients With a High Gene Risk Score, The PREDICT-RT Trial December 15, 2020 December 31, 2033
NCT04391049 Recruiting Phase 1 Testing the Addition of the Anti-cancer Viral Therapy Telomelysin™ to Chemoradiation for Patients With Advanced Esophageal Cancer and Are Not Candidates for Surgery June 29, 2020 October 1, 2025
NCT05039632 Recruiting Phase 1/Phase 2 Phase I/II Randomized Study of NBTXR3 Activated by Abscopal or RadScopal Radiation in Combination With Immunotherapy (Anti-PD-1/L-1) for Patients With Advanced Solid Malignancies May 8, 2023 February 1, 2026
NCT05050084 Recruiting Phase 3 Two Studies for Patients With Unfavorable Intermediate Risk Prostate Cancer Testing Less Intense Treatment for Patients With a Low Gene Risk Score and Testing a More Intense Treatment for Patients With a Higher Gene Risk Score November 3, 2021 April 30, 2037
NCT05050162 Recruiting Phase 2/Phase 3 Comparing High-Dose Cisplatin Every Three Weeks to Low-Dose Cisplatin Weekly When Combined With Radiation for Patients With Advanced Head and Neck Cancer October 27, 2021 February 9, 2036
NCT06004336 Recruiting Phase 2 A Randomized Trial of Maintenance Systemic Therapy After Radiation for Oligometastatic Renal Cell Carcinoma (ASTROs) October 31, 2023 January 1, 2029
NCT03213925 Recruiting Phase 2 Neoadjuvant Chemotherapy Followed by Radiotherapy Alone in Patients With Breast Cancer June 1, 2017 July 1, 2025
NCT03604991 Suspended Phase 2/Phase 3 Nivolumab and Ipilimumab in Treating Patients With Esophageal and Gastroesophageal Junction Adenocarcinoma Undergoing Surgery May 3, 2019 January 31, 2026
NCT03197506 Suspended Phase 2 Pembrolizumab and Standard Therapy in Treating Patients With Glioblastoma September 15, 2017 August 31, 2024
NCT03712605 Suspended Phase 3 Testing Pembrolizumab Versus Observation in Patients With Merkel Cell Carcinoma After Surgery, STAMP Trial November 15, 2018 December 31, 2025
NCT03958383 Suspended Phase 1/Phase 2 IT-hu14.18-IL2 With Radiation, Nivolumab and Ipilimumab for Melanoma January 30, 2020 August 15, 2025
NCT05382338 Suspended Phase 3 A Study of Treatment for Medulloblastoma Using Sodium Thiosulfate to Reduce Hearing Loss February 20, 2023 December 20, 2027
NCT00002696 Suspended Phase 3 Combination Chemotherapy in Treating Women With Stage III Breast Cancer October 1995
NCT05501665 Suspended Phase 1/Phase 2 Split Course Adaptive Radiation Therapy With Pembrolizumab With/Without Chemotherapy for Treating Stage IV Lung Cancer May 9, 2023 February 1, 2027
NCT04751370 Suspended Phase 2 Testing Nivolumab and Ipilimumab With Short-Course Radiation in Locally Advanced Rectal Cancer February 8, 2022 December 31, 2026
NCT00003040 Terminated Phase 2 S9709, Laser Surgery Plus Radiation Therapy in Treating Patients With Early Stage Cancer of the Larynx September 1997 December 2007
NCT04381988 Terminated Phase 2 A Study of Hydroxychloroquine vs Placebo to Prevent COVID-19 Infection in Patients Receiving Radiotherapy May 7, 2020 April 21, 2021
NCT00882583 Terminated Phase 1 A Study of Dasatinib, Cetuximab and Radiation With or Without Cisplatin in HNSCC July 2009 February 2016
NCT00897377 Terminated Phase 3 Treatment Strategy for Low-grade Gliomas December 2007
NCT04406857 Terminated Phase 1 Testing the Addition of a Radiation Sensitizing Drug, IPdR, to the Usual Chemotherapy Treatment (Capecitabine) During Radiation Therapy for Rectal Cancer March 17, 2021 January 18, 2023
NCT00915694 Terminated Phase 1 Nelfinavir Mesylate, Radiation Therapy, and Temozolomide in Treating Patients With Glioblastoma Multiforme April 2009 December 2015
NCT00054067 Terminated Phase 3 Chemotherapy and Radiation Therapy With or Without Surgery in Treating Patients With Stage I Cancer of the Cervix February 2003
NCT04457245 Terminated Phase 3 Randomized Trial of PSMA PET Scan Before Definitive Radiation Therapy for Prostate Cancer August 14, 2020 January 10, 2023
NCT00948688 Terminated Phase 1/Phase 2 Vorinostat With XRT and 5-FU for Locally Advanced Adenocarcinoma of the Pancreas August 2009 November 2013
NCT00955240 Terminated Phase 2 Radiation Therapy, Cisplatin, Fluorouracil, and Cetuximab in Treating Patients With Locally Advanced Anal Cancer March 2009 November 26, 2010
NCT00002899 Terminated Phase 3 Adjuvant Radiation Therapy in Treating Patients With Brain Metastases November 1996
NCT00053014 Terminated Phase 2 S0125, Chemotherapy, Total-Body Irradiation, and Peripheral Stem Cell Transplantation in Treating Older Patients With Acute Myeloid Leukemia April 2003 June 2006
NCT00002772 Terminated Phase 3 S9623, Combination Chemotherapy Plus Peripheral Stem Cell Transplantation in Treating Women With Breast Cancer July 1996 February 2004
NCT01134601 Terminated Phase 1 A Phase I Study of AZD6244 in Combination With Capecitabine and Radiotherapy in Locally Advanced Adenocarcinoma of the Rectum May 24, 2010 October 22, 2012
NCT01167192 Terminated Phase 2 Neoadjuvant Platinum-based Chemoradiation Therapy for Locally Advanced Triple Negative Breast Cancer February 2011 September 2016
NCT01186406 Terminated Phase 2 Gliadel, XRT, Temodar, Avastin Followed by Avastin, Temodar for Newly Diagnosed Glioblastoma Multiforme (GBM) April 2011 June 16, 2014
NCT01197664 Terminated Phase 1 Paricalcitol, Fluorouracil, and Radiation Therapy in Treating Patients With Rectal Cancer That Can Be Removed in Surgery August 2010 April 2014
NCT01240304 Terminated Phase 2 A Phase II Study to Assess the Efficacy and Safety of Preoperative Chemo With Radiation Therapy for Patients With Borderline Unresectable Adenocarcinoma of the Pancreas November 2010 October 2019
NCT00045617 Terminated Phase 2 S0122: Combination Chemotherapy, Radiation Therapy, and Vaccine Therapy in Limited-Stage Small Cell Lung Cancer January 2003 May 2003
NCT01305772 Terminated Phase 2 Identification of Gene Expression Signature for Panitumumab Sensitivity in Untreated Locally Advanced SCCHN January 2011 May 2012
NCT01307956 Terminated Phase 2 Panitumumab, Combination Chemotherapy, & Radiation Therapy in Esophageal or Gastroesophageal Junction Cancer February 28, 2011 December 23, 2015
NCT01324141 Terminated Phase 1 Topical MTS-01 for Dermatitis During Radiation and Chemotherapy for Anal Cancer March 18, 2011 April 15, 2015
NCT00042835 Terminated Phase 1 Erlotinib and Radiation Therapy Plus Combination Chemotherapy in Treating Patients With Inoperable Stage III Non-Small Cell Lung Cancer May 2002
NCT01373463 Terminated Phase 1 Cisplatin and Pemetrexed With Radiation Followed by Lobectomy May 2011 June 2012
NCT01400672 Terminated Phase 1 Imiquimod/Brain Tumor Initiating Cell (BTIC) Vaccine in Brain Stem Glioma July 17, 2012 October 8, 2018
NCT00041288 Terminated Phase 2 Study Of Two Non-Myeloablative Stem Cell Transplant Strategies For Low-Grade Lymphoma And CLL October 2001 January 2003
NCT01417403 Terminated Phase 1 Hydroxychloroquine in Treating Patients With Solid Tumors Undergoing Radiation Therapy for Bone Metastases August 2011 July 2014
NCT01427322 Terminated Early Phase 1 Randomized RT +/- Lapatinib for Advanced Solid Tumor Cancer Patients Receiving Radiation Therapy for Metastatic Disease September 2011 July 2015
NCT01441115 Terminated Phase 1 ECI301 and Radiation for Advanced or Metastatic Cancer September 6, 2011 April 24, 2013
NCT01461772 Terminated Phase 3 Efficacy and Safety Study of Concurrent Chemoradiation Therapy to Treat Locally Advanced Cervical Cancer December 2009 May 2014
NCT01508117 Terminated Phase 2 Phase II Axitinib (AG-013736) in Elderly Glioblastoma Multiforme (GBM) Patients August 2011 October 2012
NCT01682031 Terminated Phase 2 Selenomethionine in Reducing Mucositis in Patients With Locally Advanced Head and Neck Cancer Who Are Receiving Cisplatin and Radiation Therapy June 2009 June 2012
NCT01689974 Terminated Phase 2 Phase II Randomized Trial of Ipilimumab Versus Ipilimumab and Radiotherapy in Metastatic Melanoma January 2013 March 2015
NCT01693276 Terminated Phase 1/Phase 2 Gemcitabine/Abraxane Chemotherapy and Dose Escalated Radiotherapy for Locally Advanced, Unresectable Pancreatic Cancer September 2012 June 2014
NCT01729923 Terminated Phase 2 A Trial of Maintenance ADAPT Therapy With Capecitabine and Celecoxib in Patients With Metastatic Colorectal Cancer March 2013 September 6, 2016
NCT00033449 Terminated Phase 1 Gefitinib and Radiation Therapy With or Without Cisplatin in Treating Patients With Stage III or Stage IV Head and Neck Cancer February 2002
NCT01754519 Terminated Phase 2 Radiation Therapy in Treating Post-Menopausal Women With Early Stage Breast Cancer Undergoing Surgery May 2013 August 2015
NCT01758458 Terminated Phase 1/Phase 2 Viral Oncoprotein Targeted Autologous T Cell Therapy for Merkel Cell Carcinoma February 2013 May 2016
NCT01760941 Terminated N/A Compassionate Same-Day Evaluation & Delivery of XRT for Bony Metastasis in Hospice Patients March 2013 June 2015
NCT01767935 Terminated N/A Cryosurgery and Radiation Therapy in Treating Patients With Painful Bone Metastases July 2014 December 2014
NCT01769222 Terminated Phase 1 Ipilimumab and Local Radiation for Selected Solid Tumors February 2013 June 2015
NCT01769508 Terminated Phase 2 Study of 5-FU, Oxaliplatin, & Lapatinib Combined With Radiation Therapy to Treat HER2 Positive Esophagogastric Cancer February 2013 February 2015
NCT00031798 Terminated Phase 3 Methylphenidate to Improve Quality of Life in Patients Undergoing Radiation Therapy for Brain Tumors April 1, 2002 May 1, 2006
NCT01822275 Terminated Phase 2 Phase II Trial of Low-Dose Whole Brain Radiotherapy With Concurrent Temozolomide and Adjuvant Temozolomide in Patients With Newly-Diagnosed Glioblastoma Multiforme May 2013 September 2019
NCT01822496 Terminated Phase 2 Erlotinib Hydrochloride or Crizotinib and Chemoradiation Therapy in Treating Patients With Stage III Non-small Cell Lung Cancer November 4, 2013 June 4, 2018
NCT00031577 Terminated Phase 1 Paclitaxel Plus Radiation Therapy in Treating Children With Newly Diagnosed Brain Stem Glioma August 1999 September 2006
NCT01851161 Terminated Prone Patient Positioning in Reducing Tumor Motion and Improving Breathing Reproduction in Patients With Lung Cancer Undergoing Radiation Therapy May 2010 September 2015
NCT00030511 Terminated Phase 2 Radiation Therapy and Fluorouracil Before Surgery in Treating Patients With Primary or Recurrent Bile Duct Cancer October 2001
NCT00028704 Terminated Phase 3 Breast-Conserving Therapy Compared With Mastectomy Followed By Radiation Therapy in Treating Women With Locally Advanced Breast Cancer Previously Treated With Chemotherapy October 2001
NCT01868503 Terminated Phase 2 Lapatinib Ditosylate and Radiation Therapy in Treating Patients With Locally Advanced or Locally Recurrent Breast Cancer July 2013 July 2015
NCT05110781 Terminated Phase 2 Atezolizumab Before Surgery for the Treatment of Regionally Metastatic Head and Neck Squamous Cell Cancer With an Unknown or Historic Primary Site December 7, 2021 April 18, 2023
NCT02046187 Terminated Phase 1/Phase 2 Ketogenic Diet With Radiation and Chemotherapy for Newly Diagnosed Glioblastoma October 2013 February 2017
NCT00088881 Terminated Phase 2 Rituximab, Combination Chemotherapy, and 90-Yttrium Ibritumomab Tiuxetan for Patients With Stage I or II Non-Hodgkin's Lymphoma December 2004 March 2011
NCT00089544 Terminated Phase 2 Preoperative Thalidomide With Radiation Therapy For Patients With Low-Grade Primary Soft Tissue Sarcoma or Thalidomide With Radiation Therapy and Chemotherapy For Patients With High-Grade or Intermediate-Grade Primary Soft Tissue Sarcoma of the Arm, Leg, or Body Wall June 17, 2004 November 5, 2013
NCT00025298 Terminated Phase 2 Chemotherapy Plus Radiation Therapy With or Without Amifostine in Treating Patients With Locally Advanced Cancer of the Nasopharynx July 2001
NCT00093652 Terminated Phase 1/Phase 2 Oxaliplatin, Gefitinib, and Radiation Therapy in Treating Patients With Locally Advanced or Metastatic Esophageal Cancer May 2003
NCT02243007 Terminated Phase 2 Phase II Study of Preoperative FOLFIRINOX Versus Gemcitabine/Nab-Paclitaxel in Patients With Resectable Pancreatic Cancer September 2014 June 2016
NCT00104936 Terminated Phase 3 Radiotherapy or Radiosurgery Compared With Observation Alone in Treating Patients With Newly Diagnosed, Benign Meningioma That Has Been Partially Removed by Surgery December 2004
NCT00081224 Terminated Phase 2 Neoadjuvant Celecoxib and Capecitabine Combined With Pelvic Irradiation in Treating Patients With Stage II or Stage III Adenocarcinoma (Cancer) of the Rectum December 2004 November 2010
NCT00107471 Terminated Phase 1/Phase 2 Topotecan, G-CSF, and Radiation Therapy in Treating Young Patients With Newly Diagnosed Brain Stem Glioma October 2005
NCT00021112 Terminated Phase 2 Combination Chemotherapy Plus Radiation Therapy Followed by Surgery in Treating Patients With Stage IIIB Non-Small Cell Lung Cancer April 2001
NCT02266147 Terminated Phase 1/Phase 2 Study of SD-101 in Combination With Localized Low-dose Radiation in Patients With Untreated Low-grade B-cell Lymphoma October 2014 April 2017
NCT00109850 Terminated Phase 2 S0414 Cetuximab, Combo Chemo, and RT in Locally Advanced Esophageal Cancer May 2005 May 2012
NCT00113386 Terminated Phase 3 Cisplatin and Docetaxel With or Without Radiation Therapy in Treating Patients Who Are Undergoing Surgery for Newly Diagnosed Stage III Non-Small Cell Lung Cancer April 2005
NCT00113399 Terminated Phase 3 Combination Chemotherapy With or Without Radiation Therapy in Treating Patients With Recurrent Head and Neck Cancer That Cannot Be Removed By Surgery April 2005
NCT00020839 Terminated Phase 3 Temozolomide With or Without Radiation Therapy to the Brain in Treating Patients With Stage IV Melanoma That Is Metastatic to the Brain April 2001
NCT00118053 Terminated Phase 2 Trastuzumab, Docetaxel, and Carboplatin in Treating Women With Stage II, Stage III, or Inflammatory Breast Cancer April 2005 December 2008
NCT02392377 Terminated Phase 2 Molecular Phenotyping in Predicting Response in Patients With Stage IB-III Esophageal Cancer Receiving Combination Chemotherapy February 2015 December 2015
NCT00017277 Terminated Phase 3 Radiation Therapy With or Without Epoetin Alfa in Treating Patients With Head and Neck Cancer March 2001
NCT00158886 Terminated Phase 1 Oral Topotecan As A Radiosensitizing Agent In Rectal Cancer November 8, 2001 August 11, 2006
NCT00017173 Terminated Phase 2 S0011, Gene Therapy & Surgery Followed by Chemo & RT in Newly Diagnosed Cancer of the Mouth or Throat February 2003 July 2011
NCT02470533 Terminated Phase 2 Transarterial Chemoembolization Versus Stereotactic Body Radiation Therapy for Hepatocellular Carcinoma April 30, 2015 April 30, 2020
NCT00016276 Terminated Phase 3 Combination Chemotherapy, Surgery, and Radiation Therapy With or Without Dexrazoxane and Trastuzumab in Treating Women With Stage III or Stage IV Breast Cancer May 2001
NCT00014326 Terminated Phase 3 Involved-Field Radiation Therapy in Treating Patients With Previously Untreated Stage I or Stage II Low-Grade Non-Hodgkin's Lymphoma January 2001
NCT02530502 Terminated Phase 1 Radiation Therapy With Temozolomide and Pembrolizumab in Treating Patients With Newly Diagnosed Glioblastoma September 30, 2015 February 12, 2020
NCT00194792 Terminated Phase 2 Hormone Therapy and Combination Chemotherapy Before and After Surgery in Treating Patients With Stage I-IIIA Breast Cancer August 2005 July 2011
NCT00195078 Terminated Phase 1/Phase 2 Safety Trial of IRESSA, Cisplatin and Radiation Therapy for Patients With Head and Neck Cancer April 2004 September 2006
NCT02538471 Terminated Phase 2 LY2157299 Monohydrate (LY2157299) and Radiotherapy in Metastatic Breast Cancer August 10, 2015 February 20, 2019
NCT00014196 Terminated Phase 2 S0022:Combination Chemotherapy and Radiation Therapy in Treating Patients With Stage IIIB Non-Small Cell Lung Cancer March 2001 March 2005
NCT02584829 Terminated Phase 1/Phase 2 Localized Radiation Therapy or Recombinant Interferon Beta and Avelumab With or Without Cellular Adoptive Immunotherapy in Treating Patients With Metastatic Merkel Cell Carcinoma November 6, 2015 December 18, 2018
NCT00238277 Terminated Phase 2 Temozolomide During and After Radiation Therapy in Treating Patients Who Have Undergone Previous Surgery and Placement of Gliadel Wafers for Newly Diagnosed Glioblastoma Multiforme February 15, 2005 December 11, 2007
NCT00006994 Terminated Phase 3 S9908: Glutamine in Treating Mucositis Caused by Radiation Therapy in Patients With Newly Diagnosed Cancer of the Mouth or Throat November 2001 April 2006
NCT00238615 Terminated Phase 2 Phase II Docetaxel / Carboplatin / XRT + Surgical Resection in Stage III NSCLC March 2003 November 2014
NCT00006916 Terminated Phase 2 Radiation Therapy Followed by Bleomycin in Treating Adult Patients With Newly Diagnosed Supratentorial Glioblastoma Multiforme June 2001 December 2005
NCT00243009 Terminated Phase 2 Fludarabine and Total-Body Irradiation in Treating Patients Who Are Undergoing a Donor Stem Cell Transplant for Metastatic Kidney Cancer That Cannot Be Removed By Surgery June 2005 April 2006
NCT00006472 Terminated Phase 2 Combination Chemotherapy Plus Radiation Therapy Followed By Surgery in Treating Patients With Stage I, Stage II, or Stage III Esophageal Cancer January 2000 September 10, 2002
NCT00253552 Terminated N/A G-CSF-Treated Donor Bone Marrow Transplant in Treating Patients With Hematologic Disorders May 2004 May 2006
NCT00255684 Terminated N/A Fludarabine, Cyclophosphamide, and Total-Body Irradiation Followed by Cyclosporine and Mycophenolate Mofetil in Treating Patients Who Are Undergoing a Donor Umbilical Cord Blood Transplant for Hematologic Cancer December 2003 June 2016
NCT00262951 Terminated Phase 2 Chemoradiation in Locally Advanced Pancreatic Cancer January 2005 August 2011
NCT02911922 Terminated N/A Randomized Trial of Image -Guided Stereotactic Radiation Therapy (IG-SRT) in Prostate Cancer September 2016 April 17, 2018
NCT00268372 Terminated Phase 3 S0427, Combination Chemotherapy & RT in Treating Patients With Stage III or Stage IV Cancer of the Oropharynx December 2005 December 2007
NCT00268437 Terminated Phase 2 Radiation Therapy, Pemetrexed Disodium, and Carboplatin in Treating Patients With Locally Advanced Esophageal Cancer That Can Be Removed By Surgery April 2006 March 2015
NCT02934503 Terminated Phase 2 Study of Pembrolizumab and Chemotherapy With or Without Radiation in Small Cell Lung Cancer (SCLC) January 23, 2017 October 1, 2019
NCT00275106 Terminated Phase 3 Prednisolone or Dexamethasone Combined With Chemotherapy in Treating Young Patients With Newly Diagnosed Lymphoblastic Lymphoma September 2004 August 2012
NCT00280748 Terminated Phase 2 Whole-Brain Radiation Therapy and Pemetrexed in Treating Patients With Brain Metastases From Non-Small Cell Lung Cancer May 2005 April 2009
NCT00281879 Terminated Phase 2 Donor Stem Cell Transplant or Donor White Blood Cell Infusions in Treating Patients With Hematologic Cancer February 2006 March 2008
NCT00288054 Terminated Phase 1 S0429: Docetaxel, Cetuximab, and Radiation Therapy in Treating Patients With Stage III Non-Small Cell Lung Cancer April 2006 April 2012
NCT00290628 Terminated N/A Donor Umbilical Cord Blood Transplant in Treating Patients With Hematologic Cancer October 1999 April 2007
NCT00290719 Terminated Phase 1 Gefitinib, Cisplatin, Irinotecan, and Radiation Therapy Before Surgery in Treating Patients With Esophageal Cancer or Gastroesophageal Junction Cancer That Can Be Removed By Surgery November 2005 June 2008
NCT00296010 Terminated Phase 3 Liposomal Doxorubicin Compared With Observation or Cyclophosphamide and Methotrexate in Treating Older Women Who Have Undergone Surgery for Breast Cancer August 2005 December 2011
NCT03168464 Terminated Phase 1/Phase 2 Radiation and Immune Checkpoints Blockade in Metastatic NSCLC (BMS # CA209-632) October 9, 2017 March 11, 2022
NCT00006096 Terminated Phase 3 Radiation Therapy With or Without Cisplatin in Treating Patients With Stage I, Stage II, or Stage III Cancer of the Vulva March 2001
NCT00305643 Terminated Phase 3 Celecoxib in Preventing Hand/Foot Syndrome Caused By Capecitabine With Metastatic Breast or Colorectal Cancer February 2006 October 2008
NCT00005987 Terminated Phase 2 Filgrastim Compared With Sargramostim Plus Chemotherapy, Peripheral Stem Cell Transplantation, and Interferon Alfa in Treating Patients With Multiple Myeloma August 2000 July 2003
NCT03246113 Terminated Phase 1 Tolerability of Cannabis in Patients Receiving Concurrent Chemoradiation for Glioblastoma March 19, 2018 May 9, 2019
NCT03250299 Terminated Phase 1 Microtubule-Targeted Agent BAL101553 and Radiation Therapy in Treating Patients With Newly Diagnosed Glioblastoma June 7, 2017 August 24, 2022
NCT00005986 Terminated Phase 2 Chemotherapy, Filgrastim and Peripheral Stem Cell Transplantation in Patients With Chronic Myelogenous Leukemia August 2000
NCT03277482 Terminated Phase 1 Durvalumab, Tremelimumab + Radiotherapy in Gynecologic Cancer June 1, 2018 July 15, 2022
NCT00005984 Terminated Phase 2 Cyclophosphamide and Filgrastim Followed By SCT in Patients With Chronic or Accelerated Phase Myelogenous Leukemia August 2000 September 2005
NCT03300544 Terminated Phase 1 Talimogene Laherparepvec, Chemotherapy, and Radiation Therapy Before Surgery in Treating Patients With Locally Advanced or Metastatic Rectal Cancer May 14, 2019 March 22, 2022
NCT00334763 Terminated Phase 2 Radiation Therapy, Chemotherapy, and Bevacizumab in Treating Patients With Recurrent, Unresectable or Stage III or Stage IV Non-Small Cell Lung Cancer May 2006 November 2007
NCT00005983 Terminated Phase 3 S9927 Radiation Therapy After Surgery, Chemotherapy, and/or Hormone Therapy in Stage II Breast Cancer June 2000 March 2005
NCT00005641 Terminated Phase 2 Removal of T Cells to Prevent Graft-Versus-Host Disease in Patients Undergoing Bone Marrow Transplantation September 1997 September 2000
NCT00335959 Terminated Phase 2 S0425 Oxaliplatin, Capecitabine, and RT in Treating Patients W/Stomach Cancer That Can Be Removed By Surgery May 2006
NCT00348816 Terminated Phase 2 Docetaxel, Radiation Therapy, and Prednisone in Treating Patients Who Have Undergone Surgery For Prostate Cancer May 2006 July 8, 2016
NCT00352118 Terminated Phase 2 Combination Chemotherapy and Radiation Therapy in Treating Patients With Locally Advanced Head and Neck Cancer March 2006 April 2008
NCT00004897 Terminated Phase 2 Combination Chemotherapy and Interferon Alfa Followed by Surgery and/or Radiation Therapy in Treating Patients With Stage I, Stage II, or Stage III Esophageal Cancer October 1999 November 2007
NCT00356941 Terminated Phase 1 Oxaliplatin, Docetaxel, and Radiation Therapy in Treating Patients With Unresectable Stage II/III or Recurrent NSCLC April 2006 May 2007
NCT00360971 Terminated Phase 3 Palifermin in Lessening Oral Mucositis in Patients Undergoing Radiation Therapy and Chemotherapy for Locally Advanced Head and Neck Cancer July 2006 February 2009
NCT00361621 Terminated Phase 2 Ph II CHOP+Velcade in Mediastinal LBCL July 2006 May 2008
NCT00004859 Terminated Phase 3 Carboplatin, Paclitaxel, and Radiation Therapy With or Without Thalidomide in Patients With Stage III Non-small Cell Lung Cancer January 2000 March 2010
NCT00004227 Terminated Phase 3 Radiation Therapy With or Without Cetuximab in Treating Patients With Stage III or Stage IV Cancer of the Oropharynx, Hypopharynx, or Larynx April 1999 May 2008
NCT00388804 Terminated Phase 3 External Beam Radiation Therapy (EBRT) With or Without Hormonal Therapy in Prostate Cancer February 2005 April 2011
NCT00077103 Terminated Phase 1/Phase 2 Induction Chemotherapy Using Doxorubicin and Cisplatin Followed by Combretastatin A4 Phosphate and Radiation Therapy in Treating Patients With Newly Diagnosed Regionally Advanced Anaplastic Thyroid Cancer November 2003 December 2007
NCT03486197 Terminated Phase 2 Neutron Radiation Therapy and Pembrolizumab in Treating Participants With Advanced Urothelial Carcinoma January 17, 2019 May 1, 2024
NCT03490760 Terminated Phase 2 Durvalumab and "Booster" Radiation in Metastatic Adenocarcinoma of the Pancreas November 9, 2018 July 9, 2020
NCT00004093 Terminated Phase 1/Phase 2 Combination Chemotherapy Plus Radiation Therapy in Treating Patients With Stage III Non-small Cell Lung Cancer August 1999 March 2002
NCT00003803 Terminated Phase 3 Chemotherapy Plus Radiation Therapy in Treating Patients With Stage I, Stage II, or Stage III Non-small Cell Lung Cancer That Cannot Be Surgically Removed February 1999
NCT00469937 Terminated Phase 1 Ph I Study of Lithium During Whole Brain Radiotherapy For Patients With Brain Metastases February 2006 March 2009
NCT00471653 Terminated Pharmacokinetics in Patients With Newly Diagnosed High-Grade Glioma Receiving Temozolomide and Radiation Therapy November 11, 2006 August 18, 2009
NCT00068770 Terminated Phase 2 Celecoxib in Patients With Newly Diagnosed GBM Who Are Receiving Anticonvulsant Drugs and Undergoing RT October 2003 May 2006
NCT00493025 Terminated Phase 2 Paclitaxel, Cisplatin, Gefitinib, and Radiation Therapy Followed by Surgery and Gefitinib in Treating Patients With Locally Advanced Cancer of the Esophagus or Gastroesophageal Junction That Can Be Removed By Surgery April 2005 March 2013
NCT03634800 Terminated Phase 2 Radiotherapy With Immunotherapy for Systemic Effect in Myeloma (RISE-M) October 23, 2018 January 16, 2020
NCT03649841 Terminated Phase 2 Antiandrogen Therapy, Abiraterone Acetate, and Prednisone With or Without Neutron Radiation Therapy in Treating Patients With Prostate Cancer June 29, 2020 February 1, 2023
NCT03655080 Terminated Phase 2 Pulsed Abraxane and Radiotherapy for Improving and Maintaining Ambulation After Cancer-Related Cord Compression January 9, 2019 June 15, 2021
NCT00500890 Terminated Phase 3 Treatment of Tumors of the Choroid Plexus Epithelium September 2, 2005 December 14, 2017
NCT00068744 Terminated Phase 2/Phase 3 Radiation Therapy, Mitomycin, and Either Fluorouracil or Cisplatin in Treating Patients With Locally Advanced Anal Cancer July 2003
NCT00003777 Terminated Phase 2 Surgery, Radiation Therapy, and Combination Chemotherapy in Treating Patients With Recurrent Head and Neck Cancer December 1998 April 20, 2001
NCT00526890 Terminated Phase 2 Carboplatin, Paclitaxel, Selenomethionine, and Radiation Therapy in Treating Patients With Stage III Non-Small Cell Lung Cancer That Cannot Be Removed by Surgery October 2006 September 2010
NCT00530634 Terminated Phase 2 Surgery, Gemcitabine, Cisplatin, and Radiation Therapy in Treating Patients With Stage II or Stage III Non-Small Cell Lung Cancer August 1999 June 2013
NCT00540969 Terminated Phase 3 Cryoablation or External-Beam Radiation Therapy in Treating Patients With Painful Bone Metastases February 2008 January 2010
NCT03705351 Terminated Phase 1 Tumor Treating Fields With Chemoradiation in Newly Diagnosed GBM December 2, 2019 February 24, 2022
NCT00541112 Terminated Phase 2 Radiation Therapy, Chemotherapy, and Cetuximab Followed by Surgery, Chemotherapy, and Cetuximab in Treating Patients With Locally Advanced or Metastatic Rectal Cancer That Can Be Removed by Surgery October 29, 2007 January 29, 2010
NCT00543335 Terminated Phase 1 Sorafenib and Thoracic Radiation for Patients With Non-Small Cell Lung Cancer January 25, 2008 January 2011
NCT00068666 Terminated Phase 2 Temozolomide and Radiation Therapy in Treating Patients With Stage IV Malignant Melanoma With Measurable and Unresectable Cancer of the Central Nervous System January 2004 March 2010
NCT00544648 Terminated Phase 1/Phase 2 Ph I/II Nab-Paclitaxel & Carboplatin w/Concurrent Radiation Therapy for Unresectable Stg III NSCLC November 2007 April 2014
NCT00544778 Terminated Phase 2 Combination Chemotherapy and Dexrazoxane Followed by Surgery and Radiation Therapy in Treating Patients With Advanced Soft Tissue Sarcoma or Recurrent Bone Sarcoma August 2001
NCT00066417 Terminated Phase 2 Peripheral Stem Cell Transplant in Treating Patients With High-Risk Leukemia January 2007
NCT00003642 Terminated Phase 2 Radiation Therapy and Chemotherapy Following Surgery in Treating Patients With Stage II or Stage III Bladder Cancer October 1998
NCT00570531 Terminated Phase 2 Phase II Trial for Patients With Loco-Regional Esophageal Carcinoma June 2007 June 2013
NCT00573131 Terminated Phase 2 Efficacy and Safety of OncoGel™ Added to Chemotherapy and Radiation Before Surgery in Subjects With Esophageal Cancer January 2008 November 2010
NCT00003640 Terminated Phase 2 Transurethral Resection and Combination Chemotherapy in Treating Patients With Stage II or Stage III Bladder Cancer September 1998
NCT00603408 Terminated Phase 2 Effect of Chemotherapy and Radiation Prior to Surgery for Triple Negative Breast Cancer December 2007 December 2009
NCT00618917 Terminated Phase 1/Phase 2 MnSOD (Esophageal Protectant) to Prevent Esophagitis During Radiation/Chemotherapy Treatment for Non-Small Cell Lung Cancer (NSCLC) November 11, 2005 August 11, 2011
NCT00625183 Terminated Phase 2 Capecitabine, Oxaliplatin, Selenomethionine, and Radiation Therapy in Treating Patients Undergoing Surgery For Newly Diagnosed Stage II or III Rectal Adenocarcinoma March 2008 December 2009
NCT00062335 Terminated Phase 1 High-Dose 3-Dimensional Conformal Radiation Therapy in Treating Patients With Inoperable Stage I, Stage II, or Stage IIIA Non-Small Cell Lung Cancer April 2003
NCT00651326 Terminated Phase 3 Androgen Suppression and Radiation With/Out Docetaxel in High-Risk Localized Prostate Cancer June 2, 2008 January 18, 2011
NCT00662311 Terminated Phase 1/Phase 2 Vorinostat, Paclitaxel, and Radiation Therapy in Treating Patients Unable to Tolerate Cisplatin With Stage III Non-Small Lung Cancer That Cannot Be Removed By Surgery March 2008 September 2011
NCT00664105 Terminated Phase 2 Ph II Concurrent Chemo t/Docetaxel/Carboplatin/Radio Therapy-consolidation t/Locally Adv Inoperable Non-Small Cell Lung Cancer (NSCLC) February 2004 June 2008
NCT03988647 Terminated Phase 2 Palliative RT & Anti-PD-1/PD-L1 Checkpoint Blockade in Metastatic Merkel Cell Carcinoma July 24, 2019 January 20, 2021
NCT00707161 Terminated Phase 2 Radiation Therapy and Concurrent Cisplatin Chemotherapy for Locally Advanced or Metastatic Malignant Melanoma September 2005 February 2010
NCT00060385 Terminated Phase 2/Phase 3 Combination Chemotherapy With or Without Etoposide in Treating Older Patients With Non-Hodgkin's Lymphoma March 2003
NCT00720083 Terminated Phase 2 Chemotherapy and Radiation Therapy (RT) With or Without Vandetanib in Treating Patients With High-Risk Stage III or Stage IV Head and Neck Cancer November 2008 August 2011
NCT00732303 Terminated Phase 2 Pemetrexed and Radiation for Poor-Risk Stage III Non-Small Cell Lung Cancer January 2009 December 2010
NCT04106362 Terminated Phase 2 Radiation Therapy and Cisplatin With or Without Cetuximab in Treating Patients With HPV Positive, KRAS-Variant Stage III-IV Oropharyngeal Squamous Cell Carcinoma January 14, 2020 May 23, 2023
NCT00745134 Terminated Phase 2 Radiation Therapy and Capecitabine With or Without Curcumin Before Surgery in Treating Patients With Rectal Cancer August 11, 2008 November 11, 2022
NCT00745732 Terminated Phase 1 Radiation Therapy (XRT) and ZD6474 in Non-Small Cell Lung Cancer (NSCLC) October 9, 2008 September 2012
NCT00766636 Terminated Phase 2 Preoperative Chemotherapy (Gemcitabine and Erlotinib) With or Without Radiation Therapy September 2008
NCT00776100 Terminated Phase 2 Radiation Therapy or Observation After Chemotherapy in Treating Patients With Stage IV Non-Small Cell Lung Cancer October 2008 September 2010
NCT00788125 Terminated Phase 1/Phase 2 Dasatinib, Ifosfamide, Carboplatin, and Etoposide in Treating Young Patients With Metastatic or Recurrent Malignant Solid Tumors September 3, 2008 July 30, 2022
NCT00003152 Terminated Phase 3 Chemotherapy Plus Interferon Alfa Alone or With Radiation Therapy and Peripheral Stem Cell Transplantation in Treating Patients With Stage III or Stage IV Follicular Non-Hodgkin's Lymphoma March 1997
NCT04199754 Terminated Early Phase 1 IV Contrast-Enhanced Cone Beam Computed Tomography (CBCT) in Radiotherapy October 1, 2020 May 28, 2021
NCT00003113 Terminated Phase 2 Oral Combination Chemotherapy in Treating Elderly Patients With Intermediate or High-Grade Non-Hodgkin's Lymphomas July 1997 December 2002
NCT00808899 Terminated Phase 2 Neuroblastoma Protocol 2008: Therapy for Children With Advanced Stage High Risk Neuroblastoma December 2008 July 2009
NCT00025103 Unknown status Phase 2 Chemotherapy Followed by Surgery and Radiation Therapy With or Without Stem Cell Transplant in Treating Patients With Relapsed or Refractory Wilms' Tumor or Clear Cell Sarcoma of the Kidney May 2001
NCT01857453 Unknown status Phase 2 Interest of a Dose Decrease for Radiotherapy Associated With Chemotherapy for Treatment of Standard Risk Adult Medulloblastomas April 10, 2013 December 2021
NCT01503905 Unknown status N/A Neoadjuvant Chemotherapy for Operable Premenopausal Breast Cancer Patients December 2011 December 2021
NCT00003815 Unknown status Phase 3 Chemotherapy and Radiation Therapy Plus Bone Marrow Transplantation in Treating Patients With Aggressive Non-Hodgkin's Lymphoma June 1994
NCT03553238 Unknown status Phase 2/Phase 3 Precision Diagnosis Directing HDACi Chidamide Target Therapy for Adult ETP-ALL February 14, 2016 August 30, 2020
NCT03564704 Unknown status Phase 2/Phase 3 Precision Diagnosis Directing HDACi Chidamide Target Therapy for Adult T-LBL/ALL February 14, 2016 May 30, 2021
NCT00986557 Unknown status Phase 2 T-Lymphocyte Infusion or Standard Therapy in Treating Patients at Risk of Cytomegalovirus Infection After a Donor Stem Cell Transplant September 2009
NCT00462397 Unknown status Phase 2 Paclitaxel and Carboplatin Followed by Cisplatin and Radiation Therapy in Treating Patients With Stage IB, Stage II, Stage III, or Stage IVA Cervical Cancer June 2005
NCT00875355 Unknown status Phase 2 Radiation Therapy With or Without Temozolomide in Treating Women With Brain Metastases and Breast Cancer November 2007
NCT01461746 Unknown status Phase 2 Efficacy Study of Chemotherapy Followed by Radiation Therapy to Treat Endometrial Cancer October 2011 December 2017
NCT00002858 Unknown status Phase 3 Combination Chemotherapy Plus Radiation Therapy in Treating Patients With Small Cell Lung Cancer March 1993
NCT00492687 Unknown status Phase 2 Radiation Therapy, Temozolomide, Tamoxifen, and Carboplatin in Treating Patients With Malignant Gliomas December 2006
NCT00002884 Unknown status Phase 3 Chemotherapy and Radiation Therapy in Treating Patients With Cancer of the Esophagus March 1996
NCT00497250 Unknown status Phase 1 Phase I Study of Iressa and CRT/IMRT in Chinese Patients With IIIB/IV NSCLC After Failure of Platinum-Based Chemotherapy July 2007 October 2009
NCT00003163 Unknown status Phase 2 Peripheral Stem Cell Transplantation in Treating Patients With Multiple Myeloma or Other B-cell Cancers September 1997
NCT00766480 Unknown status N/A Study of Tissue Samples in Predicting How Well Chemotherapy and Radiation Therapy Will Kill Cancer Cells in Patients With Squamous Cell Carcinoma of the Esophagus January 2007
NCT00003284 Unknown status Phase 2 High-Dose Combination Chemotherapy Followed by Peripheral Stem Cell Transplantation in Treating Patients With Lung Cancer January 1998
NCT00509561 Unknown status Phase 2/Phase 3 Cisplatin, Capecitabine, and Radiation Therapy With or Without Cetuximab in Treating Patients With Esophageal Cancer February 2008
NCT00514397 Unknown status Phase 2 Temozolomide and Radiation Therapy in Treating Young Patients With Pontine Glioma January 2008
NCT00003788 Unknown status Phase 3 Surgery, Radiation Therapy, and Chemotherapy With or Without Photodynamic Therapy in Treating Patients With Newly Diagnosed or Recurrent Malignant Supratentorial Gliomas April 1998
NCT00003261 Unknown status Phase 2 Chemotherapy and Radiation Therapy in Treating Patients With HIV-Related Primary Central Nervous System Lymphoma May 1997
NCT00526318 Unknown status N/A Combination Chemotherapy Followed by Stem Cell Transplant and Isotretinoin in Treating Young Patients With High-Risk Neuroblastoma January 2007
NCT00154440 Unknown status Phase 3 Helicobacter - Lymphoma - Radiation Part I: Eradication, Part II: Radiation November 2001 October 2013
NCT00967655 Unknown status Phase 2 Capecitabine, Panitumumab, and Radiation Therapy With or Without Irinotecan Hydrochloride in Treating Patients Undergoing Surgery for Localized Rectal Cancer July 2009
NCT01402180 Unknown status Phase 2/Phase 3 Chemoradiation With or Without Nimotuzumab in Treating Esophageal Cancer Patients Who Suffer With Recurrence in Regional Lymph Nodes After Esophagectomy December 2010 December 2015
NCT02464774 Unknown status N/A Breast-Conserving Therapy in Patients With Triple-Negative Breast Cancer July 2015
NCT00020566 Unknown status Phase 3 Combination Chemotherapy With or Without Peripheral Stem Cell Transplantation, Radiation Therapy, and/or Surgery in Treating Patients With Ewing's Sarcoma February 2001
NCT00002531 Unknown status Phase 2 Combination Chemotherapy in Treating Adults With Acute Lymphocytic Leukemia January 1993
NCT00016887 Unknown status Phase 3 Chemotherapy Followed by Radiation Therapy and Peripheral Stem Cell Transplant Compared With Chemotherapy Plus Interferon Alfa in Treating Patients With Stage III or Stage IV Mantle Cell Lymphoma December 2000
NCT02500940 Unknown status Phase 3 Comparison the Effects of Different Neoadjuvant Chemotherapy Regimen on Acute Toxicity, Tumor Response, and Survival in Patients With Advanced Nasopharyngeal Carcinoma May 2015 May 2021
NCT00188149 Unknown status Phase 4 Optimization of the Primary Therapy for Patients With Hodgkin's Disease and Evaluation of PET May 2000 December 2007
NCT00966888 Unknown status Phase 3 Radiation Therapy or Standard Therapy in Treating Women With Stage II Breast Cancer Who Have Undergone Mastectomy January 2006
NCT00002499 Unknown status Phase 2/Phase 3 Combination Chemotherapy in Treating Children With Relapsed Acute Lymphocytic Leukemia January 1990
NCT00536952 Unknown status Early Phase 1 Pilot Study of Pulmozyme (rhDNase) in Patients With Head and Neck Cancers Treated With Radiation Therapy + Chemotherapy February 2008 December 2016
NCT00814567 Unknown status N/A Radiation Therapy in Women With Low Risk Early-Stage Breast Cancer Who Have Undergone Breast Conservation Surgery May 3, 2007 September 2020
NCT00003251 Unknown status Phase 1/Phase 2 Amifostine Plus Chemotherapy and Radiation Therapy in Treating Patients With Advanced, Unresectable Head and Neck Cancer December 1997
NCT00768911 Unknown status Phase 1 CT-322 in Combination With Radiation Therapy and Temozolomide to Treat Newly Diagnosed Glioblastoma Multiforme October 2008 June 2011
NCT00011921 Unknown status Phase 3 Chemotherapy Followed by Peripheral Stem Cell or Bone Marrow Transplant Compared With Chemotherapy Alone in Treating Patients With Small Cell Lung Cancer September 1997
NCT00058474 Unknown status Phase 3 Radiation Therapy and Either Capecitabine or Fluorouracil With or Without Oxaliplatin Before Surgery in Treating Patients With Resectable Rectal Cancer July 2004 May 2016
NCT00010088 Unknown status Phase 2 Chemotherapy in Treating Patients With Locally Advanced or Metastatic Cancer of the Pancreas or Bile Duct January 1999
NCT00010062 Unknown status Phase 2 Fluorouracil Plus Radiation Therapy Following Surgery in Treating Patients With Pancreatic Cancer October 2000
NCT00008112 Unknown status Phase 2 Cisplatin Combined With Radiation Therapy and Hyperthermia in Treating Patients With Stage II, Stage III, or Stage IV Cervical Cancer June 2000
NCT00008047 Unknown status Phase 1/Phase 2 Combination Chemotherapy Combined With Radiation Therapy in Treating Patients Who Have Stage II or Stage III Cancer of the Esophagus August 1999
NCT00003734 Unknown status Phase 3 Combination Hormone Therapy Followed by Radiation Therapy in Treating Patients With Prostate Cancer December 1998
NCT00003680 Unknown status Phase 3 Standard Chemotherapy Compared With High-Dose Chemotherapy Plus Peripheral Stem Cell Transplant in Treating Women With Advanced or Inflammatory Breast Cancer November 1998
NCT00003240 Unknown status Phase 3 Standard Therapy Given With or Without Combination Chemotherapy in Treating Patients With Non-small Cell Lung Cancer October 1995
NCT00053872 Unknown status Phase 3 Radiation Therapy Plus Combination Chemotherapy in Treating Children With Medulloblastoma February 2003
NCT00024271 Unknown status Phase 2 Surgery, Chemotherapy, and Radiation Therapy in Treating Patients With Peritoneal Cancer May 2001
NCT00245141 Unknown status Phase 2 Vincristine, Dactinomycin, and Cyclophosphamide With or Without Radiation Therapy in Treating Patients With Embryonal Rhabdomyosarcoma May 2004
NCT00024336 Unknown status Phase 2 Radiation Therapy and Tamoxifen in Treating Children With Newly Diagnosed Brain Stem Glioma August 1999
NCT00253409 Unknown status N/A Combination Chemotherapy With or Without Surgery and Radiation Therapy in Treating Patients With Mesothelioma That Can Be Removed By Surgery May 2005
NCT00025064 Unknown status Phase 2 Combination Chemotherapy With or Without Radiation Therapy and Peripheral Stem Cell Transplant in Treating Children With Hodgkin's Lymphoma January 2000
NCT02839343 Unknown status Phase 2 Combination Chemotherapy With or Without Hypofractionated Radiation Therapy Before Surgery in Treating Patients With Pancreatic Cancer December 2016
NCT00006460 Unknown status Phase 1/Phase 2 Radiation Therapy Plus Hyperbaric Oxygen in Treating Patients With Newly Diagnosed Glioblastoma Multiforme August 2000
NCT02891161 Unknown status Phase 1/Phase 2 Durvalumab And Radiation Therapy Followed by Adjuvant Durvalumab in Patients With Urothelial Cancer (T2-4 N0-2 M0) of the Bladder November 2016 March 2022
NCT00093665 Unknown status Phase 2 Fluorouracil, Cisplatin, and Radiation Therapy in Treating Patients With Stage II, Stage III, or Stage IV Nasopharyngeal Cancer November 2003
NCT04602013 Unknown status Phase 2 Sintilimab Injection Combined With Concurrent CCRT in Locally Advanced Esophageal Squamous Cell Carcinoma October 11, 2020 May 2022
NCT00093587 Unknown status N/A Antithymocyte Globulin and Cyclosporine in Preventing Graft-Versus-Host Disease in Patients Undergoing Chemotherapy With or Without Radiation Therapy Followed By Donor Stem Cell Transplant for Acute Lymphoblastic Leukemia or Acute Myeloid Leukemia August 2004
NCT00002549 Unknown status Phase 3 Combination Chemotherapy Followed by Bone Marrow or Peripheral Stem Cell Transplantation in Treating Patients With Acute Myelogenous Leukemia November 1993
NCT00003679 Unknown status Phase 3 Combination Chemotherapy in Treating Women With Breast Cancer November 1998
NCT02052102 Unknown status Phase 2 Study to See Whether Breath-Hold Techniques During RT Are Effective in Helping to Improve Sparing of the Heart October 2014 March 2017
NCT02928575 Unknown status Phase 2 Combining Sunitinib, Temozolomide and Radiation to Treat Patients Diagnosed With Glioblastoma August 2012 June 2017
NCT00274898 Unknown status Phase 2 Celecoxib or Observation After Radiation Therapy and Chemotherapy in Treating Patients With Stage II or Stage III Non-Small Cell Lung Cancer May 2004
NCT00274911 Unknown status Phase 2 Radiation Therapy Followed By Combination Chemotherapy in Treating Young Patients With Supratentorial Primitive Neuroectodermal Tumors February 2004
NCT00558519 Unknown status Phase 2 Combination Chemotherapy in Treating Young Patients With Newly Diagnosed Acute Lymphoblastic Leukemia March 12, 2008
NCT00006212 Unknown status Phase 1 Phosphorus-32 Plus Radiation Therapy and Chemotherapy in Treating Patients With Stage II or Stage III Non-small Cell Lung Cancer November 1999
NCT00275067 Unknown status Phase 1/Phase 2 Arsenic Trioxide, Temozolomide, and Radiation Therapy in Treating Patients With Malignant Glioma That Has Been Removed By Surgery May 2005 May 2021
NCT01252459 Unknown status Phase 2 Amino-acid PET Versus MRI Guided Re-irradiation in Patients With Recurrent Glioblastoma Multiforme July 2011 July 2014
NCT00275119 Unknown status Phase 2 Gemcitabine and Oxaliplatin Followed By Radiation Therapy, Fluorouracil, and Oxaliplatin in Treating Patients With Locally Advanced Pancreatic Cancer That Cannot Be Removed By Surgery November 2003
NCT00276666 Unknown status Phase 2 Radiation Therapy and Combination Chemotherapy in Treating Young Patients With Metastatic Medulloblastoma Who Have Undergone Surgery November 2001
NCT00276731 Unknown status Phase 3 Combination Chemotherapy Followed By Surgery With or Without Radiation Therapy in Treating Young Patients With Stage II or Stage III Neuroblastoma March 1995
NCT00083083 Unknown status Phase 2 Fludeoxyglucose F18 Positron Emission Tomography Imaging In Assessing Patients Before and After Treatment for Locally Advanced Non-Small Cell Lung Cancer March 2005
NCT02972333 Unknown status Phase 3 Open Label, Prospective Study to Investigate Efficacy and Safety of AZD9291 in BM From NSCLC Patients With EGFR T790M December 2016 December 2019
NCT00025324 Unknown status Phase 2 Chemotherapy, Surgery, Radiation Therapy and Bone Marrow or Peripheral Stem Cell Transplantation in Treating Patients With Primary CNS Germ Cell Tumors December 2000
NCT00025402 Unknown status Phase 3 Chemotherapy and Biological Therapy With or Without Bone Marrow or Peripheral Stem Cell Transplant in Treating Patients With Chronic Myelogenous Leukemia July 1997
NCT05112341 Unknown status Adjuvant Whole Breast Irradiation in Five Fractions Versus Fifteen Fractions in Early Breast Cancer June 1, 2021 October 1, 2023
NCT00281905 Unknown status Phase 2 Combination Chemotherapy With or Without Radiation Therapy in Treating Children With Brain Tumors June 1992
NCT00084695 Unknown status Phase 2 Umbilical Cord Blood for Stem Cell Transplantation in Treating Young Patients With Malignant or Nonmalignant Diseases September 2003
NCT00287950 Unknown status N/A Combination Chemotherapy, Surgery, and Radiation Therapy in Treating Infants With Neuroblastoma September 1992
NCT00002987 Unknown status Phase 3 Combination Chemotherapy Given With Radiation Therapy or Radiation Therapy Alone in Treating Patients With Early-Stage Hodgkin's Disease January 1997
NCT00002653 Unknown status Phase 3 Combination Chemotherapy With or Without Cyclophosphamide and Prednisone in Treating Older Patients With Multiple Myeloma September 1993
NCT00028691 Unknown status Phase 3 Chlorambucil Compared With Radiation Therapy in Treating Patients With Previously Untreated Stage III or Stage IV Follicular Lymphoma December 2002
NCT00030719 Unknown status Phase 3 Combination Chemotherapy With or Without Filgrastim Before Surgery, High-Dose Chemotherapy, and Radiation Therapy Followed by Isotretinoin With or Without Monoclonal Antibody in Treating Patients With Neuroblastoma December 2001
NCT00006030 Unknown status Phase 3 Comparison of Four Different Treatment Regimens in Treating Women With Stage I Breast Cancer January 1992
NCT00002701 Unknown status Phase 3 Combination Chemotherapy With or Without Bone Marrow Transplantation in Treating Patients With Acute Promyelocytic Leukemia October 1995
NCT00601406 Unknown status N/A Study of DNA Mutations in Predicting the Effect of External-Beam Radiation Therapy in Patients With Early Breast Cancer, Localized Prostate Cancer, or Gynecological Cancer March 2006
NCT00081029 Unknown status Phase 3 Parotid-Sparing Intensity-Modulated Radiation Therapy Compared With Conventional Radiation Therapy in Treating Patients With Oropharyngeal or Hypopharyngeal Cancer Who Are at High Risk of Radiation-Induced Xerostomia January 2004
NCT00311857 Unknown status Phase 1/Phase 2 Safety Study of Cetuximab, Radiotherapy and Temozolomide in Primary Glioblastoma Multiforme(GERT) February 2006
NCT00313521 Unknown status Phase 2 Thiotepa and Radiation Therapy in Treating Young Patients With Newly Diagnosed Malignant Brain Tumors June 1995
NCT00002702 Unknown status Phase 3 Surgery and Radiation Therapy With or Without Interleukin-2 in Treating Patients With Cancer of the Mouth or Oropharynx September 1992
NCT00003637 Unknown status Phase 3 Radiation Therapy Alone Compared to Radiation Therapy Plus Chemotherapy in Treating Patients With Previously Untreated Cancer of the Nasopharynx September 1998
NCT00003583 Unknown status Phase 2 Amifostine to Prevent Side Effects in Patients Who Are Receiving Chemotherapy and Radiation Therapy for Limited-Stage Small Cell Lung Cancer June 1997
NCT01752205 Unknown status Phase 3 Paclitaxel Plus Radiation With Erlotinib to Treat Esophageal Squamous Carcinoma November 2012 November 2014
NCT00033683 Unknown status Phase 2 Combination Chemotherapy in Treating Women With Resected Breast Cancer February 2001
NCT00003015 Unknown status Phase 3 Carboplatin Plus Vincristine in Treating Children and Adolescents With Low Grade Glioma January 1997
NCT00047138 Unknown status Phase 3 Chemotherapy Before and After Surgery in Treating Children With Wilm's Tumor January 2001
NCT00079365 Unknown status N/A Fluorouracil, External-Beam Radiation Therapy, and Gemcitabine With or Without Brachytherapy Using Phosphorus P32 in Treating Patients With Locally or Regionally Advanced Unresectable Adenocarcinoma of the Pancreas May 2001
NCT00334854 Unknown status Phase 3 Ifosfamide and Doxorubicin, Radiation Therapy, and/or Surgery in Treating Young Patients With Localized Soft Tissue Sarcoma March 2006
NCT00003437 Unknown status Phase 3 Hormone Therapy Plus Chemotherapy in Treating Children With Acute Lymphoblastic Leukemia January 1997
NCT04562337 Unknown status Phase 2 A Phase II Clinical Study of SHR-1316 Combined With Chemotherapy and Chest Radiotherapy in Extensive Small Cell Lung Cancer September 2020 December 2023
NCT00005084 Unknown status Phase 2 Magnetic Resonance Imaging in Treating Children With Progressive Low-Grade Astrocytoma February 1999
NCT00077220 Unknown status Phase 3 Paclitaxel, Carboplatin, and Radiation Therapy With or Without Adjuvant Paclitaxel and Carboplatin in Treating Patients With Stage II or Stage III Unresectable Non-Small Cell Lung Cancer June 2002
NCT00616785 Unknown status Phase 2 Combination Chemotherapy and Radiation Therapy in Treating Patients With Stage III Non-Small Cell Lung Cancer That Cannot Be Removed by Surgery June 2007
NCT00039039 Unknown status Phase 3 Combination Chemotherapy Followed by Radiation Therapy With or Without Paclitaxel in Treating Patients With Unresectable Stage III Non-Small Cell Lung Cancer February 2000
NCT00337064 Unknown status Phase 1/Phase 2 Partial Breast Radiation to the Lumpectomy Cavity With IMRT in Elderly Women June 2006
NCT00343369 Unknown status N/A Combination Chemotherapy in Treating Young Patients With Acute Lymphoblastic Leukemia January 2003
NCT00348998 Unknown status Phase 2 Bevacizumab, Hormone Therapy, and Radiation Therapy in Treating Patients With Locally Advanced Prostate Cancer April 2006
NCT00002989 Unknown status Phase 3 Combination Chemotherapy With or Without Idarubicin and Peripheral Stem Cell Transplantation in Treating Patients With Leukemia or Myelodysplastic Syndrome March 1997
NCT00002481 Unknown status Phase 2 Combination Chemotherapy and Radiation Therapy Plus Bone Marrow Transplantation in Treating Patients With Relapsed or Refractory Non-Hodgkin's Lymphoma March 1990
NCT01711697 Unknown status Phase 1 An Alternative Radiation Fractionation Strategy for Locally Advanced Non-Small Cell Lung Cancer (NSCLC) September 4, 2012 May 31, 2022
NCT04959500 Unknown status Phase 2 Newly Diagnosed Glioblastoma June 10, 2021 October 31, 2023
NCT00360750 Unknown status N/A Chemotherapy With or Without Radiation Therapy or Observation in Treating Young Patients With Advanced Retinoblastoma Who Have Undergone Surgery to Remove the Eye September 2005
NCT00360854 Unknown status Phase 1 Erlotinib Alone or in Combination With Radiation Therapy in Treating Young Patients With Refractory or Relapsed Malignant Brain Tumors or Newly Diagnosed Brain Stem Glioma May 2005
NCT00360945 Unknown status Phase 2 Cisplatin and Temozolomide in Treating Young Patients With Malignant Glioma April 2004
NCT00625937 Unknown status Phase 2 Docetaxel and S-1 Followed By Radiation Therapy and Low-Dose Cisplatin in Treating Patients With Stage III or Stage IV Head and Neck Cancer November 2006
NCT00626730 Unknown status Phase 2 Radiation Therapy in Treating Patients Who Have Undergone Surgery for Newly Diagnosed Grade II or Grade III Meningioma December 2007
NCT01671891 Unknown status Detection and Enumeration of Circulating Tumor Cells in Rectal Cancer February 2012 February 2013
NCT00811408 Unknown status Phase 1 Cidofovir in Treating Patients With Stage IB, Stage II, Stage III, or Stage IVA Cervical Cancer Who Are Receiving Chemotherapy and Radiation Therapy April 2008
NCT00004253 Unknown status Phase 2 Combination Chemotherapy and Radiation Therapy in Treating Patients With Stage II or Stage III Non-small Cell Lung Cancer That Cannot Be Removed By Surgery March 2000
NCT00077168 Unknown status Phase 2 Adjuvant Radiation Therapy Compared With Observation After Surgery in Treating Women With Estrogen Receptor Positive or Progesterone Receptor Positive Ductal Carcinoma In Situ of the Breast Who Are Receiving Tamoxifen or Anastrozole April 2004
NCT00379457 Unknown status Phase 3 Combination Chemotherapy in Treating Young Patients With Nonmetastatic Rhabdomyosarcoma June 2006
NCT00629278 Unknown status Phase 3 Combination Chemotherapy and Trastuzumab in Treating Women With Stage I, Stage II, or Stage III HER2-Positive Breast Cancer December 2007
NCT00383695 Unknown status Phase 2 Oxaliplatin, Capecitabine, and Radiation Therapy With or Without Cetuximab in Treating Patients Undergoing Surgery for High-Risk Rectal Cancer September 2005
NCT00004226 Unknown status Phase 1/Phase 2 Radiation Therapy Following Surgery in Treating Patients With Recurrent or Second Primary Cancer of the Head and Neck Following Previous Radiation Therapy May 2000
NCT00004219 Unknown status Phase 3 Lerisetron Compared With Granisetron in Preventing Nausea and Vomiting in Men Being Treated With Radiation Therapy for Stage I Seminoma
NCT00002771 Unknown status Phase 3 Chemotherapy, Interferon, and Bone Marrow Transplantation in Treating Patients With Chronic Myelogenous Leukemia January 1995
NCT00002658 Unknown status Phase 3 Combination Chemotherapy, Biological Therapy, and Bone Marrow Transplantation in Treating Patients With Acute Myeloid Leukemia January 1994
NCT03432780 Unknown status Phase 2 Radiation-hormone and Docetaxel VS Radiation-hormone in Patients With High-Risk Localized Prostate Cancer December 18, 2008 November 14, 2023
NCT00039338 Unknown status Phase 3 Chemotherapy Followed By Surgery Vs Radiotherapy Plus Chemotherapy in Patients With Stage IB or II Cervical Cancer March 2002
NCT00392886 Unknown status Phase 3 Combination Chemotherapy With or Without Etoposide Followed By an Autologous Stem Cell Transplant in Treating Young Patients With Previously Untreated Malignant Brain Tumors March 2004
NCT00004164 Unknown status Phase 2 Combination Chemotherapy in Treating Patients With Stage IIB, Stage III, or Stage IV Cancer of the Nasopharynx August 1999
NCT00398489 Unknown status Phase 2 Docetaxel, Epirubicin, and Cyclophosphamide With or Without Trastuzumab in Treating Women With Locally Advanced Breast Cancer That Can Be Removed By Surgery October 2006
NCT01546376 Unknown status Observational Study of Effect of Radiation Therapy to Immuno Status in HIV-cancer Patients August 2009
NCT00637637 Unknown status Phase 2 External-Beam Radiation Therapy With or Without Indinavir and Ritonavir in Treating Patients With Brain Metastases September 2007
NCT01048216 Unknown status N/A Partial Liver Radiotherapy for Unresectable Liver Metastases November 2006 June 2008
NCT00075556 Unknown status Phase 2 Neoadjuvant Radiation Therapy and Capecitabine in Treating Patients With Stage III or Stage IV Colorectal Adenocarcinoma January 2002
NCT00004128 Unknown status Phase 3 Combination Chemotherapy, Interleukin-2, and Peripheral Stem Cell Transplant in Treating Patients With Acute Myeloid Leukemia September 1999
NCT00410631 Unknown status Phase 3 Observation, Combination Chemotherapy, Radiation Therapy, and/or Autologous Stem Cell Transplant in Treating Young Patients With Neuroblastoma October 2004
NCT00416377 Unknown status N/A Radiation Therapy or Combination Chemotherapy in Treating Young Patients With Hodgkin's Lymphoma
NCT00416676 Unknown status Phase 3 Combination Chemotherapy and Surgery With or Without Radiation Therapy in Treating Patients With Stage 2 or Stage 3 Neuroblastoma
NCT00004097 Unknown status Phase 1 Combination Chemotherapy Plus Radiation Therapy in Treating Patients With Advanced and/or Recurrent Head and Neck Cancer August 1999
NCT00417014 Unknown status N/A Combination Chemotherapy and/or Radiation Therapy in Treating Young Patients With Hodgkin's Lymphoma
NCT00417053 Unknown status Phase 3 Combination Chemotherapy in Treating Infants With Newly Diagnosed Neuroblastoma Who Are Undergoing Surgery With or Without Autologous Bone Marrow or Peripheral Stem Cell Transplant
NCT00004094 Unknown status Phase 2 Combination Chemotherapy Plus Radiation Therapy in Treating Patients With Previously Untreated Advanced Cancer of the Mouth, Pharynx, or Larynx August 1999
NCT00425425 Unknown status Phase 1/Phase 2 Cetuximab, Oxaliplatin, Fluorouracil, and Radiation Therapy in Treating Patients With Stage II or Stage III Esophageal Cancer July 2006 May 2015
NCT00041210 Unknown status Phase 3 Combination Chemotherapy in Treating Patients With Previously Untreated Advanced Hodgkin's Lymphoma October 2001
NCT01005758 Unknown status Phase 2 Combination Chemotherapy in Treating Adult Patients With Newly Diagnosed Acute Lymphoblastic Leukemia January 2009
NCT03196401 Withdrawn Phase 1 A Study of Durvalumab (Anti-PDL1) Plus Radiation Therapy for the Treatment of Solitary Bone Plasmacytoma July 27, 2017 June 2020
NCT00024128 Withdrawn Phase 2 Peripheral Stem Cell Transplantation Followed By Infusion of White Blood Cells in Treating Patients With AIDS-Related Lymphoma August 2001 March 2003
NCT01843738 Withdrawn Phase 1 Radiation Use During Vemurafenib Treatment June 2017 August 2022
NCT06137651 Withdrawn Phase 1 Trotabresib in Combination With Vinorelbine and Radiation Therapy for the Treatment of HER2+ Breast Cancer With Central Nervous System or Leptomeningeal Metastasis December 31, 2023 March 27, 2024
NCT00005998 Withdrawn Phase 2 Peripheral Stem Cell Transplantation With Specially Treated Stem Cells in Treating Patients With Non-Hodgkin's Lymphoma or Hodgkin's Disease January 2000 March 2003
NCT01233479 Withdrawn N/A Biomarkers in Blood Samples From Young Patients With Newly Diagnosed Brain Tumors Undergoing Standard Radiation Therapy and Chemotherapy May 2010 August 24, 2017
NCT03220009 Withdrawn Phase 2 Nivolumab or Expectant Observation Following Ipilimumab, Nivolumab, and Surgery in Treating Patients With High Risk Localized, Locoregionally Advanced, or Recurrent Mucosal Melanoma November 3, 2017 July 1, 2021
NCT01836341 Withdrawn Phase 1 Afatinib In Combination With Cisplatin Or Carboplatin + Pemetrexed In Patients With EGFR-Mutant Lung Cancers Undergoing Definitive Chemoradiation April 2013 April 2015
NCT00600210 Withdrawn Phase 2 Neoadjuvant Bevacizumab and Carboplatin Followed by Concurrent Bevacizumab, Carboplatin and Radiotherapy in the Primary Treatment of Cervix Cancer January 2008 April 2011
NCT03235869 Withdrawn Early Phase 1 Radiation Therapy Plus Durvalumab for Tumor-Stage Cutaneous T-Cell Lymphoma March 1, 2018 March 1, 2023
NCT00310128 Withdrawn Phase 2 Combination Chemotherapy Followed by Rituximab and Yttrium Y 90 Ibritumomab Tiuxetan in Treating Patients With Relapsed or Refractory AIDS-Related Non-Hodgkin's Lymphoma February 2006
NCT02885727 Withdrawn Phase 2 Durvalumab Plus "Booster" RT for Metastatic Adenocarcinoma Pancreas Cancer Post Chemotherapy (GCC 1598) July 2017 December 2022
NCT03872505 Withdrawn Phase 2 Pre-operAtive Non-Anthracycline Chemotherapy, Durvalumab +/- RAdiation Therapy in Triple Negative Breast Cancer July 2022 July 2027
NCT00256841 Withdrawn Phase 1/Phase 2 Hypo-Hyperfractionated Chest Radiation for Non Small Cell Lung Cancer With Taxotere/Xeloda Combination Chemotherapy September 2005 October 2007
NCT01326468 Withdrawn N/A Torisel in Addition to Standard Chemotherapy With Radiation for Advanced Head and Neck Cancer January 2011
NCT00428194 Withdrawn Phase 1 Erlotinib, Cisplatin, and Radiation Therapy in Treating Patients With Stage IB-Stage IVA Cervical Cancer January 2007 March 2008
NCT05037019 Withdrawn N/A SIGNAL During a COVID-19 Pandemic May 2020 November 2022
NCT04854044 Withdrawn Phase 1 ONC201 and Radiation Therapy Before Surgery for the Treatment of Recurrent Glioblastoma May 1, 2021 July 1, 2026
NCT01796444 Withdrawn Phase 3 Axillary Lymph Node Dissection Versus no Dissection in Breast Cancer With Positive Sentinel Lymph Node January 2013 June 2026
NCT00006451 Withdrawn Phase 3 Bone Marrow Transplantation in Treating Patients With Leukemia April 1996 November 2000
NCT00084435 Withdrawn Phase 2 S0217, Adjuvant Cisplatin and Docetaxel After Complete Resection Stage III or IV Head and Neck Cancer July 2005 January 2007
NCT00003929 Withdrawn Phase 2 Chemotherapy, Filgrastim, and Radiation Therapy in Treating Patients With Primary Central Nervous System Lymphoma June 1998
NCT02535988 Withdrawn Phase 2 Abscopal Effect for Metastatic Colorectal Cancer September 2015 December 2017
NCT02044601 Withdrawn Phase 1/Phase 2 Biomarker-Integrated Approach of Targeted Therapy for Lung Cancer Elimination Plus External Beam Radiation Therapy (BATTLE-XRT) June 2014
NCT00258466 Withdrawn Phase 3 Radiation Therapy in Treating Patients With Stage I, Stage II, or Stage III Prostate Cancer May 2005 November 2006
NCT00452920 Withdrawn Phase 1/Phase 2 Docetaxel and Radiation Therapy in Treating Patients With Stage II, Stage III, or Stage IV Cervical Cancer September 2003 June 2009
NCT05711628 Withdrawn Phase 3 A Trial Comparing Chemotherapy Versus Novel Immune Checkpoint Inhibitor (Pembrolizumab) Plus Chemotherapy in Treating Relapsed/Refractory Classical Hodgkin Lymphoma August 10, 2023 June 30, 2028
NCT00334867 Withdrawn Phase 3 Combination Chemotherapy With or Without Topotecan in Treating Patients With Newly Diagnosed Localized Ewing's Sarcoma December 2005
NCT04105374 Withdrawn Phase 2/Phase 3 Testing the Addition of an Anti-cancer Viral Gene Therapy, Toca 511/Toca FC, to the Usual Treatment (Temozolomide and Radiation Therapy) for Newly Diagnosed Glioblastoma January 31, 2020 November 30, 2030
NCT02586610 Withdrawn Phase 2 Trial of Chemoradiation and Pembrolizumab in Patients With Rectal Cancer October 2016 December 2020
NCT04756505 Withdrawn Phase 1 Immunotherapy (NHS-IL12 & Bintrafusp Alfa) and Radiation Therapy for the Treatment of Hormone Receptor Positive, HER2 Negative Metastatic Breast Cancer, the REINA Trial March 7, 2021 February 16, 2022
NCT01465815 Withdrawn Phase 1/Phase 2 Phase I/II Study of Postoperative Adjuvant Chemoradiation for Advanced-Stage Cutaneous Squamous Cell Carcinoma of the Head and Neck (cSCCHN) December 2011 September 2013
NCT03758729 Withdrawn Phase 2 Phase II Study of Nivolumab in Combination With Radiation Therapy as Definitive Treatment for Patients With Locally Advanced, Unresectable Head and Neck Mucosal Melanoma. May 2020 May 11, 2020
NCT00025519 Withdrawn Phase 2 Peripheral Stem Cell Transplantation in Treating Patients With Metastatic or Recurrent Kidney Cancer June 2001 October 2006
NCT04995536 Withdrawn Phase 1 CpG-STAT3 siRNA CAS3/SS3 and Localized Radiation Therapy for the Treatment of Relapsed/Refractory B-Cell NHL July 27, 2021 January 4, 2024
NCT00006344 Withdrawn Phase 3 Radiation Therapy in Preventing Brain Metastases in Patients With Small Cell Lung Cancer May 2000 December 2000
NCT03977311 Withdrawn N/A MR-Guided High-Intensity Focused Ultrasound in Conjunction With Radiation Therapy for the Treatment of Locally Advanced Cervical Cancer December 31, 2021 February 28, 2026
NCT01087580 Withdrawn Phase 2 Docetaxel + Prednisone With or Without Radiation for Castrate Resistant Prostate Cancer March 2011 July 2011
NCT03628144 Withdrawn Phase 2 Immunonutrition to Reduce Toxicities in Non-Small Cell Lung Cancer July 2020 September 2023
NCT00006126 Withdrawn Phase 1 Peripheral Stem Cell Transplantation in Treating Patients With Melanoma or Small Cell Lung, Breast, Testicular, or Kidney Cancer That is Metastatic or That Cannot Be Treated With Surgery September 1999 April 2001
NCT01301612 Withdrawn Phase 2 Study of Nimotuzumab, Radiation Therapy and Cisplatin Versus Radiation Therapy and Cisplatin for Treatment of Stage IB e IVA UCC(CORUS) January 2011
NCT02662634 Withdrawn Phase 2 A Safety and Feasibility Study of AGS-003-LNG for the Treatment of Stage 3 Non Small Cell Lung Cancer March 2016 March 2018
NCT00621036 Withdrawn Phase 2 Vaccine Therapy and GM-CSF in Treating Patients With CNS Lymphoma October 19, 2007 December 8, 2008
NCT00002999 Withdrawn Phase 2 S9715, Chemotherapy and Radiation Therapy in Treating Patients With Advanced Cancer of the Nasopharynx
NCT00055887 Withdrawn Phase 3 Chemotherapy and Radiation Therapy With or Without Efaproxiral in Treating Patients With Stage III Non-Small Cell Lung Cancer November 2002
NCT03388931 Withdrawn Phase 4 Radiotherapy Dose Escalation in Locally Advanced Squamous Cell Carcinoma of the Larynx or Hypopharynx February 4, 2019 May 6, 2019
NCT00268255 Withdrawn Phase 1/Phase 2 Gefitinib and Radiation Therapy in Treating Patients With Inoperable Stage I or Stage II Non-Small Cell Lung Cancer
NCT00960427 Withdrawn Phase 1 Studying Biomarkers in Tumor Tissue and Blood Samples From Patients Undergoing Chemotherapy and Radiation Therapy for Stage II or Stage III Rectal Cancer That Can Be Removed By Surgery June 2009 April 2010
NCT00903942 Withdrawn Phase 2 Abraxane and RT for Non-Small Cell Lung Cancer (NSCLC) March 2008
NCT01432314 Withdrawn Phase 2 Efficacy of Radiation Therapy and Transarterial Chemoembolization (TACE) to Treat Hepatocellular Carcinoma (HCC) October 2011 June 2014
NCT00003273 Withdrawn Phase 2 Chemotherapy Followed by Peripheral Stem Cell Transplantation in Treating Children With Newly Diagnosed Brain Tumor November 1997
NCT04585932 Withdrawn Phase 2 Androgen Deprivation Therapy and Apalutamide With or Without Radiation Therapy for the Treatment of Biochemically Recurrent Prostate Cancer, RESTART Study November 24, 2020 January 8, 2021
NCT04917640 Withdrawn Registry for Accelerated Partial Breast Irradiation With (SBRT) or (IMRT) June 2021 December 2024
NCT00085449 Withdrawn Phase 1/Phase 2 Alemtuzumab Plus Fludarabine and Melphalan With or Without Cyclosporine, Mycophenolate Mofetil, and Low-Dose Total-Body Irradiation Therapy Followed by Donor Peripheral Stem Cell Transplant in Treating Patients With Hematologic Cancer May 2006 January 2007
NCT01416961 Withdrawn Phase 1 Integration of Neutron Therapy in the Treatment Plan for Stage III Non-Small Cell Lung Cancer (NSCLC) August 2011 December 2011
NCT00734773 Withdrawn Early Phase 1 Pilot Study of MGd + High-dose MTX-Based Chemoimmunotherapy + RT for Newly Dx PCNSL November 2008
NCT02976441 Withdrawn Early Phase 1 Autologous Stem Cell Collection and Reinfusion in Newly Diagnosed High Grade Gliomas January 2017 February 2018
NCT02376413 Withdrawn Oncoplastic Breast-conserving Surgery in Non-metastatic Breast Cancer Patients March 2015 December 2022
NCT00118300 Withdrawn Phase 1 Capecitabine and Radiation Therapy in Treating Patients With Locally Advanced Cervical Cancer or Other Pelvic Cancer April 2005
NCT00137358 Withdrawn Phase 1 Radiation With Chemotherapy and a Study Drug to the Para-Aortic Nodes in Cervical Cancer
NCT03419130 Withdrawn Phase 2 Radiation Therapy and Pembrolizumab in Treating Patients With Localized Urothelial Bladder Cancer July 18, 2018 December 31, 2022
NCT00019409 Withdrawn Phase 3 Radiation Therapy to the Head or Intrathecal Chemotherapy Plus High Dose Cytarabine in Preventing CNS Disease in Children With Acute Lymphoblastic Leukemia October 1999 July 2001
NCT05233696 Withdrawn Phase 2 Radiotherapy in Combo With Chemo and Immunotherapy in Patients With PD-L1 Positive Metastatic TNBC January 4, 2022 December 1, 2022
NCT00560495 Withdrawn Phase 1 Radiation Therapy and Ammonium Tetrathiomolybdate in Treating Patients With Stage I, Stage II, or Stage III Non-Small Cell Lung Cancer May 2007 July 2008
NCT03146039 Withdrawn Phase 2 Non-Invasive Cervical Cancer Radiotherapy for Stage IB-IVB June 2, 2017 May 15, 2019
NCT00003435 Withdrawn Phase 1 Antiviral Therapy Plus Either Peripheral Stem Cell or Umbilical Cord Blood Transplantation in Treating Patients Who Are HIV Positive and Have Hematologic Cancer May 1998
NCT00769990 Withdrawn Phase 1/Phase 2 Genistein in Treating Patients Undergoing External-Beam Radiation Therapy for Bone Metastases September 2008 April 2010
NCT02368106 Withdrawn Prospective Patient Registry for Radiation Oncology Techniques and Quality February 2018 December 2030
NCT03834571 Withdrawn Phase 2 Testing the Addition of Paclitaxel and Carboplatin Given After Standard Chemotherapy and Radiation for Cervical Cancer in HIV-positive Women May 31, 2022 January 2025
NCT00017160 Withdrawn Phase 2 Combination Chemotherapy, Radiation Therapy, and Surgery in Treating Patients With Primary or Recurrent Sarcoma
NCT03150836 Withdrawn Phase 2 Radiation Therapy and Durvalumab, With or Without Tremelimumab, in Patients With Bladder Cancer October 1, 2017 September 1, 2024
NCT00081055 Withdrawn Phase 2 OTI-010 for Graft-Versus-Host Disease Prophylaxis in Treating Patients Who Are Undergoing Donor Peripheral Stem Cell Transplantation for Hematologic Malignancies
NCT03488810 Withdrawn Phase 3 Apalutamide With Radiotherapy and Androgen Deprivation Therapy in Prostate Cancer March 10, 2020 June 15, 2026
NCT01345084 Withdrawn Phase 3 Study Comparing Radiation Therapy and Chemotherapy With or Without Nimotuzumab November 2013 November 2017
NCT04607642 Withdrawn Phase 2 Trial of BMX-001 or Placebo in Head and Neck Cancer Patients July 2021 July 2025
NCT00101140 Withdrawn Phase 2 Donor Stem Cell Transplant in Treating Patients With Acute Myeloid Leukemia in Remission
NCT02850419 Withdrawn Phase 2 Heat-Activated Target Therapy of Local-Regional Relapse in Breast Cancer Patients March 2017 February 2020
NCT00070434 Withdrawn Phase 2 S0304 Induct Chemo Then Chemo-RT in Pts w/Locally Advanced Adenocarcinoma of the Rectum August 2004
NCT00530205 Withdrawn Effects of Radiation Therapy on the Body in Patients With Stage III Non-Small Cell Lung Cancer February 2007
NCT00547443 Withdrawn Phase 1/Phase 2 Sorafenib and High-Dose Carboplatin, Paclitaxel, and External-Beam Radiation Therapy in Treating Patients With Stage III Non-Small Cell Lung Cancer July 2007 July 2009